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With increasing numbers of patients suffering from hypertension and conventional 
therapy beyond the reach of a wide population in developing countries, medicinal herbs 
with antihypertensive properties are increasingly sought by patients as an alternative, 
cheap and accessible source of treatment. The drawback, however, is that, very little or 
no reliable data is available on the precise mechanism (s) of action, safety and efficacy of 
these medicinal herbs. We, therefore, investigated the mechanisms of the cardiovascular 
effects of some medicinal plants used in traditional treatment of hypertension in South 
Africa. It was envisaged that if the mechanism (s) of the cardiovascular effects of these 
plants are elucidated, these plants might provide a cheap and therefore, accessible source 
of novel treatment for hypertension in poor developing populations. 
Based on ethnobotanical information, five plants namely Ekebergia capensis (Sparrm) 
[Maliaceae], Persea Americana (Mill) [Lauraceae], Helichrysum ceres (S. Moore) 
[Asteraceae], Sclerocarya birrea (A. Rich) [Anacardiaceae] and Hypoxis hemerocallidea 
(Fisch. & C.A. Mey) [Hypoxidaceae] were identified and authenticated by Prof. H. 
Baijnath of Botany discipline. Voucher specimens of the plants have been deposited at 
the Discipline of Botany herbarium, University of KwaZulu-Natal. Leaves from E. 
capensis, P. americana, H. ceres, and stem-bark from S. birrea were air-dried and ground 
into powder while fresh corms from H. hemerocallidea were peeled and crushed into 
smaller pieces before extracted using 95% ethanol, to yield five different crude ethanolic 
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extracts of E. capensis (EKE), P. americana (P AE), H. ceres (RCE), S. birrea (SBE) and 
H. hemerocallidea (APE). 
To evaluate the acute effects of the test extracts, six separate groups comprising of 
control and treated male normotensive Wi star rats (n=6) were anesthetized and placed on 
a continuous jugular infusion of hypotonic saline (0.077M NaCI) at 150llLl min. The left 
carotid artery was cannulated with polythene tubing and then connected to a pressure 
transducer for blood pressure measurements. After a 3h equilibration period, consecutive 
30 min blood pressure and heart rates measurements were recorded over the subsequent 
4h of Ih 30 min control, Ih treatment and Ih 30 min recovery periods. To assess the 
long-term effects of the test extracts, six separate groups comprising of control and 
treated male Dahl salt sensitive (DSS) rats (n=8) were used. The rats were orally treated 
with the test extracts (80 mg/kg body weight) while the control animals were 
administered the vehicle daily for six weeks. Blood pressure and heart rate were 
measured using the indirect tail-cuff method twice a week. The in vitro cardiotonic 
effects of the test extracts were examined on rat isolated spontaneously-beating right and 
electrically-driven left atria, to evaluate their effects on the rate and force of myocardial 
contractility, respectively. Their vascular effects were evaluated in rat isolated 
endothelium-intact and endothelium-deprived aortic nngs and In myogenic 
spontaneously-contracting portal veins. Responses of all the isolated preparations were 
measured using isometric force displacement transducer and Ugo-basile 'Gemini 
recorder' . 
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All the tested extracts demonstrated potent acute hypotensive effects in anaesthetized 
rats. However, only EKE and HCE exhibited potent bradycardiac effects. On the other 
hand, all the extracts showed antihypertensive and bradycardiac effects in DSS rats 
during a six week chronic experiment. All extracts except for EKE, exhibited 
concentration-dependent negative inotropic and chronotropic effects. The negative 
inotropic and chronotropic effects of HCE were mediated by activation of cholinergic 
receptors while the effects of the other extracts were mediated by non-specific 
mechanism (s). EKE, displayed a significant and concentration-dependent positive 
inotropic and chronotropic effects which involved activation of B-adrenergic receptors 
and voltage-gated calcium channels. The test extracts also exhibited significant and 
concentration-dependent vasorelaxant effects, In both endothelium-intact and 
endothelium-deprived aortic nngs. In some cases the vasorelaxant effects of the test 
extracts in intact aortic rings were shown to involve activation of endothelium-derived 
vasorelaxing factors, opening of potassium channels and blockade of calcium channels. 
In rat isolated portal veins, all test extracts except for EKE and HCE, caused an initial 
and transient increase in contraction followed by a long lasting venorelaxation. HCE 
caused significant and concentration dependent venorelaxation which was mediated by 
activation of cholinergic receptors . EKE induced tonic contractions at higher 
concentrations and this effect was shown to involve the voltage-gated calcium channels. 
The present study provides some of the possible mechanism (s) of the cardiovascular 
effects of E. capensis, P. americana, H. ceres, S. birrea and H. hemerocallidea. 
Therefore, these plants would have the potential to provide a cheap and indeed, 
accessible source of novel treatment for hypertension in poor developing populations. 
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1.0 INTRODUCTIONILITERA TURE REVIEW 
1.1 General 
Hypertension, defined as an average diastolic pressure higher than 90 rrunHg and a 
systolic pressure higher than 140 rrunHg is a common health problem in developed 
countries. Its prevalence is reported to be on the increase in populations of the developing 
world (WHO Guidelines, 1999). Human hypertension is regarded usually as a slow-
occurring disorder leading to cardiovascular complications that cause most of the 
morbidity and mortality in the elderly (Weindruch, 1995). Hypertension is a highly 
prevalent risk factor for cardiovascular disease (CVD), which affects approximately 1 
billion individuals worldwide (Pearson, Jamison, and Tergo-Gauderies, 1993). 
Epidemiological studies have revealed that hypertension affected one quarter of the world 
population in the year of the millennium and it is predicted that this proportion will 
increase dramatically over the next two decades (Kearney, Whelton, Reynolds, Muntner, 
Whelton and He, 2005; Whelton, Brancati, Appel, and Clag, 1995). 
Hypertension is important not only because of its high worldwide frequency, but also 
because it is a major modifiable risk factor for numerous cardiovascular diseases, such as 
stroke and coronary artery disease (Poulter, 2003). The most recent World Health 
Organization report highlighted the importance of blood pressure as a major 
1 
cardiovascular risk factor when it identified hypertension as a single most important 
preventable cause of premature death in developed countries (Ezzati, Vander and Lawes, 
2005). Known as 'the silent killer' it may exist for a long period of time without 
manifesting symptoms such as impairing the patient's quality of life (QOL). Symptoms 
may only show after it has caused serious irreversible pathology and complications. It 
creates marked effects on patients and the society as a whole, either because of 
hypertension per se, or through its complications that can lead to the development of 
stroke, renal dysfunction, cardiovascular diseases such as heart attack, ischaemic heart 
diseases, coronary diseases and heart failure, which can cause death or irreversible 
disability (Murray and Lopez, 1994). 
There are basically two types of hypertension classified based on their causes. It is known 
that more than 95% of hypertensive patients in the community are of essential 
hypertension (primary hypertension), sometimes called idiopathic hypertension (Sheila, 
Doggrell and Brown, 1998). This type of hypertension has no known specific cause 
though many cases are attributed to a genetic and hereditary origin. Many theories trying 
to determine a specific cause thought it might be multifactorial (Zicha and Kunes, 1999). 
This makes therapeutic intervention more difficult as it basically relies on symptomatic 
treatment. This can result in many abnormalities in the physiological regulatory systems 
for blood pressure including neurotransmitters and humoral factors with abnormalities of 
the cardiac and vascular smooth muscle and endothelium. There is a need, therefore, for 
improved integration of multidisciplinary research to clarify the pathophysiology of this 
complex and multifaceted disorder. 
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The other type of hypertension known as secondary hypertension results from underlying 
and identifiable causes and this makes therapeutic intervention a little easier. This type of 
hypertension is only found in less than 5% of hypertensive patients (Zicha and Kunes, 
1999). 
1.2 Primary hypertension 
Despite the fact that primary (essential) hypertension is one of the most prevalent 
diseases and an important risk factor for cardiovascular morbidity and mortality, the 
underlying pathophysiological abdormalities leading to the development of elevated 
arterial pressure in this disorder remain elusive (Zicha and Kunes, 1999). Indeed, there is 
no unifying hypothesis to account for the pathogenesis of primary hypertension (Zicha 
and Kunes, 1999). Studies indicate a natural progression of this disease, suggesting that 
early elevations in blood volume and cardiac output might initiate subsequent increases in 
systemic vascular resistance resulting in increased blood pressure (Sheila, Doggrell and 
Brown, 1998). Under normal conditions there is a consistent relationship that exists 
between the extracellular fluid volume and blood volume (Guyton and Hall, 1994). A 
chronic increase in sodium levels in the body due to excessive sodium retention leads to a 
chronic increase in the extracellular fluid volume, part of which is proportionately 
distributed to blood volume compartments. Increased blood volume will cause an 
increase in blood pressure either by increasing cardiac output or total peripheral 
resistance or both (Guyton and Hall, 1994). Thus, the mechanisms that regulate sodium 
balance are primarily responsible for control of blood pressure. Therefore, the long-term 
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regulation of arterial blood pressure may be intimately linked to the ability of the kidney 
to maintain normal sodium balance, extracellular fluid volume and blood volume at 
normal blood pressure. Guyton (1991) suggested that a basic underlying defect in many 
hypertensive patients is an inability of the kidneys to adequately handle sodium; thus, 
initiating the pathogenesis of most if not all cases of hypertension. On the other hand, 
when derangements in the renal function include increased levels of humoral or neural 
factors that directly induce vascular smooth muscle constriction, peripheral vascular 
resistance is increased (Navar, 1997). Therefore, decreased renal sodium excretion in the 
face of normal or increased sodium intake can lead to chronic increases in extracellular 
fluid volume which eventually leads to hypertension. In addition, activation of the renin-
angiotensin-aldosterone system causes increased sodium retention which results in 
reduced water loss into the urine. The renin-angiotensin system serves as one of the most 
powerful regulators of blood pressure and sodium balance. Angiotensin II exerts its 
actions by activating its receptors (AT1) , located on the membranes of the proximal and 
distal tubules of the nephron (Mitchell and Navar, 1995). Its vasoconstrictive actions in 
the kidney cause a decrease in blood flow and sodium excretion and this promotes tubular 
reabsorption of sodium and water. Angiotensin II also regulates secretion of aldosterone 
by the adrenal gland. Aldosterone increases sodium reabsorption in the distal tubules of 
the nephron by activating the cytoplasmic mineralocorticoid receptor (MR) (O'Neil, 
1990). Therefore, both angiotensin and aldosterone although by different mechanisms 
stimulate distal tubular sodium reabsorption and decreases sodium and water loss by the 
kidney (Guyton, Coleman, Cowley, Scheel, Manning, and Norman, 1972; Cowley, 
1992). 
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There is recent evidence for increased vascular tone in essential hypertension (Tepel and 
Zidek, 1998). This could be mediated by increased sympathetic activity or by increased 
circulating levels of angiotensin II and endothelins which enhance vasoconstriction tone 
thereby increasing total peripheral vascular resistance (Mitchell and Navar, 1995). 
Furthermore, many mechanisms may operate to initiate and sustain hypertension. 
Therefore, it is clear that essential hypertension is a multifactorial dysfunctional process 
that can be caused by a myriad of different conditions ranging from stimulatory 
influences that inappropriately enhance tubular sodium reabsorption and systemic 
vascular resistance. Thus, the underlying cause of primary hypertension is not clear and 
this prevents the adoption of methods to more effectively manage or prevent its 
development. 
Treatment of primary hypertension involves a pharmacologic intervention which 
antagonizes the effects of humoral substances like angiotensin II and calcium entry into 
cells (Mitchell and Navar, 1995). However, these treatments do not target the cause(s) of 
the underlying disease. An understanding of the normal mechanisms regulating sodium 
balance and how derangements lead to altered sodium homeostasis and hypertension may 
provide the basis for the rational approach to the treatment of essential hypertension. 
1.3 Secondary hypertension 
Secondary hypertension accounts for approximately 5-10% of all cases of hypertension 
(Zicha and Kunes, 1999). There are many known conditions that can cause secondary 
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hypertension, some of which are renal artery stenosis, chronic renal diseases, primary 
hyperaldosteronism, stress and phaeochromocytoma. 
1.3.1 Renal artery stenosis 
The narrowing of the vessel lumen as a result of renal artery diseases causes a reduction 
in pressure at the afferent arteriole in the kidney. Reduced arteriolar pressure and reduced 
renal perfusion stimulate renin release by the kidney (Tepel and Zidek, 1998). This 
increases circulating angiotensin II and aldosterone. Increased circulating levels of 
angiotensin II causes systemic vasoconstriction which increases total peripheral vascular 
resistance. Increased levels of aldosterone enhance renal reabsorption of sodium and 
water resulting in expansion of extracellular fluid volume. This causes an increase in 
blood volume with subsequent increases in cardiac output. Thus, hypertension due to 
renal artery stenosis results from both an increase in total peripheral resistance and an 
increase in cardiac output. 
1.3.2 Chronic renal diseases. 
Chronic renal diseases such as diabetic nephropathy, glomerulonephritis can damage 
nephrons in the kidney resulting in impairment of normal excretion of sodium and 
water; thus increasing the extracellular fluid volume, blood volume and hence 
workload of the heart (Tepel and Zidek, 1998). Chronic renal diseases may also cause 
increased release of renin resulting in renin-dependent form of hypertension (Mitchell 
and Navar, 1995). 
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1.3.3 Primary hyperaldosteronism 
Primary aldosteronism can be defined as overproduction of aldosterone independent of its 
normal chronic regulatory factors such as angiotensin II (Gordon, Stowasser, Tunny, 
Klemm, Rutherford, 1994). Hypertension, hypokalemia, suppressed plasma renin activity 
and increased secretion of aldosterone characterize this syndrome (Conn, 1955). It 
appears that with the current screening methods, primary aldosteronism may be the most 
common form of secondary hypertension, with its prevalence approaching 10% of all 
persons with hypertension worldwide (Stowasser, 2001; Fardella, Mosso, Gomez-
Sanchez, 2000). The most common sUbtypes of primary aldosteronism are bilateral 
idiopathic hyperaldosteronism (IRA) and unilateral aldosterone producing adenoma 
(APA) (Young, 1999). Hyperaldosteronism also can result secondarily from any state of 
increased renin, such as renal artery stenosis, which results in increased circulating 
concentrations of angiotensin II and stimulation of aldosterone release (Lifton, 1996). 
Recently, it has been demonstrated that aldosterone accelerates hypertension in animal 
models of malignant hypertension (Rizzoni, Porteri, Castellano, 1996). Some studies 
have recently reported that aldosterone inhibits nitric oxide synthesis by increasing 
oxidative stress and thereby causing endothelial dysfunction with subsequent impairment 
in vasodilation (Rizzoni, Porteri, Castellano, 1996). Thus, increased secretion of 
aldosterone may cause an elevation of blood pressure by increasing both cardiac output 




Emotional stress leads to activation of the sympathetic nervous system which causes 
increased release of noradrenaline from sympathetic nerves in the heart and blood 
vessels, leading to increased cardiac output and increased systemic vascular resistance 
(Pernini, Muller and Buhler, 1991). Activation of the sympathetic nervous system also 
increases circulating angiotensin II, aldosterone, and vasopressin, which can increase 
systemic vascular resistance contributing to a sustained increase in blood pressure 
(Mitchel and Navar, 1995). Urban hypertension is a good example of stress-induced 
hypertension. 
1.3.5 Phaeochromocytoma 
Phaeochromocytoma, a tumor usually found in the adrenal medulla releases a mixture of 
adrenaline and noradrenaline and this can lead to very high levels of circulating 
catecholamines (Bertram, 2004). High levels of circulating catecholamines may cause an 
increased sympathetic activation, which plays a role in short-term regulation of blood 
pressure (DiBona and Kopp, 1997). Catecholamines induce activation of both alpha-
adrenoceptor mediated systemic vasoconstriction and beta-adrenoceptor mediated cardiac 
stimulation. The former effect of catecholamines results in increased total peripheral 
vascular resistance and the latter in increased heart rate and myocardial contraction 
causing an increased cardiac output (Bertram, 2004) . On the other hand, the direct effects 
of increased activation of the sympathetic nervous system on the kidney function may 
result in renal sodium retention caused by decreases in glomerular filtration rate (GPR) 
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and increases in tubular reabsorption (Vari and Vavar, 1995). Taken together, these 
effects of catecholamines may contribute to significant elevations in blood pressure. 
1.4 Regulation of blood pressure 
Blood pressure is a product of the cardiac output (CO) and the total peripheral vascular 
resistance (TPR), mathematically represented by an equation: 
BP = CO x TPR 
= (Heart rate x stroke volume) x TPR 
(Vander, Sherman and Luciano, 2001) 
An imbalance in this relationship is required for any change in blood pressure to occur. 
Thus, either an increase in CO or TPR, or both factors , results in an increase in blood 
pressure. This imbalance reflects a disruption of the normal pressure natriuresis 
relationship. 
Therefore, two main concepts on the aetiology of hypertension have been posed to 
explain the key mechanisms that must become reset in order to sustain blood pressure 
changes in the long term. For one of them, an abnormally increased total peripheral 
resistance (TPR) is the key alteration in hypertension (Cowley, 1992). For the other, 
the kidney exerts a dominant control of blood pressure through the adaptation of blood 
volume by means of a pressure-sensitive, natriuresis-driven, diuretic mechanism 
(Guyton and Hall , 1994). Strong evidence supports the idea that total peripheral 
resistance (TPR) is increased in all forms of human and experimental hypertension 
(Somova, Channa and Khan, 1999). The aetiological participation of TPR in the origin 
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and long-term maintenance of hypertension has been extensively debated (Guyton and 
Hall , 1994). It now seems clear that the renal , pressure-sensitive natriuresis and 
diuresis is the main mechanism of blood pressure control in the long term (Guyton, et 
al. , 1972 and Cowley, 1992). However, regardless of the origin of hypertension, the 
actual increase in arterial blood pressure is caused by either an increase in TPR or an 
increase in (CO) or both (Vander, Sherman and Luciano, 2001). The former is 
determined by the vascular tone of systemic resistance vessels, whereas the latter is 
determined by heart rate and stroke volume. 
1.5 Regulation of cardiac and vascular smooth muscle contraction and 
relaxation 
The process of smooth and cardiac muscle contraction IS regulated principally by 
receptors and mechanical activation of the contractile proteins, myosIn and actin. A 
change in membrane potential brought on by the firing of action potential or by activation 
of stretch-dependent ion channels in the plasma membrane, can also bring about 
contraction (Mcdolnad, Pelzer, Trautwein and Pelzer, 1994). For contraction to occur, 
myosin light chain kinase (MLCK) must phosphorylate the light chain of myosin to 
enable the molecular interaction of myosin and actin. The energy released from ATP by 
myosin ATPase activity results in the cycling of the myosin cross-bridges with actin for 
contraction. Contraction of smooth muscle is initiated by calcium-mediated change in the 
thick filaments. The intracellular concentration of calcium increases in response to 
specific stimuli through the voltage-dependent L-type Ca 2+ channels (dihydropyridine 
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receptors) (Mcdolnad et aI., 1994). Agonists such as noradrenaline bind to their receptors 
which are coupled to G-protein which, activate adenylate cyclase to form cyclic 
adenosine monophosphate (cAMP) from ATP. Increased cAMP activates a cAMP-
dependent protein kinase that phosphorylates the voltage-dependent L-type Ca 2+ 
channels (dihydropyridine receptors), which cause increased calcium entry into the cells. 
The increased cytosolic calcium triggers a subsequent release of calcium from 
intracellular stores (sarcoplasmic reticulum) through calcium release channels (ryanodine 
receptors) by a process known as Ca 2+ -induced Ca 2+ release (CICR) (Fabiato, 1983). In 
cardiac muscle cells, increased cytosolic free calcium combines with an acidic protein, 
calmodulin. This complex activates myosin light chain kinase to phosphorylate the light 
chain of myosin thereby enhancing cardiac contraction (inotropy) (Mcdolnad et aI., 
1994). In vascular smooth muscle cell, these receptors are also coupled to G-protein, 
which stimulates formation of cAMP. However, unlike in cardiac myocyte, an increase in 
cAMP in vascular smooth muscle cells leads to smooth muscle relaxation (Barany, 1996). 
The reason for this is that cAMP inhibits myosin light chain kinase responsible for 
phosphorylating smooth muscle myosin. In addition to calcium-dependent activation of 
myosin light chain kinase, the state of myosin light chain phosphorylation is further 
regulated by myosin light chain phosphatase also known as myosin phosphatase, which 
removes the high-energy phosphate from the light chain of myosin to promote smooth 
muscle relaxation (Barany, 1996; Fukata, Mutsuki and Kaibuchi, 2001 ; Ridrey, 1996). 
The myosin binding subunit, when phosphorylated, inhibits the enzymatic activity of 
myosin light chain phosphatase allowing the light chain of myosin to remain 
phosphorylated, thereby promoting contraction (Mcdolnad et aI., 1994). Smooth muscle 
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relaxation occurs as a result of either removal of the contractile stimulus or by the direct 
action of a substance that stimulates inhibition of the contractile mechanism. However, 
whatever mechanism is involved, the process of relaxation requires a decreased 
intracellular calcium concentration and increased myosin light chain phosphatase activity 
(Morgan, 1990; Somlyo, Wu, Lalker and Somlyo, 1999). A decrease in the intracellular 
concentration of activator calcium elicits smooth muscle cell relaxation. 
1.6 In vitro models for the study of cardiovascular system 
1.6.1 Perfused organ system 
Perfused organ preparations such as the modified Langendorff technique and the working 
heart preparation have been used to evaluate integrative myocardial functions in vitro 
upon exposure to different drugs and toxins. The isolated heart model such as the 
Langendorff heart allows for a broad range of physiological and pharmacological studies 
to be performed, while at the same time removing confounding effects of other organ 
systems (McFaul and McGrath, 1987). The working preparation is perfused through the 
left atrium to generate a left-sided working preparation. The perfusion fluid reaching the 
ventricle is ejected via the aorta into a chamber against hydrostatic pressure to mimic 
physiological resistance to flow . Potassium arrested-hearts can also be used to examine 
flow-dependent effects in the absence of myocardial function (McFaul and McGrath, 
1987). The paced and perfused heart model led to the development of the Screenit 
system, which is a model that provides detailed information on drug-induced 
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eletrophysiological effects. In brief, the Screenit system allows for a classification of 
drugs that is based on their effects on the action potential of the heart (Valentin, 
Hoffman, De Clerck, Hammond and Hondeghem, 2004). 
Like wise, blood vessel segments from vascular beds can be isolated and processed for 
perfusion in vitro. Aortic preparations are most often preferred since tissue can be readily 
accessed for perfusion and superfusion (Crass, Hulsey and Bulkley, 1988). Use of 
perfused preparation in toxicological studies is advantageous because the level of 
structural organization is similar to that encountered in vivo, and changes in physiological 
or pharmacological sensitivity, excitability and contractility can be readily evaluated 
(Valentin et al., 2004). In the case of vascular preparations, endothelial cells can be 
eliminated to directly assess interactions between luminal and medial cells. The most 
significant limitations of perfused preparations are the small number of replicate 
preparations that can be processed at anyone time, and the short time available for 
isolation and placement of the tissue under physiological conditions. As with cardiac 
preparations, measurements of contractility, rate of tension development and stress 
development can be used to evaluate the vascular effects of drugs and chemicals. 
1.6.2 Organ culture 
Ingwall, DeLuca, Sybers and Wildenthal (1975) first described the culture of whole fetal 
hearts to study processes associated with myocardial cell injury. However, some studies 
reported variations of this technology (Tanaka, Kasuya, Saito and Shigenobu, 1987 and 
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Gotlieb and Boden, 1984). Organ culture preparations offer long term stability, and allow 
the study of cell-cell and cell-substratum interactions, as well as structural functional 
relationships of the matrix (Koo and Gottlieb, 1992). More recently, isolated frog and 
mouse hearts have been used to evaluate the toxicity of Ipomoea carnea, a poisonous 
aqueous plant (Bachlav, Burande, Rangari and Mehta, 1999). Based on the combined 
effect of atropine, calcium channel blockers and several salt solutions it was 
demonstrated that l. carnea produced positive inotropic effects due to sodium extrusion 
or release of intracellular calcium. 
1.6.3 Tissue slices. 
The use of tissue slices as an in vitro model started gaining more acceptance as improved 
methods for obtaining reliable and consistent slices were made available. Thin slice 
preparations of cardiac tissue have been developed and characterized as models to 
evaluate toxicity of xenobiotics (Gandolfi, Brondel, Fisher and Michaudi, 1995). One of 
the advantages of this system is that assessment of the toxic potential of a chemical can 
be performed after a brief term or continuous exposure with this model. This model also 
allows study of the interactions between heterogeneous cell types comprising the tissue 
being studied there by providing a controlled system for the study of toxicity and 
cardiovascular injury in vitro (Gandolfi, Brondel, Fisher and Michaudi, 1995). 
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1.6.4 Isolated muscle preparations. 
Strips of atrial, ventricles or papillary muscles (Foex, 1988), as well as strips from 
various vascular beds (Hester and Ramos, 1991), have been used to evaluate tension 
development in vitro in a bath containing oxygenated physiological solutions. Isolated 
preparations operate under constant conditions of carbon dioxide exchange, ionic 
gradients, and diffusion of by-products of cellular metabolism (Foex, 1988). In the case 
of vascular preparations, spiral strips or simple ring preparations are preferred over 
longitudinal strips to avoid alterations in the geometry of muscle fibres (Foex, 1988). 
After equilibration in a physiological solution, isolated preparations are subject to 
multiple stress/ relaxation cycles to define the length at which maximal contractility 
occurs in the response to a contractile agonist. Experiments can be conducted to evaluate 
isometric or isotonic force development, or a quick-release contraction in which the after 
load is varied during contraction (Foex, 1988). Because oxygenation of the tissue 
depends on diffusion, the thickness of the strips and the concentration of oxygen in the 
bath must be carefully monitored. Concentration-response relationships can be 
constructed for selected contractile agonists in the absence or presence of toxicant 
(Gibbs, Woolley, Kostanas and Gibson, 1984; Togna, Dolci and Caprino, 1984). These 
relationships are obtained by cumulative increases in the concentration of each agonist 
without intervening washout until attainment of maximal developed force. In the case of 
vascular preparations the effects of relaxing agents can also be evaluated. The vessel 
segment is pre-contracted to about 70-80% of the maximal contraction, and then 
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challenged with the relaxing agent. Isolated preparations can be controlled with precision, 
but their stability is limited to brief periods of time (Foex, 1988). 
Significant progress has been made in advancing the application of isolated vascular 
preparations to study vascular effects of plant extracts. Aortic rings from different strains 
of rats, guinea-pigs and rabbits are presently and widely used in vitro to evaluate the 
effects of different drugs (Hester and Ramos, 1991). The endothelium plays a greater 
role in the regulation of the vascular tone as such in vitro studies using isolated vascular 
tissues like arteries and veins has helped significantly in understanding the role of the 
endothelium both in normal and diseased conditions (Andriambeloson, Stoclet and 
Andriantsitohaina, 1999). 
1.6.5 Cell culture system 
Primary cultures can be established with relative ease from cell suspension of cardiac and 
vascular tissue. Vascular endothelial and smooth muscle cultures can also be established 
by the explant method in which pieces of tissue are placed in a culture vessel to allow for 
cellular migration and proliferation in vitro. Neonatal and embryonic cells of cardiac 
origin proliferate readily under appropriate conditions in vitro (Kasten, 1972).Vascular 
endothelial and smooth muscle cells derived from large and medium-sized vessels of 
embryonic, neonatal, or adult animals proliferate readily under appropriate conditions in 
vitro (Ramos, 1990). As such, cultures can be propagated to prepare cell strains that 
retain variable degrees of differentiation as a function of cultivation in vitro. Previous 
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studies demonstrated the establishment of three mouse endothelial cell lines from aorta, 
brain capillaries, and heart capillaries (Bastaki, 1997). These cell lines exhibit 
endogenous expression of specific markers, as evidenced by angiotensin-converting 
enzyme, acetylated LDL receptor, constitutive endothelial nitric oxide synthase, and 
vascular cell adhesion molecule-1 and bind Griffonia simplicifolia-I lectin (Bastaki et al., 
1997). In other studies, an in vitro model of vascular injury by menadione-induced 
oxidative stress in bovine heart microvascular endothelial cells was developed 
(Kossenjans, Rymaszewski, Barankiewicz, Bobst and Ashraf, 1996). Evidence was 
obtained that menadione toxicity was mediated by poly (ADP-ribose) polymerase 
activation by hydrogen peroxide. Other important considerations related to the use of 
cultured cell systems in toxicology studies include recognition that the presence of serum 
modulates antioxidant capabilities in vitro (Bishop, Mirza, Crapo and Freeman, 1985), 
and that cardiovascular cells in culture undergo variable degrees of differentiation 
(Owens and Thompson, 1986). 
1.7 Animal models of experimental hypertension. 
It is generally believed that both genetic and environmental factors and their interactions 
playa critical role in the pathogenesis of hypertension and other cardiovascular diseases. 
Accordingly, there are substantial individual variations in these two triggering elements 
leading to many variations in the direct and indirect effects on the cardiovascular system 
which are difficult to differentiate, thereby rendering the study of essential hypertension 
difficult (Sheila, Doggrell and Brown, 1998). Since hypertension and associated 
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cardiovascular diseases are the leading causes of death of human beings, medical 
scientists are dedicated to elucidate the mechanism of and explore the treatment for 
hypertension. Animal models of human disease have been widely used to study aetiology 
and pathogenesis of human disease, to prevent disease or to find a therapy and identify 
risk factors contributing to the disease. Probably the most commonly and widely used 
animal is the rat, not only on account of its comparatively low maintenance cost and easy 
handling, but also because the pathophysiology developed in these animals is quite 
similar to that observed in humans and that many techniques have been developed to 
measure relevant functional parameters using a rat model (Sheila, Doggrell and Brown, 
1998). For decades, rat models of hypertension have provided a powerful tool for the 
study of cardiovascular diseases in their early stages, as well as the investigation of the 
mechanisms of the pathogenesis of cardiovascular diseases and effects of drug 
intervention. It has been suggested that an ideal animal model for any cardiovascular 
disease in humans should at least possess five characteristics: (i) mimic the human 
disease, (ii) allow studies in chronic, stable disease, (iii) produce symptoms which are 
predictable and controllable, (iv) satisfy economical, technical and animal welfare 
considerations, and (v) allow measurement of relevant cardiac, biochemical and 
haemodynamic parameters (Sheila, Doggrell and Brown, 1998). However, the use of rat 
model as well as other animal models has some limitations. For example, it is argued that 
cardiovascular diseases such as hypertension and heart failure usually develop slowly in 
humans in contrast to the acute onset of symptoms in many surgical or drug-induced rat 
models of these diseases . Furthermore, these diseases are uncommon in young humans, 
but markedly increase with age whereas most models of hypertension and heart failure 
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only use young adult rats (Weindruch, 1995). Currently, the use of animal models is 
being limited by ethical concerns and legislation, as a reaction to the opposed opinions 
within the community on the necessity for the use of animals in research. Cell dispersion 
from adult hearts and the culture of neonatal or adult cardiac fibroblasts or neonatal 
cardiomyocytes have replaced some animal studies since these allow studies of a single 
cell type in the absence of homeostatic mechanisms over a wider range of experimental 
conditions than easily obtained in vivo (Sheila, Doggrell and Brown, 1998). 
1.7.1 The major rat models of hypertension. 
Basically, animal models of hypertension comprise primary and secondary hypertension. 
The primary hypertension includes genetically-induced and environmentally-induced 
hypertension, whereas the secondary hypertension includes pharmacologically-induced 
and renal-induced hypertension . 
1.7.2 GeneticaUy-induced hypertension. 
Animals that have undergone artificial genetic manipulation are predestined to become 
hypertensive. It is believed that genetically hypertensive rats comprise the most popular 
models to study essential hypertension (Yagil and Yagil , 2005). Two good examples of 
genetically hypertensive rats are; spontaneously hypertensive rats (SHR) and the Dahl 
salt sensitive rats (DSS). 
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1.7.2.1 Spontaneously hypertensive (SHR) 
The most commonly used model of cardiovascular disease is the spontaneously 
hypertensive rat (SHR), originally inbred from Wistar stock often with the Wistar Kyoto 
rat (WKY) as their normotensive control (Sheila, Doggrell and Brown, 1998). These rats 
develop hypertension at about 4-6 weeks of age, largely independent of dietary levels of 
either Na+ or Cr. The various colonies of SHR are pre- hypertensive for the first 6-8 
weeks of their lives with systolic blood pressure around 100-120 mmHg (Adams, Bobik 
and Komer, 1989) and then hypertension develops over the next 12-14 weeks (McGuire, 
1985). Similar to human beings, hypertension develops more rapidly and becomes more 
severe in male than female in SHR (Adams, Bobik and Komer, 1989). In vivo studies 
have shown that, in the early stages of hypertension, SHRs have an increased cardiac 
output with normal total peripheral resistance (Smith and Hutchins, 1979). However, as 
the animals progress into the established hypertension state, the cardiac output returns to 
normal and the hypertrophied blood vessels produce an increase in the total peripheral 
resistance (Smith and Hutchins, 1979). 
Studies in hypertension have commonly resorted to the use of SHRs which have, within 
each colony, uniform polygenetic disposition and excitatory factors (Lindpaintner, Kreutz 
and Ganten, 1992). These factors produce uniform changes in the indirect and direct 
effects on the cardiovascular system resulting in the reduction of individual variations. 
This lack of inter-individual variation is one of the major advantages of the SHR, but it 
means that the SHR can only model one of many possible causes of human hypertension 
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(Lindpaintner, Kreutz and Ganten, 1992). Another advantage of the SHR is that it follows 
the same progression of hypertension as human hypertension with pre-hypertensive, 
developing and sustained hypertensive phases with each phase lasting at least several 
weeks (Folkow, 1993). Because SHRs have a pre-hypertensive state, they have the 
important potential to be used in studies of the cause and development of hypertension. 
The SHR is a useful model as pharmacological agents which lower blood pressure in 
SHR are also effective in hypertensives. The SHR is a chronic stable model producing 
symptoms which are predictable and controllable and avoiding difficult or life-
threatening technical interventions (Sheila, Doggrell and Brown, 1998). Thus, it is not 
surprising that SHRs have been used extensively and successfully for 30 years to test 
medicines for their effectiveness in lowering blood pressure, and to study the 
mechanisms of established hypertension. The common criticism of the SHR model is that 
it has been around for a long time yet we still know little about the cause of the onset of 
hypertension (Sheila, Doggrell and Brown, 1998). 
1.7.2.2 Spontaneously hypertensive rats with heart failure (SHRs-F) 
The SHR-F rat model has been long known to have many similarities to human essential 
hypertension-induced heart failure including the important feature that impaired 
myocardial performance is a late feature that precedes overt failure (Pfeffer, Pfeffer, 
Fishbein and Frohlich, 1979). The SHR-F model is a good model of human hypertension-
induced heart failure as these conditions have many features in common. In the SHR, 
failure occurs around 2 years of age and may, therefore, be compromised by the effects of 
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ageing (Bing, Brooks and Robinson, 1995). This may make the interpretation of the rat 
data more difficult but it could also be argued that, since human heart failure is also 
commonly complicated by the effects of ageing, the aged SHR is the more realistic model 
(Sheila, Doggrell and Brown, 1998). This is a non-intervention model; as such there is no 
need for skilled technical assistance or mortality associated with surgery. The major 
disadvantage of the SHR-F model is the extended time frame and, therefore, increased 
costs of these experiments compared with other models of heart failure (Sheila, Doggrell 
and Brown, 1998). 
1.7.2.3 Stroke-prone spontaneously hypertensive rats (SHR-SP) 
The SHR stroke prone rat model (SHR-SP) is a further developed sub-strain of SHR, 
with even higher levels of blood pressure and a strong tendency to die from stroke 
(Yamori, 1984). For instance, the SHR- SP rats are hypertensive at 5 weeks and systolic 
blood pressure rises to at least 250 rrunHg in males, in contrast to pressures of around 200 
rrunHg in SHR (Rubin, Miller, Rohrbacher and Walsh, 1984). Salt-loading accelerates 
the development of hypertension and the occurrence of stroke in this rat model 
(Bannister, 1992). However, development of stroke increases with age with 65% due to 
atheroma and thrombosis, 15 % due to haemorrhage and 15 % to embolism (Bannister, 
1992). These lesions are similar to humans and as such, SHR-SP has been used to 
investigate preventive strategies for both stroke and cardiac hypertrophy due to severe 
hypertension (Rubin, Miller, Rohrbacher and Walsh, 1984). However, SHR-SP dies in 
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early to mid-adulthood (52-64 weeks or around 14-20 weeks old following salt-loading) 
(Vacher, Richer, Fornes and Clozel, 1996). Therefore, this model does not mimic the 
most common age of onset of stroke in humans. Furthermore, there is insufficient 
evidence that effective therapeutic regimes in the SHR-SP can be translated into effective 
prevention of stroke in humans (Sheila, Doggrell and Brown, 1998). 
1.7.2.4 Dahl salt-sensitive rats 
Another model is the Dahl salt-sensitive rat, originally derived from Sprague-Dawley rat 
stock by Dahl on the basis of developing hypertension with high NaCI diet, with Dahl salt 
resistant rats as their corresponding control group (Sheila, Doggrell and Brown, 1998). 
When fed with normal salt diets, these rats become hypertensive, indicating that this is a 
genetic model of hypertension with the feature of salt sensitivity. However, Dahl salt 
sensitive rats become extremely hypertensive during a high sodium diet (Dahl, Heine and 
Tassinari, 1962). The introduction of this model has significantly helped researchers 
understand salt sensitive hypertension in humans. The development of hypertension and 
heart failure in this model can be controlled by titration of the amount of salt in their diet, 
and is reportedly to be more rapid and greater in male than female (Dahl, Heine and 
Tassinari, 1962). Addition of 8% NaCI to the diet at 6 weeks of age leads to concentric 
left ventricular hypertrophy at 11 weeks. Marked left ventricular dilation at 15-20 weeks 
leads to laboured respiration, left ventricular hypokinesis and sudden death (lnoko, 
Kihara, Morii, Fujiwara and Sasayama, 1994). There is also a reduction in response of the 
left papillary muscle to isoprenaline in this model (lnoko, et al., 1994). These contractile 
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parameters appear to be very similar to those reported in end-stage human heart failure 
(Sheila, Doggrell and Brown, 1998). Recent studies have shown that modulation of nitric 
oxide (NO) production from L-arginine is integrally involved in the development of 
hypertension in these salt-sensitive rats (Greene, Yu, Roman and Crowley, 1990). 
Moreover, a large body of evidence suggests that the cardiovascular and renal deficits in 
Dahl salt sensitive rats are caused by a deficiency in nitric oxide-mediated vascular 
relaxation, particularly in the kidneys (Morgan, 1990). Salt is considered to be one of 
environmental triggers for human hypertension (Sheila, Doggrell and Brown, 1998). 
However, the appropriateness of this model may be questioned as the parallel group of 
humans who are as exquisitively salt-sensitive as the Dahl salt-sensitive rat may be a 
subset of African-Americans with inherited hypertension, salt sensitivity and a 
predisposition to kidney damage (Sanders, 1996) rather than a significant proportion of 
hypertensive humans. The symptoms of this model do, however, have many 
characteristics in common with the human disease (Sheila, Doggrell and Brown, 1998). 
Other advantages are that it is easy, non-invasive, relatively quick and consistent. This 
model is potentially useful in studies of the role of the L-arginine/ NO pathway as a 
mechanism by which a well-compensated hypertrophied heart eventually decompensates 
(Sheila, Doggrell and Brown, 1998). 
1.7.2.5 Transgenic rats 
Transgenic techniques are now increasingly used since they offer the possibility of 
analyzing responses by selected genes (Paul, Wagner, Hoffman, Urata and Ganten, 
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1994). The most commonly used species for transgenic experiments are mice (Sheila, 
Doggrell and Brown, 1998). However, their small size limits their usefulness in 
cardiovascular research as few techniques are available for functional studies. Since the 
renin-angiotensin system plays an important role in controlling the cardiovascular 
system, the murine Ren-2 gene was chosen to generate transgenic rats [TOR (mRen-2d) 
27 rat] (Lee, Bohm, Kim, Bachmann, Bachmann, Bader and Oanten, 1995). The 
transgenic rat was produced by introduction of the murine Ren- 2 gene into the rat 
genome (Muller, Hilgers and Bohlender, 1995). The TOR (mRen-2d) 27 rat represents a 
well documented genetic model of hypertension. It provides a monogenic model of 
hypertension to study the role of the local RAS specifically in cardiovascular remodeling 
(Lee, et ai., 1995). Therefore, the major advantage of this model lies in the monogenic 
pathogenesis of hypertension, which allows investigation of precise phenotypic changes 
in various organs caused by a genetic perturbation of the RAS system. However, this 
model cannot be considered as genuine model of polygenic human hypertension, since 
this transgenic rat line is a model of hypertension with a precisely defined monogenetic 
defect (Lee et ai., 1995). Moreover, this rat model is characterized by an activation of 
tissue RAS and a depressed plasma and kidney renin activity (Muller, Hilgers and 
Bohlender, 1995), yet human hypertension is usually associated with normal or high 
plasma renin concentrations (Sheila, Doggrell and Brown, 1998). However, this model 
may provide a better understanding of the role of local renin-angiotensin systems in 
cardiovascular disease (Ohta, Kim, Wanibuchi, Oanten and Iwao, 1996). Transgenic rats 
expressing the human angiotensinogen gene have been used to test the functional 
importance of the local human renin- angiotensin system (Muller, Hilgers and Bohlender, 
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The deoxycorticosterone acetate (DOCA)-salt-induced model of hypertension is a typical 
representative of pharmacologically-induced hypertension. Weekly subcutaneous 
injections of deoxycorticosterone acetate (30 mg kg· l twice a week and salt loading as 
1 % NaCl in the drinking water is required to induce hypertension in rats (de Champlain, 
Krakoff and Axelrod, 1967; Schenk and McNeil, 1992). Saline is an important co-factor 
because it expedites the development of hypertension and makes it more severe (see 1.1). 
Nephrectomised rats given deoxycorticosterone or NaCl alone do not show any major 
changes in blood pressure, and it is only the combination of deoxycorticosterone and 
NaCl that produces a major increase in blood pressure with increases in cardiac and renal 
weight (Schenk and McNeil , 1992). Hypertension develops more quickly and becomes 
more severe in male than female DOCA-salt rats (Crofton and Share, 1997), suggesting 
the role of exogenous sex hormones, such as estrogen and progesterone. Whereas the 
direct cardiovascular effects of estrogen are poorly understood, its effects are believed to 
be mediated, at least in part, through the ability of this hormone to increase nitric oxide 
synthesis (Hishikawa, Nakaki, Marumo, Suzuki, Kato and Saruta, 1995). Nitric oxide 
plays a role in the endothelium-dependent vasodilation, thereby reducing the total 
peripheral resistance and hence, blood pressure. The combination of DOCA-salt and 
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unilateral nephrectomy results in hypertension, cardiac and renal hypertrophy, and 
nephrosclerosis (Sellye, 1942). DOCA-salt hypertension is a low renin and volume 
overloaded form of hypertension (Crofton, and Share, 1997). There is evidence that 
arginine vasopressin (A VP) plays a role in both the development and maintenance of 
DOCA-salt hypertension (Sellye, 1942; Crofton and Share, 1978). The major limitations 
of the DOCA-salt model are: (1) the pharmacological large doses of drug required; (2) 
requirement for surgical reduction of renal mass; and (3) ingestion of a large amount of 
NaCI required (Sheila, Doggrell and Brown, 1998). Furthermore, hypersecretion of 
deoxycorticosterone is rarely observed in humans and is a result of a genetic defect 
(Crofton and Share, 1997). The major advantage of this model is that it allows 
investigating the role of sodium in the developmental stages of hypertension. 
1.7.4 Diabetic hypertensive rats 
Diabetes mellitus is an important risk factor in patients with hypertension and heart 
disease. Furthermore, diabetics have a high incidence of cardiovascular diseases, 
especially hypertension, atherosclerotic coronary disease, cardiomyopathy and 
microvascular damage (Kannel, Hjortland and Castelli, 1974 and Hsueh, 1992). Rapid 
injection of streptozotocin to adult rats produces many of the characteristics 
cardiovascular and renal pathophysiological features similar to those of humans with 
uncontrolled insulin-dependent diabetes (National diabetes Data Group, 1979). However, 
these rats can survive without exogenous insulin for at least 12 weeks and are usually 
normotensive (van Zwieten, Kam and PijI, 1996). Streptozotocin-induced diabetics show 
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characteristics similar to those of hypertensive-insulin-dependent diabetic humans 
(National diabetes Data Group, 1979). These rats show progressive cardiac deterioration 
(van Zwieten, Kam and Pijl, 1996) and have been used to measure responses of 
antihypertensive drugs on hypertrophy and vascular permeability (Hulthen, Cao, Rumble, 
Cooper and Johnston, 1996). However, this model may not be relevant since it is an 
insulin-dependent model, yet 85% of diabetics are non-insulin-dependent with many of 
these patients being hypertensive and obese (van Zwieten, Kam and Pijl, 1996). 
Therefore, models of non-insulin-dependent diabetic hypertension may be more relevant. 
The genetically- determined obese Zucker rat fulfils the criteria as a relevant model of 
non-insulin-dependent diabetes (van Zwieten, Kam and Pijl, 1996). The model exhibits 
moderately elevated blood pressure, progressive kidney damage and 
hypercholesterolaemia (Math, 1995). A newer genetic model of human non- insulin-
dependent diabetes is the Otsuka Long-Evans Tokushima fatty rat which develops mild 
hypertension with typical cardiac and renal complications such as perivascular fibrosis 
and glomerulosclerosis (Yagi, Kim, Wanibuchi, Yamashita, Yamamura and Iwao, 1997). 
1.7.5 Renal-induced hypertension (renovascular hypertension) 
The physiological function of the kidney includes maintenance of electrolyte and fluid 
balance and secretion of renin, an important component of the RAS. Thus, its 
involvement in the regulation of blood pressure and its important role in the development 
of hypertension are well accepted. The first renovascular hypertension was induced by 
partial constriction of the renal artery of a dog in 1934 (Goldblatt, Lynch, Hanzal and 
Summerville, 1934). Since then, many renal-induced models of hypertension 
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(Renovascular hypertension) have been successfully established in rats, rabbits, sheep, 
and cats (Zandberg, 1984). Generally, renal-induced experimental hypertension includes 
two-kidney Goldblatt hypertension; where occlusion is done to one renal artery by a clip 
while the contralateral kidney is left intact; and one-kidney Goldblatt hypertension, where 
one renal artery is clipped and the contralateral kidney is removed. These models are 
volume overload forms of hypertension, as there is stimulation of the renin-angiotensin-
aldosterone system in the absence of renal electrolyte and fluid loss. This would be an 
ideal model for studying the role of volume expansion in the development of 
hypertension. During the early developmental stage of these two renal-dependent models, 
when the clip is removed, arterial blood pressure returns to normal (Liard, Cowley, 
McCaan, McCaan and Guyton, 1974; Ten Berg, Lenen and De Jong, 1979). Thus, renal-
induced hypertension is reversible and reproducible. Furthermore, these models provide a 
unique opportunity to investigate the changes which occur specifically at the level of the 
kidney, as well as the role of the kidney in the long-term blood pressure control. If the 
reversal of hypertension is time-dependent, it would suggest that relevant changes, 
perhaps structural, have developed. 
1. 7.6 Pulmonary hypertension 
Pulmonary hypertension is uncommon disorder characterized by elevation of pulmonary 
vascular resistance and progressive right ventricular failure (Grossman, 1992). 
Pulmonary hypertension (PH) was historically classified in two categories based on its 
mode of occurrences: primary pulmonary hypertension, a rare disorder without a known 
29 
underlying cause, or pulmonary hypertension secondary to a variety of chronic lung and 
heart diseases (Mannino, 2002). The latter exhibits a much larger incidence and 
considerable morbidity and mortality (Grossman, 1992). The most common causes of 
secondary pulmonary hypertension is obstructive pulmonary disease, left ventricular 
systolic failure, pulmonary thromboembolism and hypoventilation (Mannino, 2002 and 
Grossman, 1992). Pulmonary hypertension is associated with functional and vascular 
changes that are modulated by endothelium-derived vasodilators and vasoconstrictors 
(Pietra, 2004). Pulmonary endothelium has an important modulatory role in maintaining 
a low basal pulmonary vascular tone by releasing a balanced amount of vasodilators, 
(including nitric oxide (NO) and prostacyclin) and vasoconstrictors (including 
endothelin-1 [ET-1]). Under physiological conditions, a precise and balanced release of 
vasodilators and vasoconstrictors contribute to appropriate organ perfusion. However, 
this balance is altered in disease states such as pulmonary hypertension (Chantal, 1999). 
In patients with pulmonary hypertension an imbalance in favour of vasoconstrictor 
release is observed (Chantal, 1999). The cause of endothelial dysfunction associated with 
pulmonary hypertension is not always clear although there is a hereditary component in 
patients with a familial history of primary pulmonary hypertension (Lane, 2000). In 
addition, many of the vasoconstrictors, including ET -1, also have a growth promoting 
effect on smooth muscle cells, ultimately leading to structural changes with increased 
muscularization and resistance to flow. Moreover, reduced production of prostacyclin and 
NO contributes to increased thrombogenicity (Pietra, 2004). 
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1.7.7 Portal hypertension 
Portal hypertension is the most common complication of chronic liver diseases. This 
syndrome, defined by a pathological increase in the portal venous pressure, is 
characterized by an increase in the pressure gradient between portal vein and inferior 
vena cava, which is in normal condition within 1-5 mmHg (Ratti, Pozzi and Bosch, 
2005). However, portal hypertension begins to manifest its complications when the portal 
pressure rises above the threshold value of 10-12 mmHg (Garcia-Tsao, Groszmann, 
Fisher, Conn, Atterbury and Glickman, 1985). Oesophageal variceal hemorrhage is a 
major complication of portal hypertension, therefore pharmacological treatment of portal 
hypertension aims to treat acute bleeding episodes or prevent variceal bleeding (Navasa, 
Bosch, Rodes, 1991). The two widely used vasoconstrictors in the treatment of acute 
variceal bleeding are vasopressin and somatostatin while propranolol is used as a 
prophylactic drug for prevention of variceal bleeding (Navasa, Bosch and Rodes., 1991). 
Because of the combined impact of these complications, portal hypertension represents 
the main cause of death in patients with cirrhosis (Ratti, Pozzi and Bosch, 2005). 
The portal pressure gradient is the result of the interaction between portal blood flow and 
the vascular resistance that opposes the flow. Thus, portal pressure gradient can originate 
from an increase in intrahepatic vascular resistance, an increase in hepatic blood flow or 
from a combination of both . For many years, the increase in vascular resistance in portal 
venous system was thought to be determined by the disruption of liver architecture due to 
the progressive deposition of collagen in the Disse's space, scarring and nodule formation 
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(Ratti, Pozzi and Bosch, 2005). However, recent studies have demonstrated that 
vasoactive mediators may modulate intrahepatic vascular resistance. Thus, insufficient 
release of hepatic vasodilators, overproduction of vasoconstrictors, and a hyporeactivity 
to vasodilators are all responsible for the dynamic component of the increased 
intrahepatic resistance in liver cirrhosis (Groszmann and Abraldes, 2005; Garcia-Pagan 
and Bosch, 2004). An increased portal blood flow is generally observed in advanced 
stages of portal hypertension, and it is the result of an excessive arteriolar vasodilation in 
splanchnic organs draining in the portal venous system (Vorobioff, Bredfeldt and 
Groszmann, 1984). 
The possibility of the pharmacological manipulation of the increased intrahepatic 
resistance of cirrhotic livers has challenged the paradigm that it was only possible to 
lower portal pressure by reducing the increased splanchnic blood flow with splanchnic 
vasoconstrictors (Garcia-Pagan and Bosch, 2004). However, reducing hepatic vascular 
resistance represents a novel strategy to treat portal hypertension, with the advantage of 
avoiding a further decrease in liver blood flow, but of improving liver perfusion 
(Loureiro-Silva, Cadelina, Iwakiri and Groszmann, 2003). Indeed, it has been 
demonstrated that increasing nitric oxide within the liver or reducing or blocking the 
effect of different vasoconstrictors can modulate hepatic vascular tone in cirrhotic livers 
(Garcia-Pagan and Bosch, 2004). 
There are mainly two types of pharmacological approaches towards the treatment of 
portal hypertension: by reducing portal blood flow or portal vascular resistance. The 
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former is the basis for use of vasoconstrictors, the latter, vasodilators (Navasa, Bosch and 
Rodes, 1991). However, current therapeutic drugs for portal hypertension are quite 
limited due to their side effects or low efficacy. In this context, it is well justified to 
search for some potential alternatives in the treatment of portal hypertension. 
1.7.8 Insulin resistance and hypertension. 
Hypertension is approximately twice as common in diabetic subjects as in the general 
population (Tauscher, Egger and Herman, 1989). The frequent association of impaired 
glucose tolerance, diabetes mellitus, obesity and hypertension was first reported in 1929 
(Major, 1929). The presence of insulin resistance with compensatory hyperinsulinemia is 
considered as the common underlying metabolic disorder that links these conditions. 
Studies have also documented an independent association of hypertension with insulin 
resistance (Ferrannini, Buzzigoli, Bonadonna and Giorico, 1987). These authors showed 
a severe impairment of insulin-mediated glucose uptake in a group of lean hypertensive 
subjects with normal glucose tolerance. Since this first report, the relationship between 
hypertension and insulin resistance in human essential hypertension has stimulated great 
interest and debate (Rossetti and Frontoni , 1993). 
Insulin resistance with compensatory hyperinsulinemia is commonly described in non 
obese patients with essential hypertension (Major, 1929; Bonora, Zavaroni, Alpi, 
Pezzarossa, Bruschi and DalI' Aglio, 1987). However, the relationship between 
33 
hypertension and insulin resistance is still not completely understood, since the impact of 
high blood pressure per se on insulin-mediated glucose metabolism is not easily 
distinguishable. 
The past few years, animal models of genetic and acquired hypertension have been 
studied in order to address this question. One would envisage an impaired insulin-
mediated glucose metabolism in animal models of hypertension if the decreased insulin 
sensitivity described in hypertensive individuals is the consequence of metabolic or 
hemodynamic alterations due to elevated blood pressure. Indeed, several researchers have 
reported impairment in insulin-mediated glucose metabolism in genetic animal models of 
hypertension. For example, Mondon and Reaven, (1988) reported impairment in insulin-
mediated glucose metabolism in genetic animal model of hypertension, demonstrating a 
decreased whole body insulin clearance and insulin mediated glucose metabolism. In a 
separate study, Somova, Channa and Khan , (1999), demonstrated an impairment in 
insulin mediated glucose metabolism in Dahl salt sensitive rats, a genetically non-diabetic 
and non-obese insulin resistant rat model of hypertension. 
Among the various mechanisms postulated to link insulin resistance and 
hyperinsulinemia to hypertension, sympathetic activation seems, to be the most 
important. This is suggested by the finding that insulin infusion in most of the clinical 
conditions, like in the case of obesity-related hypertension, increases muscle nerve 
sympathetic activity in healthy subjects (Berne, Fagius, Pollare, Hjelmdahl. 1992) and in 
borderline hypertensive patients (Anderson, Balon, Hoffmann, Sinkey and Mark, 1992). 
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Additionally, both insulin resistance and hypertension have been associated with 
impaired endothelial function and insulin-mediated vasodilation (Panza, Quyyumi, Brush 
and Epstein, 1990 and Petrie, Ueda, Webb, Elliott and Connell, 1996). A large body of 
evidence indicates that insulin causes limb vasodilatation, decreases adrenergic-mediated 
vasoconstriction, and potentiates acetylcholine-mediated vasodilatation (Baron, 1996). 
All of these actions appear to protect against the development of arterial hypertension. It 
could be anticipated, therefore, that if the vasculature is resistant to insulin 
vasomodulation, just as skeletal muscle is resistant to insulin's metabolic action; this 
same defect, insulin resistance might be responsible for the development or maintenance 
of arterial hypertension . Alternatively, insulin could enhance vascular responsiveness and 
sustain arterial hypertension directly by activating the sympathetic nervous system, which 
acts on the vasculature, heart, and kidneys (Anderson et al., 1992). Importantly, because 
insulin is a direct vasodilator, activation of other physiological mechanisms is probably 
required if insulin is to have a causal role in the pathogenesis of hypertension. Therefore, 
interventions to improve insulin sensitivity and hypertension should be initiated early. 
1.8 Incidence and prevalence of hypertension in developing nations 
It is predicted that almost three-quarters of the world-wide population with hypertension 
will be in developing countries by the year 2025 (Kearney et al., 2005), with this 
occurrence fuelled by urbanization. Urbanization in Africa has played a significant role in 
modification of lifestyle patterns. For example, with urbanization, black South Africans 
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undergo a nutritional transition from traditional, rural, carbohydrate food with a low 
glycaemic index to a diet high in fat and poor-quality carbohydrate fast foods (Bourne, 
Lambert and Steyn, 2002). This has resulted in 58.5% of South African black women 
becoming over weight or obese, with some women's shapes augmented by the culturally 
desirable value of obesity (Bourne, Lambert and Steyn, 2002). 
Prevalence of hypertension in developing nations has been difficult to quantify possibly 
because the majority of the developing countries do not have national estimates of 
prevalence of hypertension (Ibrahim, 1995). A World Health Organisation analysis 
showed that the prevalence of hypertension in developing countries varied from 1 % in 
some African countries to more than 30% in Brazil (Nissinen, Bothig, Granroth and 
Lopez, 1988). The prevalence of hypertension in black people in the West Indies and 
United States of America has been found to be higher than those in any part of sub-
Saharan Africa (Seedat, 2000). 
Epidemiological studies in Egypt indicate that hypertension is extremely common 
among Egyptians, and it is believed that this situation exists in many other developing 
countries (CAPMSA, 1990). Cardiovascular diseases in Egypt are now the main cause 
of death being responsible for 42.5% of all deaths, while 20 years earlier they accounted 
for only 12.4% of mortality (CAPMSA, 1990). Comparing the prevalence of 
hypertension in three countries, China, Egypt and United States of America, it has been 
shown that Egypt has the highest prevalence rate of hypertension according to the 
Egyptian National Hypertension Project data (Ibrahim, 1995). Mortality statistics have 
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shown a downward trend in mortality from hypertension and cardiovascular diseases in 
most developing countries (Seedat, 2000). According to the recent editorial on heart 
diseases in Africa it is concluded that coronary heart diseases account for a small but 
progressively growing proportion of heart diseases (Walker and Sareli, 1997). However, 
the low trend in the prevalence of hypertension and cardiovascular disease will probably 
change due to urbanization and acculturation just as was the case with black Americans 
and in western populations (Morris, 1951; Perkoff and Strand, 1973; Seedat, 1983; 
Krornhout, 1996 and Gandhi, 1997). 
The prevalence of hypertension among South African Blacks is higher (34% among 
women and 27% among men) and as is the case with all urban populations, it rises with 
age (Edwards, 1995). Furthermore, in a study conducted in the adult population of 
Durban in South Africa, hypertension was demonstrated to be highest in urban Zulus 
(25%), intermediate in whites (17.2%) and lowest in ethnically Indian people (14.2%) 
(Seedat, 1983). Several theories have attributed the cause of this high prevalence to diet, 
change of exercise patterns, breakdown of culture, and stressful aspects of urban life 
(Edwards, 1995). Reviews have indicated that in South Africa just as it is the case with 
other countries, the prevalence in the rural communities is much lower than in the cities 
(Seedat, 1983; Fraser, 1986). For instance, it was shown to be 4.1 % in Ghana (Pobee, 
1977), 5.9% in Nigeria (Oviasu, 1978), 7% in Lesotho (Mokhobo, 1976) and 7.37% in 
the rural Zulu (Seedat, 1983). It is suggested that exposure to stressors, such as natural 
disasters, industrial noise, overcrowding, unemployment and environments posing 
constant threats are among other factors that have been linked to the development of 
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hypertension (Edwards, 1995). There are a number of factors that could be attributed to 
the projected rise in persistent hypertension and cardiovascular disease mortality rate in 
future like adverse life style changes that are accompanying industrialization and 
urbanization, salt consumption in Africa is increasing, (Whelton, He, Appel, 2002). 
Cigarette smoking has increased in Africa as tobacco companies lose their holds in the 
developed world, they are turning to developing nations as their target markets, alcohol 
consumption is on the increase in Africa, physical inactivity and many more (Diabetes 
Prevention Program Research Group, 2002). 
Additionally, due to economic constraints facing developing countries, diseases such as 
HIV/AIDS along with the ravages of persistent infectious diseases, famine, drought and 
civil strife, take priorities for restricted health budgets over apparently non-urgent health 
priorities such as hypertension. Thus, these factors will continue to dominate over 
hypertension and, therefore, its prevalence and incidence will continue to increase in 
developing countries. Under this situation, global approaches focusing on lifestyle 
changes should be initiated as preventive measures, whereas approaches for individuals 
should focus on extensive search for cheaper and easily accessible antihypertensive 
therapy such as utilization of medicinal plants traditionally used as antihypertensives. 
1.9 Evaluation and diagnosis of hypertension 
It is recommended that accurate measurements of blood pressure and verification of 
elevated blood pressure be made on multiple occasions over time (Phyllis, 2003). White 
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coat hypertension present in 20% of patients with elevated blood pressure is said to be 
associated with a low cardiovascular risk (Phyllis, 2003). However, studies indicate that 
it may be a precursor of sustained hypertension and therefore warrants monitoring 
(Phyllis, 2003). When diagnosing and evaluating a person for hypertension, apart from 
history taking and physical examination, it is required that several tests that include 
urinalysis, complete blood count, blood chemical tests (i .e., potassium, sodium, creatine, 
fasting glucose, total cholesterol and high density and low density lipoprotein) and a 12 
lead electrocardiography are routinely conducted (Phyllis, 2003). The evaluation should 
identify signs of cardiovascular, cerebrovascular or peripheral vascular diseases and other 
risk factors that are frequently present in patients with hypertension (Materson, Reda and 
Cushman, 1994). It is also recommended to investigate further, severe hypertension or 
clinical or laboratory results that could suggest the possibility of renal disease, adrenal 
hypertension or renovascular hypertension (Phyllis, 2003). According to the Joint 
National Committee on Prevention, Detection, Evaluation and Treatment of Blood 
Pressure, blood pressure is classified as in table below: 
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1.9.1 Classification of blood pressure in adults 
Category Blood pressure (mmHg) 
Optimal <120/80 
Normal <1301<85 
High normal 130-139 systolic pressure or 85-89 diastolic pressure 
H ypertensi on 
Stage 1 (mild) 140-159 systolic pressure or 90-99 diastolic pressure 
Stage 2 160-179 systolic pressure or100-109 diastolic pressure 
(moderate) 
Stage 3 2:180 systolic pressure or 2:110 diastolic pressure 
(severe) 
Stage 4 2:210 systolic pressure or 2: 120 diastolic 
(malignant) 
Isolated 
systolic 2:140 systolic pressure or <90 diastolic 
hypertensi on 
Adapted from Staessen, Wang, Bianchi and Birkenhager, (2003). 
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1.10 Blood pressure measurement in experimental animals. 
Animal models of hypertension play an essential role in exploring the mechanisms of 
blood pressure control and the actions of the cardiovascular drugs. Arterial blood 
pressure is often measured to assess the response of the cardiovascular system to 
treatment (e.g., to drug or stress) or as an endpoint (e.g., studies of hypertension). The 
manner in which blood pressure is measured varies from one laboratory to another, and 
the specific values obtained, their reliability and interpretation, are strongly influenced by 
the method selected. The measurement of blood pressure in conscious rats has been 
restricted to two methods: The direct and indirect measurements. 
1.10.1 Indirect methods. 
Indirect methods refer to the noninvasive methods of blood pressure measurement. The 
most common indirect method used in rodent studies has been the use of a tail-cuff 
device which comes in combination with blood flow sensor. There are a number of tail-
cuff devices available, including one intended for use in small animals, such as rats (e.g., 
rrTe Life Sciences 31, USA). Indirect methods have some advantages in that they are 
less demanding technically and they are suitable for chronic studies since serious risks to 
the animal health are minimal. However, the indirect methods suffer from the limitations 
of being indirect, discontinuous, and requiring restraint of animals. Additionally, in most 
cases, some degree of heating of the animal is usually used to ensure sufficient tail blood 
flow for easy measurement to be made (Bunag, 1991). The issue of restraint stress, heat 
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stress, and environmental influences on physiological parameters in the most commonly 
used rat models of hypertensions has been raised (Sponer, Muller-Beckmann and Martin, 
1973). It has been suggested that, even when minimal external warming is used, the 
combination of restraint and warming may lead to significant increase in the core body 
temperature (Sponer, Muller-Beckmann and Martin, 1973). Since both restraint and 
warming constitutes stresses that may affect blood pressure, the values of blood pressure 
obtained with tail-cuff method may, not only reflect the animals' general blood pressure 
levels but also the reactivity of blood pressure to the stress of the procedure. Because of 
these limitations, it is often recommended that results obtained by tail-cuff method be 
verified by direct blood pressure measurement (Bunag and Butterfield, 1982). 
1.10.2 Direct methods. 
Direct methods refer to techniques by which arterial blood pressure is measured directly 
with the aid of a sensor device (catheter) implanted invasively within a suitable artery. 
The sensor is connected to a calibrated pressure transducer for blood pressure 
measurement (Sponer, Muller-Beckmann and Martin, 1973). This is the most accurate 
method of blood pressure measurement. 
The major advantages of this method are firstly, that the materials needed for the 
procedure are inexpensive. Secondly, the precise calibration is easier and the whole 
procedure can be performed under normal physiological conditions without involving the 
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warming, restraining of the animals and this allows continuous long-term blood pressure 
recordings under conditions of relatively low stress. 
Disadvantages of the direct methods include: (1) the disturbance to the animal, its blood 
pressure and heart rate, caused by catheter implantation surgery and anaesthesia; (2) the 
method from the technical point of view is critical , such that if not properly done, it 
creates the potential for infection, and the potential for loss of catheter patency (Sponer, 
Muller-Beckmann and Martin, 1973). This may lead to a degradation or loss of blood 
pressure signal and limited dynamic response, which makes detection of the true systolic 
and diastolic pressures challenging in small animals with high heart rates (Sponer, 
Muller-Beckmann and Martin, 1973). 
1.11 Management and treatment of hypertension 
The primary goal of the treatment or management of hypertension is to prevent 
cardiovascular diseases and death (Phyllis, 2003). Successful treatment of hypertension 
has been associated with reductions in the risk of cardiovascular mortality and morbidity, 
cardiovascular events, left ventricular hypertrophy, stroke, myocardial infarction, 
alzheimer's, dementia, renal complications, deterioration of renal function, renal failure 
and other complications (Guidelines Part I: Detection and Diagnosis of hypertension, 
2003 and Collins, 1990). Hypertension can be managed, controlled and treated either by 
using the available conventional antihypertensive drugs or through non-pharmacological 
approach (e.g. , lifestyle modification). 
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1.11.1 Treatment of hypertension using drugs. 
A vailable antihypertensive drugs classified according to their principle regulatory site or 
mechanism (s) on which they act are described below. 
1.11.1.1 Calcium channel blockers 
Calcium channel blockers preferentially bind to the L-type high voltage calcium channels 
and this inhibits influx of calcium ions across the cell membrane (Bertram, 2004). 
Blockade of calcium channels in vascular endothelial cells inhibits vasoconstriction and 
enhances vasodilation. This results in reduced total peripheral vascular resistance and 
subsequent blood pressure. On the other hand, blockade of calcium channels in 
myocardial cells, results in inhibition of force and rate of myocardial contractions. The 
result is a decrease in cardiac output leading to a decrease in blood pressure (Bertram, 
2004). Dihydropyridines, class of calcium channel blockers are more selective as 
vasodilators. Drugs in this class such as nifedipine exert their effects more on the blood 
vessels and have less cardiac depressant effect (Bertram, 2004). Their common side 
effects include headache, excessive hypotension, oedema and reflex tachycardia 
(Bertram, 2004). Non-dihydropyridines such as verapamil have greater cardiodepressant 
effect and may decrease heart rate and cardiac output. These cardiac selective non-
dihydropyridine calcium channel blockers can result in excessive bradycardia and 
impaired electrical conduction (Bertram, 2004). 
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1.11.1.2 Beta-adrenergic blockers 
The beta adrenergic blockers appear to lower blood pressure and provide target organ 
protection by several different mechanisms. Beta-adrenergic blockers inhibit the renin-
angiotensin system by decreasing renin release by the juxtaglomerular cells of the kidney 
(Lopez-Sendon, Swedberg, Mcmurray, Tamargo, maggion, Dargie, Tendera, Waagstein, 
Kjekshus, Lechat and Torp-Pedersen, 2004). These drugs also inhibit the sympathetic 
nervous system outflow, and decreasing force and rate of cardiac contractility with a 
decrease in cardiac output (Lopez-Sendon et a!., 2004). Thus, the drugs act by reducing 
adrenergic nerve stimulation, the excitatory nerve stimulation that causes 
vasoconstriction, tachycardia and positive inotropy, thereby resulting in reduced vascular 
resistance and cardiac output. 
The beta blockers are classified into three generations of agents; the first generation 8-
blockers, the second generation 8-blockers and the third generation 8-blockers (Michael, 
2005). The first generation 8-blockers are also known as non-selective 8-blockers. These 
8-blockers exert equal blockade of 81 and 82 adrenergic receptors . A typical example in 
this class is propranolol (Michael, 2005). The second generation agents are called 
selective B-blockers, since they exhibit higher binding affinity to 81 than to 82 receptors. 
These drugs include metoprolol and atenolol (Brixius, Bundkirchen, Bolck, Mehlhorn 
and Schwinger, 2001). The third generation 8-blockers appear to have a high binding 
affinity for aI-adrenergic receptors and exhibit vasodilating activity through their 
blockade of aI-adrenergic receptors . A good example is labetalol. Nebivolol, in contrast, 
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is a third generation B-blocker that has a higher affinity for B1 and provides endothelium-
dependent vasodilation associated with activation of the L-arginine/nitric oxide pathway 
(Bowman, Chen and Ford, 1994; Ritter, 2001). Despite the protective potential offered by 
these drugs, concerns regarding their safety and tolerability, including potential adverse 
metabolic effects limit their use in clinical practice (Michael, 2005). 
1.11.1.3 Angiotensin-converting enzyme inhibitors (ACE-inhibitors) 
These drugs lower blood pressure by reducing plasma concentrations of angiotensin II 
and aldosterone by blocking ACE-effects of converting angiotensin I to angiotensin II, 
thereby, disrupting the renin-angiotensin-aldosterone system (Collins, 1990). They also 
block the break down of bradykinin, a vasodilator substance (Bertram, 2004 ).,By 
blocking the break down of bradykinin, ACE- inhibitors increase the bradykinin levels, 
which contribute to vasodilation. Therefore, ACE- inhibitors lower blood pressure by: 
dilating arteries and veins by blocking angiotensin II formation and inhibiting bradykinin 
metabolism. They also lower blood pressure by down regulating sympathetic adrenergic 
activity and by promoting renal excretion of sodium and water by blocking the effects of 
angiotensin II in the kidney and by blocking angiotensin II stimulation of aldosterone 
sectretion. Captopril and enalapril are examples of antihypertensive drugs in this class 
(Bertram, 2004). 
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The common annoying side effect of angiotensin converting enzyme inhibitors is dry 
cough which is attributed to the effect of bradykinin (Bertram, 2004). Hypotension can 
also be a problem especially in heart failure patients (Bertram, 2004). 
1.11.1.4 Angiotensin II Receptor Blockers (ARBs). 
Angiotensin receptor blockers (ARBs) are receptor antagonists that block the type 1 
angiotensin II receptors (AT1) on blood vessels (Dzau, 1993). They block the effects of 
angiotensin II thereby preventing angiotensin II induced vasoconstriction. Therefore, 
these drugs appear to lower blood pressure by lowering the total peripheral vascular 
resistance. These drugs also decrease aldosterone synthesis and therefore, sodium 
excretion is increased. ARBs are appearing as the most effective antihypertensive 
therapy, which interferes with the renin-angiotensin system compared with ACE-
inhibitors. This is because, in spite of their therapeutic efficiency, ACE- inhibitors are not 
highly effective in lowering angiotensin II levels, since other enzymes, such as chymase, 
are able to synthesize angiotensin II (Reilly, Tewksbury, Schechter and Travis, 1982). In 
fact, chymase-dependent angiotensin II production is up regulated in human diabetic 
kidney and diseased blood vessels (Doggrell and Wanstall, 2004). Therefore, the most 




As expected, in most forms of hypertension, the hypertensive state is maintained by an 
elevation in blood volume, which in tum increases the cardiac output. The sodium 
retention resulting from increased RAAS activity is associated with increased 
extracellular fluid volume. Diuretic drugs appear to lower blood pressure by increasing 
renal sodium and water loss thereby, decreasing extracellular fluid volume, blood volume 
and cardiac output (Bertram, 1990). Thiazide diuretics are more appropriate for most 
patients with mild or moderate hypertension. The primary site of action of thiazide 
diuretics is on the distal tubules where they produce increased urinary excretion of 
sodium and potassium (Bertram, 2004). More powerful diuretics such as furosemide are 
more appropriate in severe hypertension. These diuretics act on the loop of Henle where 
they promote sodium, potassium and water excretion. The common side effects of 
thiazides and furosemide include hypokalaemia, hyperuricaemia, hyperglycaemia, 
hypovolaemia and glycosuria (Parry, 1984). 
Potassium sparing diuretics are useful to prevent excessive potassium depletion and to 
enhance the natriuretic effects of other diuretics (Bertram, 2004). However, these 
diuretics are said to be less potent when they are used alone, but become more useful 
when they are used in combination with other diuretics. A good example in this class of 
diuretics is spironolactone, an aldosterone antagonistic agent. This drug antagonizes the 
effect of aldosterone on the distal tubule thereby, increasing sodium excretion and 
promoting the retention of potassium (Parry, 1984). 
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1.12 Medicinal plants. 
Economic problems facing the developing populations and poor health services resulted 
in the search for cheap and easily accessible alternative therapies from natural sources for 
many human ailments including hypertension. The most important cheap source of 
treatment is medicinal plants. Among all known natural drugs, those originating from 
plant tissues have been celebrated since antiquity as apparently limitless source of novel 
drugs (De Pasquale, 1984). A main fraction of population in developing countries 
remains dependant on ancestral plant knowledge for health care (Balick, 1990). This ratio 
keeps increasing with the state of poverty of these countries. In addition, WHO 
encourages the inclusion of medicinal plants in programmes of developing countries 
because of the great potential these plants represent in combating various diseases 
(WHO, 1992). It is estimated that more than 80% of the population in developing 
countries depend on plants for their medical needs (Balick, 1990). 
According to the Herbal Medicinal Industry, a medicinal plant is any plant used in order 
to alter physiological and pathological process. A phytopharmaceutical preparation or 
herbal medicine is any manufactured medicine obtained exclusively from plants (aerial 
and non-aerial parts , juices, resins , oils and fruits) (Arias, 1999). 
Plants can be used as therapeutical resources in different ways (Rates, 2000). They can 
be used as herbal teas, or as other home remedies, when they are considered as medicinal 
plants. They can be used as crude extracts or "standard enriched fractions" in 
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pharmaceutical preparations such as tinctures, fluid extracts, powder, pills and capsules, 
when they are considered as phytopharmaceutical preparations or herbal medicines. 
Plants can be subjected to successive extraction and purification procedures to isolate the 
compounds of interest which can be active and used directly as a drug (Rates, 2000). 
Several plant extracts with potential therapeutic properties for treatment of hypertension 
and its associated complications, such as coronary heart diseases, angina, arrhythmias and 
congestive heart failure have been identified (Miller, 1998; Gelfand, Mavi, Ndemera and 
Drummon, 1985; Somova, Nadar, Rammanan and Shode, 2003; Osim, Mbajiorgu, 
Mukarati, Makufa, Munjeri and Musabayane, 1996). Thus, the economic view of health 
services and the recognition that the research on medicinal plants used in folk medicine 
represent a suitable approach for the development of new drugs (Elisabetsky and Posey, 
1986), have led to an increased interest in the search for plants with hypotensive 
properties. The following section describes some of the medicinal plants that have been 
studied and demonstrated hypotensive properties. 
1.12.1 Dorstenia scabra [Moraceae] 
Dorstenia scabra also known as Dorstenia psilurus, is a small herb occurring in Central 
Africa and reaching 80 cm in height and 7 cm in girth (Hutchings, 1989). The plant 
usually grows on the borders of rivers and lakes. The leaf extract of Dorstenia scabra is 
widely used in ethnomedical practice in the grassland region of Cameroon for the 
treatment of arthralgia and cardiovascular disorders, mainly hypertension (Dimo, 
Rakotonirina, Tan, Dongo, Dongmo, Kamtchouing, Azay, Abegaz, Cros, and Ngadjui, 
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2001). A decoction of the leaves and roots is used to treat rheumatism, snakebites, and 
headache and stomach disorders (Ngadjui, Dongo, Happi, Bezabih, and Abegaz, 1998). 
Elsewhere, the plant extract is used as a diuretic, tonic, stimulant and analgesic (Ruppelt, 
Pereira, Goncalves and Pereira, 1991). The chemical constituents of D.scabra include 
phenolic compounds (6,8-diphenyl-3' [0], 4' -( 2,2-dimethylpyrano)-3,5,7-
trihydroflavone,3,6-di-phenyl-(2-hydroxy-3-methylbut-3-enyl)-5,7 ,2' ,4,-
tetrahydroxyflavone, as well as the common sterol 2-sitosterol (Ngadjui et ai., 1998). 
Recently, methanolic extract of this plant has been shown to exhibit hypotensive effects 
in fructose-induced hypertensive rats, an insulin resistant model of hypertension (Dimo, 
et ai., 2001). 
1.12.2 Ajuga iva L. [Labiatae] 
Ajuga iva is one of the most commonly used medicinal plant in Morocco (Bellakhdar, 
Claisse, Fleurentin, Y ounos, 1991). Various parts of this plant have been used for a 
variety of human ailments such as hypertension, diabetes mellitus, kidney disorders fever, 
toothache and dysentery (Ziyyat, Legssyer, Mekhfi, Dassouli, Serhrouchni, Benjelloun, 
1997). Furthermore, it has been reported that some species of the genus Ajuga are 
especially used as diuretic agents (Aliotta and Pollio, 1994) and as a remedy for 
hypertension (Kokwaro, 1976). Recently, studies have reported the hypoglycaemic effect 
of the aqueous extract of this plant in streptozotocin-induced diabetic rats (Hilaly and 
Lyoussi, 2002). In trying to establish the scientific basis for the traditional use of this 
plant as an anti-hypertensive, Hilaly, Lyoussi, Wibo and Morel (2004) demonstrated the 
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hypotensive and vasorelaxant effects of aqueous extracts of this plant in vivo and in vitro, 
respectively in experimental animal paradigms. Furthermore, compounds isolated from 
the genus Ajuga, are reported to exert cardiotonic activities (Kuria and Muriuki, 1984), 
1.12.3 Cosciniumfenestratum Colebr. [Menispermaceae] 
Coscinium Jenestratum, is a woody climber found in South East Asia. The plant is widely 
used in the region for medicinal purposes (Siwon, Verpoorte, Van Essen and Svendsen, 
1980). Various parts of this plant have been used for a variety of human ailments such as 
fever, muscle pain, stomach pain, malaria, diarrhoea, ulcers and infection of the eyes 
(Siwon, et ai., 1980). In the North-Eastern part of Thailand, aqueous extracts of the dried 
wood is widely used for traditional treatment of high blood cholesterol, hyperglycaemia 
as well as hypertension (Singh, Singh, Bani and Malhotra, 1990). Laboratory studies have 
reported the hypotensive effects of ethanolic wood extract of the plant in anaesthetized 
rats, dogs and guinea pigs (Singh et al. , 1990). Chemical investigations on the wood of 
Coscinium Jenestratum have resulted in isolation of berberine as the main alkaloidal 
constituent and a smaller amount of protoberberine (Rojsanga, Gritsanapan, Suntornsuk, 
2006). Recently, Coscinium Jenestratum has been reported to possess various 
pharmacological actions such as antioxidant (Venukumar, and Latha, 2002) 
antiproliferative (Ueda, Tezuka, Banskota, Le Tran, Tran, Harimaya, Saiki and Kadota, 
2002), antidiabetic, antihypertensive (Punitha, Rajendran, Shirwaikar and Shirwaikar, 
2005 and antibacterial (Nair, Narasimhan, Shiburaj and Abraham, 2005) activities. 
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1.12.4 Costus afer Ker. [Zingiberaceae] 
Costus afer is a tall perennial herbaceous, unbranched medicinal plant with creeping 
rhizome. Commonly known as gingerlily, the plant is found in moist or shady forests and 
riverbanks of tropical West Africa including Nigeria, Ghana and Cameroon (Iwu, 1983). 
This plant and other species of the genus are used as remedy for cough, inflammation, 
arthritis, as laxative, and purgative" diuretics, rheumatism and treatment of several 
diseases including hypertension (Oliver, 1960). In Nigeria the decoction of the stem or 
powdered fruits is used as cough medicine. Whole boiled root is applied to cuts and 
sores, and soothing fomentation for rheumatic pains prepared with boiled leaves (Oliver, 
1986; Iwu and Anyanwu 1982). Studies on animals demonstrated that decoctions of the 
stem ameliorated all signs associated with adjuvant-induced polyarthritis in rats 
(Awouters, Niemeeger, Lanaert, Jaseen, 1978). In Cameroon and Ivory Coast, the 
decoction of the plant is given to diabetic patients to alleviate the clinical signs associated 
with diabetes mellitus (lwu, 1993). Phytochemical screening of the extract revealed the 
presence of saponins, cyanogenic glycosides, tannins, flavonoids and carbohydrates 
(Oliver, 1986). 
1.12.5 Berberis vulgaris L. var. [Berberidaceae] 
Berberis vulgaris is a bush with yellow to brown coloured bark. The plant has obviate 
leaves, bearing pendulous yellow flowers in spring (Aynehchi , 1986).Various parts of 
this plant, such as, its root, bark, leaf and fruit have been used as folk medicine for long 
in Iran (Zargari, 1983). In Iranian traditional medicine the plant is reported to possess 
53 
several properties, such as antibacterial, antiarrhythmic, antihypertensive and antipyretic 
activities (Zargari, 1983; Aynehchi, 1986). Furthermore, the crude extract of this plant 
has been shown to exert anticholinergic activities (Shamsa, Ahmadiani and 
Khosrokhavar, 1999). In an attempt to establish the scientific basis for the traditional use 
of this plant as an anti-hypertensive, Fatehi, Saleh, Hassanabad, Farrokhfal, lafarzadeh, 
Davodi , (2005) demonstrated the hypotensive effects of aqueous extracts of this plant in 
DOCA-salt induced hypertensive rats . In addition, they demonstrated the vasodilatory 
effect of the aqueous extract of this plant in vitro. Pharmacological studies on an alkaloid 
isolated from this plant, demonstrated that it possesses potent vasodilatory and 
antiarrhythmic activity, and prolongs the action potential duration in Purkinje fibres and 
ventricular muscles (Chiou, Yen and Chen, 1991; Ricciopo, 1993 and Kathleen , 2000). 
There is some evidence that alkaloids isolated from Berberis vulgaris have anti-
inflammatory and antinociceptive effects (Kupeli, Kosar, Yesilada, Husnu and Baser, 
2002). 
1.12.6 Croton cajucara Benth. [Euphorhiaceae] 
Croton cajucara is a large tree that grows abundantly in Amazon region of Brazil and 
other parts in the Southern region of Africa (Berg, 1982). In Brazil, it is locally called as 
sacaca and extracts prepared from its stem bark are used in folk medicine to treat hepatic 
and kidney disorders, obesity, and hypertension (Berg, 1982). Chemical investigations on 
the bark have led to the isolation of several diterpenes, which include trans-
dehydrocrotonin (t-DCTN), trans-crotonin (t-CTN), cis-cajucarin B, trans-cajucarin B, 
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cajucarin A, cajucarinolide and sacacarin, and a triterpene acetyl aleuritolic acid (Maciel, 
Pinto, Brabo and Silva, 1998). Studies carried out with the most active compound, t-
DCTN, revealed its wide pharmacological profile that includes anti-inflammatory, 
gastroprotective, hypoglycemic, hypolipidemic, anti-estrogenic, vasorelaxant, 
cytotoxicity and anti-tumour actions (Brito, Roctry'guez, Hiruma-Lima, Haun and Nunes, 
1998; Ichihara, Takeya, Hitotsuyanagi and Morita, 1992). 
1.12.7 Cecropia pachystachya Mart. [Moraceae] 
Cecropia pachystachya also known as Cecropia adenopus is a plant that grows in 
paranaense phytogeographical province, in Northeast Argentina, Paraguay and southern 
Brazil (Cabrera and Willink, 1980). The plant reaches a height of about 10 m and has 
large wide palm-shaped leaves that are dark-green in colour in the upper and silver-grey 
below. The plant is widely employed in herbal medicine as a dietary supplement, used for 
treating cough and asthma and also as cardiotonic, antihypertensive and diuretic (Gupta, 
1995). More recently, an in vitro study demonstrated the antioxidant properties of the 
extracts of this popular plant (Velazquez, Tournier, Mordujovich de Buschiazzo, 
Saavedra and Schinella, 2003). Some laboratory studies have reported the 
antihypertensive (Salas, Brenes and Morales, 1987), diuretic (Vargas Howell and Ulate 
Montero, 1996), hypoglycemic (Roman-Ramos, Flores-Saenz, Partida-Hernandez, Lara-
Lemus, Alarcon-Aguilar, 1991), analgesic and central depressor effect (Perez-Guerrero, 
Herrera, Ortiz, Alvarez de Sotomayor, Fernandez, 2001) of this plant. The 
phytochemical analysis of the plant revealed the presence of alkaloids, cardiotonic 
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glycosides, flavonoids, tannins, triterpenoids and saponin glycosides (Morton, 1981). It is 
likely that the antihypertensive properties of this plant are attributed to the presence of 
these compounds. 
1.12.8 Zingiber officinale Roscoe. [Zingiberaceae] 
Zingiber officinale is a large biennial herb that grows abundantly in South Asia. The 
rhizome of the plant, commonly known as ginger, is widely used for its medicinal 
properties (Ghayur, Gilani, Maria, Afridi and Houghton, 2005). Ginger is well known all 
over the world especially for its use in disorders of the gastrointestinal tract such as 
constipation, dyspepsia, diarrhoea, nausea and vomiting (Tyler, 1993). Ginger is also 
commonly used by the traditional healers in South Asia for treatment of cardiopathy, high 
blood pressure, palpitations and to improve the circulation for its use as a vasodilator 
(Kapoor, 1990; Duke, 2002). Recently, the hypotensive, endothelium-independent 
vasodilator and cardio-suppressant properties of this plant have been reported (Ghayur 
and Gilani , 2005). Current observations suggests that the aqueous ginger extract lowers 
blood pressure through a dual inhibitory effect mediated via stimulation of muscarinic 
receptors and blockade of Ca2+ channels (Ghayur, Gilani , Maria, Afridi and Houghton, 
2005). Phytochemical studies have shown that the major active compounds of ginger are 
the gingerols, shogaols, zingerone, phytosterols and paradol (Langner, Greifenberg and 
Gruenwald, 1998). 6-gingeroJ and 6-shogaol are the major gingerol and shogaol present 
in the rhizome (Connell and McLachlan, 1972). 
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1.12.9 Eugenia uniflora L. [Myrtaceae] 
Eugenia uniflora is one of the common plant species growing in subtropical North and 
North Eastern Argentina, Brazil , Uruguay and Paraguay (Rotman, 1995). The plant 
grows from 3 tolOm in height. It bears red fruits which are edible. Its ovate leaves are 
used in folk medicine for the treatment of hypertension and digestive disorders in 
Argentina (Amat and Yagia, 1991). In Paraguay, leaves are reported to have diuretic and 
anti-inflammatory properties, both of which, offer cardioprotection in humans (Amat and 
Yagia, 1991). Recent laboratory studies in rats reported the hypotensive, vasodilatory and 
diuretic activities of aqueous leaf extract of this plant (Consolini, Baldini and Anibal, 
1999). This provides the pharmacological basis for the empirical use of this plant as 
antihypertensive. 
The phytochemical profile of this plant revealed the presence of phenolic compounds, 
flavonoids, leucoanthocyanidis, steroids and triterpenoids, essential oils, limonene, 
cineol, pulegone, camphor and sesquiterpenes (Bandon, Mendiondo, Rondina and 
Coussio 1972; Retamar, 1982; Adebajo, Oloke and Aladesanmi 1989). Essential oils 
present in the leaf of the plant have been shown to possess antibacterial and antifungal 
effects, while flavonoids have antioxidant properties (Consolini, Baldini and Anibal, 
1999). 
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1.12.10 Urtica dioica L. [Urticaceae] 
Urtica dioica is a perennial herb, which grows up to 1800 m in deserted field (Pignatti, 
1982). The stem is erect and green; the leaves are opposite, cordate at the base, oblong or 
ovate, finely toothed, dark green above and paler beneath. The small, green, dioecious 
flowers occur as racemes in the axils of the upper leaves. Usually, the plant has either 
male or female flowers, in separate inflorescences. In many ethnobotanical reports, the 
aerial parts of Urtica dioica are recognized as a natural remedy for hypertension (Ziyyat, 
Legssyer, Mekhfi, Dassouli, Serhrouchni and Benjelloun, 1997). The aqueous extracts of 
aerial parts have been reported to exhibit hypotensive and diuretic effects (Tahri, Yamani, 
Legssyer, Aziz, Mekhfi, Bonouham and Ziyyat, 2000) and prostatic antihyperplasic 
activity in vitro (Lichius and Muth, 1997). 
1.12.11 Botany of plants used in the study 
The plants used in the present study were chosen based on the following criteria: 
i) information for their use in traditional medicine in the treatment of hypertension 
and its associated diseases, such as diabetes mellitus; 
ii) the presence of natural compounds with structural similarities to the already 
known bioactive compounds with cardiovascular properties. 
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1.12.11.1 Ekebergia capensis Sparrm [Maliaceae] 
Ekebergia is a small genus of African trees belonging to the family of the Maliaceae. 
(Mabina, 1995). This is a fairly large tree, widespread in Eastern Africa from Sudan to 
the Cape (See Figure 1). Ekebergia capensis, or the Cape Ash as it is known locally, is 
used medicinally and magically by the Zulu people. Decoctions made from the chopped 
bark are traditionally taken as an emetic for heartburn, for coughs and other respiratory 
complaints while leaves are used in an infusion as a purgative parasiticide (Hutchings, 
Scott, Lewis, Cunningham, 1996; Bryant, 1966). The use of the plant in curing 
tuberculosis-related symptoms such as cough, fever, blood in the sputum, etc. has been 
reported (Hutchings, Scott, Lewis, Cunningham, 1996). In the KwaZulu-Natal province 
of South Africa, the roots of Ekebergia capensis are used in a decoction to treat gastritis, 
hyperacidity and coughing (Pujol, 1990). An extract from the bark is used to treat coughs 
and root extracts are used in the treatment of dysentery (Pooley, 1993). The roots have 
been used for the treatment of diarrhoea by the Kikuyu tribe (Gachathi, 1989). Extracts 
from Ekebergia capensis have been reported to inhibit drug-resistant and drug sensitive 
strain of mycobacterium tuberculosis. For instance, at a concentration of 1.0 mg/mI, the 
plant extract effectively inhibited a drug resistant strain (CCK028469V) (Lall, and 
Meyer, 1999). Furthermore, decoctions made from the wood of this plant are used by the 
local Zulu community to either provide supplements that promote foetal growth or to act 
as uterotonic agents that induce or facilitate labour (Sewram, Raynor, Mulholland, and 
Raidoo., 2000). 
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Previous phytochemical studies have resulted in isolation of several compounds including 
b-sitosterol ; oleanonic acid ;3-epioleanolic acid; 2,3,22,23-tetrahydroxy-2,6,10,15,19,23-
hexamethyl-6,10,14,18-tetra-cosatetraene and 7-hydroxy-6-methoxycoumarin, 3a-
hydroxy-3-deoxyangolensate, limonoids, ekebergin and beta-amyrin ( Serge,1998; 
Nashiyama, Moriyasu, Ichimaru, Tachibana, Kato, Mathenge. 1996). A major class of 
bioactive compounds present in this plant are triterpenes, which have been reported to 
exhibit a large variety of cardiovascular actions of medicinal herbs. For example, 
oleanolic acid, a major triterpene present in this plant (Sewram et ai., 2000) has been 
reported to possess antihypertensive, antidysrhythmic, cardiotonic, diuretic, 
hypoglycaemic, antihyperlipidemic and antioxidant properties (Somova, Nadar, 
Rammanan and Shode, 2003 and Somova, Mipando and Shode, 2004). Thus, Ekebergia 
capensis was chosen based on the presence of triterpenes which, have been demonstrated 
to exhibit cardioprotective actions. 
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Figure 1. Flowers (left) and leaves (right) of Ekerbegia capensis plant. 
1.12.11.2 Sclerocarya birrea (A. Rich). Hochst. [Anacardiaceae] 
The Marula (Sclerocarya hirrea) is one of the most highly valued indigenous trees in the 
Southern Africa. It is reported that the Tonga people celebrate the feast of the first fruits 
by pouring a drink offering of the fresh juice of the fruit over the tombs of the dead chiefs 
(Palgrave, 1983). The pulp of the fruit is delicious and the nut is also edible. Some tribes 
such as the Pedi make a relish from the leaves (Fox and Young, 1982). Sclerocarya 
birrea commonly known as 'Marula' is a medium sized tree that grows up to 
approximately 15 meters in height (See Figure 2). It bears flaky rough stem bark and 
small flowers with red sepals and yellow petals. The plant produces large rounded fruits 
which contain edible nuts with high content of vitamin C, a naturally occurring 
antioxidant (Balick, 1990). 
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An ethnophannacological survey identified a number of medicinal uses of this plant in 
Southern, Eastern and tropical West Africa (Watt and Breyer-Brandwijk 1962; Oliver-
Bever 1986 and Hutchings, Scott, Lewis and Cunningham, 1996). Zulu people use bark 
decoctions for diarrhoea. Bark decoctions are used for dysentery and diarrhoea in some 
parts of Southern Africa (Watt and Breyer-Brandwijk, 1962). The Venda use bark for 
treating fevers, stomach ailments and ulcers (Mobogo, 1990). The bark decoction is used 
as anticough; the leaves, the pulp of fruit and mistletoe are used for hypertension (Guinko 
1984). The bark and leaves are also used as antihyperglycemic (Nacoulma-Ouedraogo, 
1996). Roots are used for many purposes including sore eyes in Zimbabwe (Gelfand, 
Mavi, Drummond and Ndemera, 1985). In addition, the presence of a large amount of 
ascorbic acid, a powerful antioxidant, could be of relevance in the counteraction of some 
of the clinical features associated with hypertension (Eromosele, Eromosele and 
Kuzhkuzha, 1991). Recently, Ojewole, (2003) reported the anti-inflammatory activity of 
aqueous and methanolic extracts of this plant in an experimental mammalian animal 
model. 
Chemical analysis of this plant reveals the presence of (-)-Epicatechin-3-galloyl ester 
(Galvez, Crespo, Zarzuelo, Dde Witte and Spiessens, 1993), crude oil carbohydrate, 
crude protein, fibre and saponins (Ogbobe, 1992), minerals (Smith, Clegg, Keen and 
Grivetti. 1996) and ascorbic acid (Eromosele, Eromosele and Kuzhkuzha, 1991), 
alkaloids, anthocyans, flavonoids , tannins and saponosides (Galvez et ai. , 1993). 
Saponins have been reported to stimulate nitric oxide release from vascular endothelial 
cells to induce vascular smooth muscle relaxation (Rice-Evans, Miller and Paganga, 
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1996). Similarly, plant derived polyphenols, including flavonoids have been 
demonstrated to relax blood vessels in an endothelium-dependent, nitric oxide-mediated 
manner (Fitzpatrick, Hirschfield, Ricci, Jantzen and Coffey, 1995; Rice-Evans, Miller 
and Paganga, 1996; Andriambeloson, Stoclet and Andriantsitohaina, 1999; Huang, Chan, 
Lau, Yao, Chan and Chen 1999). Flavonoids, saponins and tannins have also been 
demonstrated to possess angiotensin converting enzyme inhibitory activity (Lacaille-
Dubois, Franck and Wagner, 2001). Therefore, the presence of these pharmacologically 
active compounds with cardiovascular activities prompted us to include this plant in the 
present study. 
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Figure 2. Stem, leaves flowers and fruits of Sclerocarya birrea 
1.12.11.3 Persea americana Mill. [Lauraceae] 
Persea americana Mill. Lauraceae, a native oftropical America Mexico, is now widely 
cultivated throughout the tropics and subtropics of the world. Commonly known as 
Avocado pear, Alligator pear or Mexican avocado, it is an evergreen tree, 14-20 m high 
with large spreading and flat-topped crown and deeply fissured brow corky bole (See 
Figure 3). The branches are grey and also fissured but the twigs are green and smooth 
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(FAO. 1986). The plant bears fruits of various shapes and colours. The fruits are 
spherical, ovoid, ellipsoid or pyriform of about 8-20 cm long depending on the variety 
(Ross, 1999). The fruits are green, red or purple with a creamy or whitish pulp which is 
highly nutritious. In addition to its nutritional values, Persea americana is widely used in 
the traditional medicine of many countries. Ethnopharmacy of the Aztec culture used 
decocts of avocado seeds as a potent agent to treat mycotic and parasitic infections. Also 
local anaesthetic effects of avocado seeds preparations are known to decrease muscle 
pain (Argueta, Cano and Rodarte, 1994; Cabrera, 1996). Morphological parts of this plant 
are extensively used in traditional medicine for the treatment of various ailments. In 
Congo Brazzaville, a decoction of the stem bark is taken to relieve cough; while in 
Mexico, it is used as an aphrodisiac, emmenagogue, to prevent miscarriage, and in the 
treatment of haemorrhage between menstrual periods, insomnia, anaemia, diabetes, 
diarrhoea, dysentery and so forth (Watt and Breyer-Brandwijk, 1962). The leaves are 
used in Brazil and Jamaica for the treatment of high blood pressure (Watt and Breyer-
Brandwijk, 1962). The hot water extract is orally taken as a diuretic and for hypertension 
in West Africa (Ross, 1999). Previous studies on this plant have shown that the leaf 
extracts of Persea americana possess a catalogue of pharmacological activities, including 
analgesic, anti-inflammatory, antidiabetic, hypoglycaemic, hypotensive and 
antihypertensive properties (Adeyemi, Okpo and Ogunti, 2002; Antia, Okonon and Okon, 
2005; Adeboye, Fajonyomi, Makinde, and Taiwo, 1999). However, the mechanisms of 
the antihypertensive action of the extracts from this plant have not been established. 
Thus, Persea americana was included in the present study in order to elucidate the 
mechanisms of its reported antihypertensive activity. 
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Phytochemical screening of the Persea americana reveals the presence of alkaloids, 
coumarins and triterpene glycosides and tannins, (Valeri and Gimeno, 1953), saponins 
and flavonoids (Geissman and Dittmar, 1965), phytosterols, triterpenes (Werman, 
Mokadyand Neeman, 1990; Lozano, Dhuique Mayer, Bannon and Gaydou, 1993) fatty 
acids, furanoic acids (Farines, Soulier, Rancurel, Montaudoin and Leborgne, 1995), 
some carotenoids, vitamin B, vitamins C and E (Slater, Shankman, Shepherd and Alfin-
Slater. 1975). 
Figure 3. Shows a picture of a branch of Persea americana with some fruits. 
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1.12.11.4 Helichrysum ceres S. Moore [Asteraceae] 
The genus Helichrysum, belonging to the family Asteraceae is represented by 
approximately 500 species in the world. This genus is represented in South African flora 
by 245 species (Hilliard, 1983). The plant Helichrysum is a perennial, aromatic shrub 
which bears a large number of bracts located in several rows and which are yellow and 
shiny (Hutchings, 1989) (See Figure 4). The plant is traditionally used for treatment of 
various human ailments (Litvinenko, Popova, Popova, and Bubenchikova 1992). Some 
members of this genus have stimulatory activity on the secretion of gastric juice. 
Moreover, some species from this genus are used in folk medicine for their anti -
inflammatory and anti-allergic properties (Carini, Aldini , Furlanetto, Stefania nd Facino., 
2001). Other species from this genus are reported to be used in the treatment of 
tuberculosis, (Watt and Breyer-Brandwijk, 1962). Helichrysum ceres is reported to be 
used in the treatment of hypertension, infectious diseases and respiratory diseases in most 
parts of the Southern Africa (Hutchings, 1989; Watt and Breyer-Brandwijk, 1962). For 
instance, Zimbabwean traditional healers use extracts of Helichrysum ceres for 
management of heart and kidney disorders (Musabayane, Munjeri and Mdege, 2003). 
Recent laboratory studies have reported the hypotensive, natriuretic and diuretic effects 
of aqueous leaf and root extracts in rats (Musabayane, Munjeri and Mdege, 2003). 
The medicinal properties of this genus are mainly attributed to the presence of flavonoids, 
but they may be also influenced by other organic and inorganic components, such as 
coumarins, phenolic acids and antioxidant micronutrients , e.g. Cu, Mn, Zn (Dombrowicz, 
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Swiatek, and Kopycki, 1994). In the present study the plant was chosen with the aim of 
elucidating the mechanisms of its reported cardiovascular actions. 
Figure 4. Helichrysum ceres plant 
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1.12.11.5 Hypoxis hemerocallidea Fisch. & Mey [Hypoxidaceae]. 
Hypoxis hemerocallidea, formerly known as Hypoxis rooperi, is a plant that belongs to a 
family known as hypoxidaceae. The plant is commonly referred to as 'African potato' 
even though the underground stem does not look like a potato but it's a corm bearing 
many nodes and nodules (See Figure 5). The plant is widely used in traditional medicine 
for different ailments. For instance, the plant is used by the Zulu community for 
hypertension, arthritis, diabetes, urinary tract infections (Hutchings, 1989). The plant is 
also used as a stimulant of human immune system and therefore indirectly relieving mv-
AIDS infections, as an agent for slowing down the growth of cancer cells, as having 
positive effect in combating "yuppie flu" and as being effective in alleviating arthritis 
(Hutchings, 1989; Drewes and Hom., 1999). Other pharmacological studies have 
reported anti-inflammatory activity, anti-microbial and anti-cancer activities of the 
Hypoxis plant (Ojewole 2005; Albrecht, 1996). Others have reported antioxidant property 
of extracts from this plant (Laporta, Perez-Fons, Mallavia, Cuturla and Michol, 2007). 
Ojewole and Zibula, (2000) reported the potent hypoglycaemic effects of Hypoxis 
hemerocallidea corm methanolic extract in both normal and diabetic Wi star rats. 
Diabetes mellitus and hypertension are commonly associated conditions. Moreover, 
epidemiological studies indicate that the prevalence of hypertension in type 2 diabetes is 
higher than in the general population (UK Prospective Diabetes Study Group, 1998). 
Thus, based on its reported hypoglycaemic effects and its use in traditional medicine for 
treatment of hypertension, we selected this plant to investigate its pharmacological basis 
for its use in the treatment of hypertension. 
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The phytochemical studies have reported the presence of hypoxoside as a major 
compound which is biologically inactive, but once formed it is rapidly converted to a 
more biologically active aglycone form, called rooperol (Drewes, Hall, Learmonth and 
Upfold, 1984; Albrecht, 1996). Other compounds present in Hypoxis plant include ~­
sitosterol, stigmasterol, ~-sitosterol glycoside and sitostanol (Mills, Cooper, Seely and 
Kanfer, 2005). 
Figure 5. Hypoxis hemerocallidea plant 
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1.13 Basis of the project. 
The available conventional treatments of hypertension are far too costly and inaccessible 
to the poor majority in the developing nations. Thus, in spite of the effective conventional 
drug therapy available for hypertensive patients in general, economic problems in the 
developing nations continue to influence the lower rate of control of hypertension. 
Moreover, the cost analysis of possible antihypertensive drug treatment indicates that the 
developing countries cannot afford the same treatment as developed countries (Nissine, 
Bothig Granroth and Lopez, 1988). It is evident enough, therefore, that with increasing 
numbers of patients suffering from hypertension and conventional therapy beyond the 
reach of a wide population in developing countries, medicinal herbs with 
antihypertensive properties are increasingly sought by patients as well as health care 
professionals as an alternative, cheap and accessible source of treatment. However, 
although a lot of medicinal plants are used in the treatment of cardiovascular disorders or 
display antihypertensive activities, there is little or no reliable information regarding their 
safety and mechanisms of actions. Screening of anti-hypertensive effects in traditional 
medicines has been performed over many years by utilizing several animal models 
(Villar, Paya and Terencio, 1986). Our research team in the Departments of Physiology 
and Pharmacology at the University of KwaZulu Natal, Westville campus embarked on a 
huge project of screening the biopharmacological effects of some African medicinal 
plants on cardiovascular functions, in an effort to identify cheap and accessible treatment 
of hypertension and its complications. The present study forms part of this project and is 
aimed at establishing the mechanism(s) of the cardiovascular effects of some medicinal 
plants used in the traditional treatment of hypertension and other cardiac disorders by 
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traditional health practitioners. It is envisaged that treatment of hypertension in poor 
African nations would become cheaper and therefore accessible by using scientifically 
proven phytotherapy. Thus, it would be necessary to establish the mechanism (s) of the 
cardiovascular effects and efficacy of the traditional herbs and develop them into 
therapeutic formulations that are readily affordable and accessible to the community. In 
Western medicine, drug development has become increasingly more mechanistic in focus 
with the aim of exclud~ng unwanted side-effects (Hansen, Nyman, Smitt, Adsersen, 
Gudiksen, Rajasekharan and Pushpangadan, 1995). Similarly, the focus of the present 
study is on the establishment of the mechanisms of the cardiovascular effects of some 
medicinal plants used in traditional management of hypertension and other cardiovascular 
disorders in the Southern region of Africa. 
We hypothesized that if the mechanisms of the cardiovascular effects of Hypoxis 
hemerocallidea corm (,African Potato'), Ekebergia capensis, Persea americana 
(A vocado) and Helichrysum ceres leaf and Sclerocarya birrea stem-bark ethanolic 
extracts could be established, then these plants would have the potential to provide a 
cheap and accessible source of treatment of hypertension and other cardiovascular 
disorders . 
There are no reports based on scientific observations in the literature on the mechanisms 
of the cardiovascular effects of these plants. Therefore, in the present study, the effects 
of ethanolic extracts of these plants on heart rate and blood pressure were evaluated in 
rats . Contractility of rat isolated atria, aortic rings and portal veins were studied in vitro. 
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The in VlVO cardiovascular studies were performed on both normotensive and 
hypertensive rats to verify whether the extracts had the ability to modify cardiovascular 
functions under pathological conditions. To establish possible mechanisms of the 
cardiovascular activities of the extracts , use was made of the positive standard control 
drugs used in conventional medicine, whose mechanisms of action are well established. 
1.14 Aims 
The main aim of the present study was to establish the mechanisms of cardiovascular 
effects of some medicinal plants used in traditional treatment of hypertension and other 
cardiac disorders in South Africa. 
1.14.1 Objectives: 
i) To evaluate the in vitro and in vivo cardiovascular effects of various extracts of 
some medicinal plants. 
ii) To establish the mechanism (s) of the cardiovascular effects of various extracts of 
some medicinal plants. 
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CHAPTER 2 
2.0 MA TERIALS AND METHODS 
2.1 Ethical consideration. 
All the procedures followed were approved by the Ethics Committee of the University of 
KwaZulu-Natal (Ethical clearance number: HSS/05014A, See Appendix 1) and 
conformed to the "Principles of laboratory animal care" (WIH publication 85-123, 
revised in 1985). 
2.2 Materials 
2.2.1 Drugs 
Methoxamine hydrochloride, acetylcholine chloride, indomethacin, NG-nitro-L-arginine-
methyl-ester (L-NAME), methylene blue, atropine sulphate, glibenclamide, propranolol, 
noradrenaline, prazosin, reserpine and nifedipine were obtained from Sigma (St. Louis, 
MO 63178, USA), Heparin Novo (Nordisk (Pty) Ltd, Johannesburg, RSA) All other 
chemicals and reagents were of the analytical grade and supplied by Merck chemicals 
(Pty) Ltd, 259 Davidson Rd, Wadenville, RSA). Indomethacin was dissolved in 0.5% 
sodium bicarbonate. Glibenclamide was dissolved in dimethyl sulfoxide (DMSO). All 
other drugs, including Krebs' solution were freshly prepared in deionized water. 
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2.3 Identification of plants and collection of plant materials. 
Five plants namely Ekebergia capensis (Sparrm) [Maliaceae], Persea americana (Mill) 
[Lauraceae], Helichrysum ceres (S. Moore) [Asteraceae], Sclerocarya birrea (A. Rich) 
[Anacardiaceae] and Hypoxis hemerocallidea (Fisch. & c.A. Mey) [Hypoxidaceae] were 
identified and authenticated by Prof. H. Baijnath of Botany Discipline. The plant 
materials were collected in different areas in KwaZulu-Natal Province between July and 
December 2004. Voucher specimens of the plants have been deposited at the Discipline 
of Botany Herbarium, University of KwaZulu-Natal. 
2.4 Plant extraction. 
2.4.1 Leaf and corm extraction. 
Leaves from E. capensis, H. ceres and P. americana were air-dried under room 
temperature. The air-dried plant leaves were then ground separately into powder using a 
commercial blender (Waring blender) and then weighed. The ground material was soaked 
in 99% ethanol for 48 hours after which, the soaked material was filtered using 30 cm 
filter paper (Whatman, England). The filtrate was concentrated under reduced pressure in 
a vacuo using a rotary evaporator at 55°C (Buchi, Lotavapor, Essen, Germany). The 
concentrated crude extract was recovered and allowed to air-dry under room temperature 
and thereafter, the percent yield was determined. The recovered extracts from E. 
capensis, H. ceres and P. americana were represented as EKE, HCE and PAE, 
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respectively. For H. hemerocallidea the extraction method was the same except that fresh 
corms were crushed into smaller pieces after peeling. The concentrated crude extract was 
recovered and freeze dried to yield a brown powdery material which was represented as 
APE. 
2.4.2 Stem-bark extraction. 
Stem-bark from Sclerocarya birrea was air-dried and ground into powder using a 
Thomas-Wiley Laboratory mill model 4 (Arthur H Thomas company Philadelphia, PA., 
USA). Following this, the extraction procedure was as described in 2.4.1. The final crude 
extract was denoted SBE. 
All extracts were freshly prepared on each day of experiment by dissolving in DMSO 
using the method previously described by Musabayane, Bwititi and Ojewole, (2006). 
2.5 Animals 
Male Wistar (250-300 g) and weanling Dahl salt-sensitive (DSS) rats (100-150 g) bred 
and housed at Biomedical Research Unit of the University of KwaZulu-Natal were used 
for the in vivo acute and chronic studies, respectively. Male Wi star rats weighing 350-400 
g were used for in vitro studies. The animals were maintained under the conditions of 
constant temperature (22±2 DC), carbon dioxide content of <5000 p.p.m., relative 
humidity of 55 ± 5%, and illumination (12h lighUdark cycles) and the noise levels of <65 
76 
decibels. The animals were fed with standard animal chow (Epol-diet 4700, Epol, RSA) 
and had free access to drinking water. 
2.6 Blood pressure measurement 
2.6.1 Acute studies. 
The effects of the test extracts on the mean arterial blood pressure and heart rate were 
evaluated in anaesthetized male Wistar normotensive rats using a method previously 
described by Musabayane, Munjeri and Mdege, (2003). On each day of experimentation, 
the animals were anaesthetized by an intraperitoneal injection of trapanal (sodium 5-
ethyl-(1-methylbutyl)-2-thiobarbiturate, Byk Gulden, Konstanz, Federal Republic of 
Germany) at O.l1g.! kg. body weight. The animals were tracheotomized to maintain clear 
airway entry. The rats were placed on a warming table (CF Palmer, London, England) to 
maintain their body temperature at 37 ± 1°C. The left carotid artery was catheterized with 
heparinized saline (50 units/ml saline) polythene tubing (internal diameter, 0.58mm and 
external diameter 0.96mm, Clay Adams, New Jersey, USA). The catheter was then 
connected to a pressure transducer (Statham MLT0380, Ad instruments, compatible with 
PowerLab system ML41OIW, Inc, Bella Vista, Australia) for continuous measurement of 
blood pressure and heart rate. The right external jugular vein was cannulated with the 
same type of tubing to allow continuous infusion of 0.077 M NaCl (Merk Ltd) at 150flLl 
min (Harvard Apparatus, Model 2400003, South Natick, Massachusetts, USA). The 
perfusion of this solution is used in order to maintain a correct plasmatic oncotic pressure 
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and to avoid fluid shifts during surgery (Maddox, Price and Floyd, 1977). The urinary 
bladder of each rat was also cannulated with similar caliber polythene tubing via an 
incision in the abdominal wall just for urine voidance. 
Following a 3h equilibration period, blood pressure and heart rate measurements were 
recorded over the 4h post-equilibration period of 1h control, 1h 30 min treatment and Ih 
30 min recovery periods. Thus, after a 3h equilibration period, two control measurement 
periods of 30 minutes each were allowed. At the end of this control period, the plant 
extracts were added to the infusate and delivered at 0.06 Ilg/ min for 90 minutes, giving a 
total dose of 120 mg/ kg body weight. During this treatment period, three experimental 
measurements of 30 minutes each were taken. After the treatment period, the infusion of 
the plant extracts was discontinued and replaced again by the 0.077 M NaCl at 150 ilL! 
min and three recovery measurement periods of 30 minutes each were allowed. The 
control animals (n=6) were continuously infused with 0.077 M NaCl at 150 ilL! min 
throughout the experimental period. Therewith, urine was voided continuously via the 
cannulated urinary bladder. Data from the control group was used as baseline. 
2.6.2 Chronic studies. 
In order to evaluate the long-term effects of the test extracts on blood pressure and heart 
rate, six separate groups comprising of one control group and five treated groups of 
weanling male Dahl salt sensitive rats (n=8, per group) were used. The Dahl salt 
sensitive rats develop hypertension as they progress with age. 
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Before the chronic experiment started the rats were subjected to a training programme for 
one week so as to allow them to become accustomed to the whole procedure involved in 
blood pressure measurement. This training programme involved: the handling of the rats, 
placing them in restrainers and holders, preheating and the measurement of blood 
pressure on the tail. The values obtained during the training programme were not 
included in the analysis at the end of the experiment. After the training period, systolic 
blood pressure, diastolic blood pressure, mean arterial pressure and heart rate were 
measured using an indirect tail cuff computerised blood pressure monitor (IITC Life 
Sciences Model 31, Life sciences, Woodland Hills, California, USA). This unit works 
with IITC hardware blood pressure system that determines both blood pressure and heart 
rate. The system employs an automatic scanner and pump, sensing cuff and amplifier to 
measure and count the pulse rate in the animal tail. The results are displayed as data plots 
and summary data of systolic, diastolic and mean blood pressure and heart rate on the 
computer screen. Small, medium and large restraining devices and 2 different tail cuffs 
(lOmm and 15mm) were used to compensate for the increase in body weight during the 
6- week programme. Three readings were observed for each rat per session. Owing to the 
sensitivity of the method, no prolonged preliminary warming of the animals was 
necessary, but a constant room temperature of 26°C was maintained. 
2.6.2.1 Treatment 
The extracts were prepared fresh on each day of the experiment by using the method 
previously described by Musabayane, Bwititi and Ojewole, (2006). The extracts were 
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dissolved in dimethyl sulfoxide (DMSO, 2 ml) and normal saline (19 ml). The animals 
were treated with specific extracts orally by gavage at a dose of 80 mgl kg. body weight 
daily at 09hOO for six weeks. The animals in the control group were given an equal 
volume of DMSO-saline dissolution medium (1 mll kg. body weight) free of crude 
extract. 
2.7 In vitro pharmacological studies. 
2.7.1 Cardiotonic experiments. 
The experimental procedure used for rat isolated atria was adopted from that described by 
Ojewole (2006) . Briefly, male Wi star rats were sacrificed by stunning and 
exsanguination. An incision was made on the skin of the thorax and the underlying 
muscle layer. The ribs and the diaphragm were cut open to expose the heart. The entire 
heart was excised rapidly and placed in a petri dish containing Krebs Hensenlet 
physiological solution (of the following composition : NaCI, 118mM; KCI, 4.7mM; 
NaH2P04.2H20, 1.28 mM; NaHC03, 25.0 mM; CaCh.2H20, 2.52 mM; MgCh, 1.2 mM; 
glucose, 5.55 mM at pH adjusted to 7.4) aerated continuously with carbogen (a mixture 
of 95% oxygen and 5% carbon dioxide). The right and left atria were isolated and 
transferred to another petri dish also containing Krebs-Hensenlet physiological solution 
which was aerated continuously at 34±1°C. In order to evaluate the effects of the plant 
extracts on the rate of myocardial contraction, the rat isolated spontaneously-beating right 
atria were used. The rat isolated electrically-driven left atria were used to evaluate the 
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effects of the various extracts on the force of myocardial contraction. The ends of the 
contraction axis of the right atrial tissue were tied with cotton threads. The isolated left 
atrium was impaled on a thin platinum wire electrode, while in tying up the cotton thread, 
a round loop was made at one end to hook the right atrial tissue to a fixed position in the 
organ bath. The atrial tissues were then suspended inside the 30-rnl Ugo Basile organ 
bath (Ugo-Basile, Comerio, Italy) containing Krebs-Hensenlet physiological solution 
under an applied resting tension of 1.0g. The left atrium was electrically driven with 
square wave pulses of 5msec. duration at a frequency of 3 Hz and a supramaximal 
voltage of 5-10 volts, delivered by an SRI stimulator (Preamplifier, Bioscience, United 
Kingdom). The physiological solution was continuously aerated with carbogen at 
34±I°C. The other end of the cotton thread was connected to isometric force 
displacement transducer (model 7200, Ugo-Basile, Comerio, Italy). The atrial tissues 
were allowed to equilibrate for a period of 60 minutes, during which time the bathing 
physiological solution was changed every 15 minutes. 
2.7.1.1 Experimental protocol 
After an equilibration period, graded concentrations of EKE, HCE, P AE, APE, SBE 
and/or reference drugs were added to the organ bath cumulatively to generate cumulative 
concentration-response curves for each extract or standard positive drugs. Isometric 
contractions were recorded by means of Ugo-Basile force-displacement transducers 
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(model 7200, Ugo Basile, Comerio, Italy), and pen-writing 'Gemini' recorders (Gemini 
7070, Ugo-Basile, Comerio, Italy). 
2.7.1.2 Cholinergic mechanisms 
To find out whether the inotropic and chronotropic effects exhibited by the test extracts 
were mediated through cholinergic receptors, the atrial preparations were pretreated with 
atropine sulphate (lflM), a muscarinic receptor antagonist (Arunlakhshana and Schild, 
1959). Atropine sulphate was added to the organ bath ten minutes before re-
determination of the effects of the test extracts/drugs. The cumulative concentration-
response curves generated for each extract/drug in the presence of atropine were then 
compared to those generated in the absence of atropine. The effects of the extracts/drugs 
were expressed as percentage of the baseline values (n= 8 preparations for each 
concentration). 
2.7.1.3 Adrenergic mechanisms. 
In order to examine the involvement of beta-adrenergic receptors in the inotropic and 
chronotropic effects of the test extracts, the atrial preparations were pretreated with 
propranolol (lflM), a non-selective beta adrenergic receptor blocking agent (Hoffman 
and Lefkowitz, 1990). Propranolol was added 5 minutes before re-determination of the 
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effects of the test extracts. The cumulative concentration-response curves generated for 
each extract/drugs in the presence of propranolol were then compared to those generated 
in the absence of propranolol (n= 8 preparations for each concentration). 
2.7.1.4 Involvement of catecholamines 
To examine whether the cardiotonic effects of the test extracts were mediated through 
modulation of noradrenaline release from junctional stores, the atrial preparations were 
pretreated with reserpine (5IlM), to deplete junctional noradrenaline stores (Salzmann, 
Bormann, Herzig, Markstein and Scholtysik, 1985). The cumulative concentration-
response curves were then generated for each extract and compared to those generated in 
the absence of reserpine (n= 8 preparations for each concentration). 
2.7.1.5 Effects of various extracts on positive inotropic effects of 
noradrenaline and calcium. 
The effects of various extracts on noradrenaline-induced positive inotropic effects were 
investigated in rat isolated electrically-driven left atrial muscle preparations. After an 
equilibration period, cumulative concentration-response curve (O.I-1.6IlM) for 
noradrenaline was generated in the absence of the test extracts (n= 8 preparations for each 
concentration). Then the left atrial muscle preparations were pretreated with a known 
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concentration of the test extract for 10 minutes, followed by cumulative addition of 
noradrenaline (0.1-1.6IlM) to re-establish the cumulative concentration-response curves. 
The cumulative concentration-response curves generated in the presence of the test 
extracts were compared to those generated in the absence of the extracts. The similar 
procedure was followed to determine antagonistic effects of the extracts on calcium-
induced positive inotropic effects in the rat isolated left atria. The concentrations of 
calcium used were 0.5-8 IlM (in each case n= 8 preparations). 
2.7.2 Vascular experiments 
2.7.2.1 Preparation of aortic rings. 
The experimental procedure used for rat isolated aorta was adopted from that described in 
detail by Ojewole (2006). Briefly, male Wistar rats were sacrificed by stunning and 
exsanguination. The descending thoracic aorta was quickly removed and placed in a petri 
dish containing Krebs-Hensenlet physiological solution (of composition as described in 
2.7.1). The aorta was freed of extraneous and excess connective tissue and cut into rings 
of about 4-5 rom in width. The dissecting procedures were carefully done to protect the 
functional endothelium from inadvertent damage. When required by the experimental 
protocol, mechanical removal of endothelium was achieved by gently rubbing the luminal 
surface of the aortic ring six times back and forth with a distilled water- moistened cotton 
wool. A pair of isolated aortic rings, one with intact functional endothelium and the other 
one without a functional endothelium, were always set up in parallel for comparison. The 
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rings were suspended under the resting tension of 1 g, in a 30-ml Ugo-Basile organ-bath 
(Ugo-Basile, Comerio, Italy) containing Krebs Hensenlet physiological solution 
maintained at 36 ±1°C and aerated continuously with carbogen (a mixture of 95% oxygen 
and 5% carbon dioxide). The aortic preparations were left to equilibrate for 60 minutes 
during which, the physiological bathing solution was changed every 15 minutes before 
they were challenged with graded concentrations of various plant extracts. 
2.7.2.2 Experimental protocol. 
After an equilibration period of 60 minutes, the aortic rings were contracted with 
methoxamine hydrochloride (ME, 10 flM). After a sub-maximal and stable contraction 
was achieved, acetylcholine (Ach, 10 flM) was added to the organ bath to induce 
vasorelaxation so as to confirm the integrity of the endothelium. A relaxation 2: 70% 
induced by acetylcholine on the methoxamine-induced contraction was considered 
representative of an acceptable presence of a functional endothelial layer, while a 
relaxation:s 10%, indicated a satisfactory effectiveness of the endothelium removal. 
2.7.2.3 First protocol-aortic rings with functional endothelium. 
Forty minutes after the confirmation of endothelial integrity, the endothelium-intact 
aortic rings were pre-contracted with methoxamine hydrochloride (10 flM) or low 
potassium concentration, K+ (20mM) or high potassium concentration, K+ (80mM). After 
a sustained stable tonic contraction was achieved, graded concentrations of various plant 
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extracts were added to the organ bath cumulatively to obtain concentration-dependent 
relaxant responses. The vasorelaxant effects of the extracts were calculated from the 
decrease of tonic contraction and expressed as the percentage of maximal contraction 
induced by the agonist (n= 8 preparations for each concentration). 
2.7.2.4 Second protocol- aortic rings without functional endothelium. 
Forty minutes after the confirmation of endothelial removal, the aortic rings were pre-
contracted with methoxamine hydrochloride. After a sustained stable tonic contraction 
was achieved, graded concentrations of various plant extracts were added cumulatively to 
the organ bath containing the endothelium-deprived aortic rings, to obtain cumulative-
concentration-dependent relaxant responses. The responses obtained in the endothelium-
deprived aortic rings were compared with those obtained in endothelium-intact aortic 
rings (2.7.2.3). 
2.7.2.5 Third protocol- involvement of endothelium-derived relaxing factors. 
To verify the involvement of the endothelium-derived vasodilators, 40 minutes after the 
confirmation of endothelial integrity, specific inhibitors were added to the organ bath, 30 
minutes before the aortic rings were pre-contracted with methoxamine hydrochloride. 
Thus, to investigate the role of nitric oxide, prostacyclin and cyclic guanosine 
monophosphate (cGMP), the endothelium-intact aortic rings were pretreated with L-
NAME (100 11M) a nitric oxide synthase inhibitor, indomethacin (10 11M), a 
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cyclooxygenase inhibitor and methylene blue (10 11M), a guanylate cyclase inhibitor, 
respectively, 30 minutes before the aortic rings were pre-contracted with methoxamine 
hydrochloride. After a sustained stable tonic contraction was achieved, graded 
concentrations of various plant extracts were added cumulatively to the organ bath 
containing the endothelium-intact aortic rings to obtain cumulative-concentration-
dependent relaxant responses. The responses obtained in the presence of specific 
inhibitors were compared with those obtained in the absence of the inhibitors (2.7.2.3). 
2.7.2.6 Fourth protocol- involvement of potassium and calcium channels. 
To investigate whether the vascular effects of the test extracts involved potassium 
channels, 40 minutes after the confirmation of endothelial integrity, the endothelium-
intact aortic rings were precontracted with low potassium concentration (K+ 20mM). 
After a stable tonic contraction was achieved, graded concentrations of various extracts 
were added to the organ bath to generate cumulative-concentration response curves. To 
verify the involvement of modulation of ATP-sensitive potassium channels, the aortic 
rings were pretreated with glibenclamide (311M), an ATP-sensitive potassium channel 
blocker, 10 minutes before precontracted with (K+ 20mM). After a stable tonic 
contraction was achieved, cumulative-concentration response curves for the extracts were 
re-established. The cumulative-concentration response curves generated in the presence 
of glibenclamide were compared to those generated in the absence of glibenclamide. 
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To investigate whether the vasorelaxant effects of various extracts involved modulation 
of calcium channels, 40 minutes after the confirmation of endothelial integrity, the 
endothelium-intact aortic rings were precontracted with high potassium concentration (K+ 
80rnM). After a stable tonic contraction was achieved, graded concentrations of various 
extracts were added cumulatively to the organ bath to establish cumulative-concentration 
response curves. 
2.7.3 Studies on portal veins 
2.7.3.1 Preparation of portal veins. 
Healthy male Wistar rats were sacrificed by stunning and exsanguination. The abdomen 
of the rat was quickly opened by midline incision, and the intestines were pulled aside. 
The portal veins were carefully cleaned free of associated connective, extraneous and 
fatty tissues. The portal veins were tied with a cotton thread at each end (between the 
hepatic bifurcation of the vein and the anterior mesenteric vein) and then excised. From 
the time of the dissection, the portal veins were maintained in Krebs-Henseleit 
physiological solution (of composition described in 2.7 .1). Each isolated portal vein was 
suspended vertically under an applied resting tension of 0.5 g in a 30-rnl Ugo-Basile 
organ-bath (Ugo-Basile, Comerio, Italy) containing Krebs-Henseleit physiological 
solution which was maintained at 36±I°C, pH 7.4 and continuously bubbled with 
carbogen (95% oxygen and 5% carbon dioxide gas mixture) . Two isolated venous tissue 
preparations (control and treatment) were always set-up for comparison. The venous 
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preparations were allowed to equilibrate for 60 minutes during which time the bathing 
physiological solution was changed every 15 minutes before they were challenged with 
graded concentrations of various test extracts. The tissue responses were recorded 
isometrically by means of Ugo-Basile force displacement transducers (model 7200 Ugo-
Basile, Comerio, Italy) and pen-writing "Gemini" recorders (model 7070 Ugo Basile, 
Comerio, Italy). 
2.7.3.2 Experimental protocol. 
After an equilibration period of 60 minutes, graded concentrations of various test extracts 
were added to the organ bath cumulatively to establish cumulative-concentration 
dependent responses. To investigate whether the effects of the extracts involved 
modulation of cholinergic receptors, alpha-adrenergic receptors and calcium channels, 
the portal vein preparations were pretreated with atropine sulphate (a muscarinic receptor 
blocker) prazosin (alpha I-adrenergic receptor blocker) and nifedipine (L-type voltage-
operated calcium channel blocker), respectively, 5 minutes before re-establishing the 
cumulative-concentration dependent responses. The responses obtained in the presence of 
specific blockers were compared with those obtained in the absence of the blockers. The 
effects of the extracts were calculated as percentage of the baseline values (n=8 
preparations for each concentration). 
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2.7.4 Data analysis. 
Values obtained are presented as means (± SEM). The data obtained were treated and 
presented separately for normotensive Wistar and hypertensive DSS-treated rats to 
determine the effects of various plant extracts on the parameters measured. Data from the 
control normotensive Wistar and hypertensive DSS rats were used as baseline. Duration 
of the acute effects of the test extracts on mean arterial blood pressure was used as a basis 
to classify the extracts. Extracts of E. capensis, H. hemerocallidea and P. americana 
caused a transient fall in mean arterial blood pressure and were classified as group A 
extracts. Extracts from H. ceres and S. birrea caused a persistent reduction in mean 
arterial blood pressure and were classified as group B extracts. In vitro cardiotonic 
experiments, data from vehicle-treated preparations were used as baseline. Therefore, the 
inotropic and chronotropic effects of the extracts were calculated as percentage of the 
baseline values. In experiments involving aortic rings, the effects of the extracts were 
calculated as percentage of the maximum contractile response of the aortic preparations 
to an agonist (methoxamine or potassium). Statistical significance was determined 
through one-way analysis of variances (ANOV A) followed by Dunnett multiple 
comparison test to compare the means. A value of p < 0.05 was considered statistically 
significant. Graphs were plotted and statistical analysis was performed using GraphPad 





The results in this chapter will describe the following ;( 1) plant extraction, (2) acute and 
long-term effects of plant extracts on blood pressure and heart rate, (3) in vivo inotropic 
effects of the plant extracts. 
3.1 Plant extraction results. 
Five plants namely Ekebergia capensis (Sparrm) [Maliaceae], Persea Americana (Mill) 
[Lauraceae], Helichrysum ceres (S. Moore) [Asteraceae], Sclerocarya birrea (A. Rich) 
[Anacardiaceae] and Hypoxis hemerocallidea (Fisch. & C.A. Mey) [Rypoxidaceae] were 
extracted using 95% ethanol to yield five different ethanolic extracts denoted EKE, PAE, 
RCE, SBE and APE, respectively. The percent yield of these crude extracts ranged from 
8% to 15 % (Table 1). 
Table 1. % yield of crude ethanolic extracts. 
Plant % 
Hypoxis hemerocallidea (APE) 10 
Persea americana (PAE) 8 
Sclerocarya birrea (SBE) 13 
Helichrysum ceres (RCE) 10 
Ekebergia capensis (EKE) 15 
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3.2 Blood pressure. 
3.2.1 Acute effects of extracts on mean arterial pressure (MAP) and heart rate 
Plant extracts were divided into groups of A and B based on the duration of their acute 
effects on MAP as previously described in section 2.8.4. In this study, the acute effects of 
group A test extracts, namely, EKE, APE, PAE and group B extracts, namely, HCE, SBE 
on MAP and heart rate were evaluated in male anaesthetized Wistar normotensive rats. 
Group A extracts, namely, EKE, APE, and PAE at a dose of 120 mg/kg. body weight, 
caused significant reductions in the mean arterial pressure (MAP) during treatment 
period. However, this effect was so transient, such that the MAP started to increase 
progressively before the end of treatment period (Figure 6). During recovery period, the 
MAP increased progressively to values that were comparable to those recorded during 
control period. On the other hand, group A extracts, did not exhibit any significant effect 
on the heart rate (Table 2). 
In contrast, group B extracts, namely, HCE and SBE at the same dose of 120 mg/kg. 
body weight, induced significant and progressive, long-lasting reductions in the MAP, 
with no significant effect on the heart rate during treatment period (Figure 6). This fall in 
the MAP persisted during recovery period, such that the MAP values at the end of 
recovery period were significantly lower as compared to those recorded during 




















- * ~ '''Jr'' 
* 
90~----~------r-----~----~ 
o 60 120 180 240 







Effects of various plant extracts infusion on the mean arterial blood pressure In 
normotensive male Wistar rats . Values are means ± SEM; (n=6 animals per group). 
P*<O.05 by comparison with control period. 
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3.2.2 Long-term effects of various extracts on blood pressure and heart rate. 
To evaluate the long-term effects of the various test extracts on mean arterial blood 
pressure (MAP), systolic and diastolic blood pressures and heart rate, separate groups of 
Dahl salt sensitive-rats (DSS) were treated with extracts at a dose of 80 mgt kg. body 
weight, daily for six weeks at 09hOO. 
In this study, the MAP, systolic and diastolic blood pressures in DSS-untreated rats 
increased progressively and significantly to develop hypertension in week five. At the 
end of six weeks, the DSS-untreated rats displayed extremely higher blood pressure 
(MAP, systolic, diastolic) values while blood pressure values in the treated groups were 
within the normal range by comparison with values in week one (Figures 7, 8 ). In 
addition, in the DSS-untreated rats, the heart rate increased following a similar pattern 
(Table 3). 
The extracts from both groups (A and B), prevented the increase in the MAP, systolic and 
diastolic blood pressures in the DSS-treated groups during the entire period of study 
(Figures 7, 8). In addition, group A extracts, APE and P AE substantially but transiently 
reduced the MAP and systolic blood pressures during week 4 and 5 compared to week 1. 
While ReE from group B caused a potent decrease in systolic blood pressure during 
week 5 compared to weekI. Therefore, each test extract demonstrated antihypertensive 
potential by preventing increases in the MAP, systolic and diastolic blood pressures in 
Dahl salt sensitive rats, a genetically hypertensive rat model. 
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In Group A extracts, EKE exhibited no significant effect on the heart rate, whereas, APE 
and P AE exhibited significant decreases in heart rates from week 4. Group B extracts, 
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Figure 7. 
Effects of long-tenn treatment of various plant extracts on the mean arterial blood 
pressure in DSS rats. Values are means ±SEM; (n=8 animals per group). 
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Figure 8. 
Effects of long-term treatment of various plant extracts on systolic (A) and diastolic (B) 
blood pressure in DSS rats. Values are means ±SEM; (n=8 animals per group). 








Acute effects of various plant extracts on heart rate. Values are means ± SEM, (n=6 animals per group). 
P* < O.OS by comparison with control period. 
Treatment Time in minutes 
30 60 90 120 150 180 210 
Control 410±6 41O±6 409±6 408±6 411±4 410±6 41O±4 
APE 373±12 377±14 386±8 36S±6 370±9 382±7 381±3 
PAE 392±14 39S±17 394±16 392±12 39S±11 390±21 400±11 
EKE 41O±S 409±7 408±S 411±1O 409±7 41O±1O 41O±9 
HCE 400±4 396±6 400±1O 401±4 400±1O 400±12 403±1O 















Effects of long-term oral treatment of various plant extracts on heart rate in DSS rats. Animals were administered 80 
mg /kg. body weight daily for 6 weeks. Values are means ± SEM, (n=8). 
p.. < 0.05 by comparison with values in week 1. 
Treatment Time in weeks 
1 2 3 4 5 6 7 
Control 380±12 380±1O 401±7 380±9 379±12 381±18 396±9 
EKE 354±15 353±19 358±15 365±16 359±12 352±12 345±8 
APE 381±12 376±9 356±14* 331±11* 306±12* 409 ±8* 399±6* 
PAE 381±14 371±16 378±12 365±15* 354±9* 365±15* 354±13* 
HCE 381±12 369±18 387±17 360±11* 364±6* 348±1O* 341±6* 
SBE 381±13 376±12 370±17 367±14* 361± 9* 359±11* 356±7* 
99 
CHAPTER 4 
4.0 IN VITRO CARDIOTONIC RESULTS. 
This chapter will describe the effects of the positive standard drugs (noradrenaline, 
acetylcholine and calcium) and various extracts, EKE, APE, PAE, HCE and SBE on the 
rate (chronotropy) and force (inotropy) of myocardial contraction. In addition, the 
antagonistic effects of the extracts on the positive inotropic effects of noradrenaline and 
calcium will also be described. 
4.1 Cardiotonic effects of noradrenaline. 
The effects of noradrenaline on the rate of myocardial contractions (chronotropy) were 
evaluated on the rat isolated spontaneously-beating right atria. Noradrenaline caused a 
significant and concentration-dependent (0.1-1 .6 11M) increase in the rate of spontaneous 
contractions (positive chronotropy) of the right atrial muscles. This effect was completely 
abolished by prior treatment of the atrial muscle preparations with propranolol (111M), a 
non-selective beta adrenergic receptor blocker (Figure 9A). Additionally, the effects of 
noradrenaline on the force of myocardial contraction (inotropy) were evaluated on the rat 
isolated electrically-driven left atria. Similarly, noradrenaline induced a significant and 
concentration-dependent (0.1-1.6 11M) increase in the force of myocardial contraction 
(positive inotropy) in the electrically-driven left atrial muscle. Pretreatment of the left 
~ li-Y T .' . 
" 080254 
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atrial muscle preparations with propranolol resulted in a complete inhibition of the 
positive inotropic effects of noradrenaline (Figure 9B). 
101 
c: 
0) 0 s:. .-... t) 





















* * ________ --11 
O~~~~~:=~~,-------~ 
* * * 
0.0 0.5 1.0 1.5 
Noradrenaline concentration (~M) 
-+- Noradrenaline 
~. + Propranolol 
Concentration-dependent response curves showing the effects of noradrenaline (0.1-
1.6jlM) on the rate (A) and force (B) of myocardial contraction in the absence and 
presence of propranolol (ljlM). Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with noradrenaline alone. 
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4.2 Cardiotonic effects of acetylcholine (Ach). 
The effects of acetylcholine on the rate of myocardial contraction were evaluated in the 
rat isolated spontaneously-beating right atria. Acetylcholine induced significant and 
concentration-dependent (0.2-1 .0 flM) decreases in the rate of spontaneous contractions 
(negative chronotropy) of the right atrial muscles. This cardio-inhibitory effect of 
acetylcholine on the rate of myocardial contractions was completely abolished by prior 
treatment of the right atria with atropine sulphate (1 flM) , a cholinergic receptor 
antagonist (Figure lOA). The effects of acetylcholine on the force of myocardial 
contraction were examined in the rat isolated electrically-driven left atria. Acetylcholine 
significantly reduced the force of myocardial contraction (negative inotropy) in a 
concentration-dependent manner (0.2-1.0 flM). Similarly, pretreatment of the left atrial 
muscle preparations with atropine sulphate (IflM) completely abolished the cardio-
inhibitory effects of acetylcholine on the force of myocardial contraction (Figure lOB). 
Thus acetylcholine exhibited negative chronotropic and inotropic effects in rat isolated 
right and left atria respectively. These cardio-inhibitory effects of acetylcholine were 
completely abolished in the presence of atropine sulphate (Figure 10). 
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Concentration-dependent response curves showing the effects of acetylcholine (0.2-1~M) 
on the rate (A) and force (B) of myocardial contraction in the absence and presence of 
atropine (1~M). Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with control. 
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4.3 Cardiotonic effects of EKE 
The effects of EKE on the rate of myocardial contraction were evaluated in rat isolated 
spontaneously-beating right atria. EKE induced a significant and concentration-
dependent (2.5-40 mg/ml) increase in the rate of spontaneous contractions (positive 
chronotropy) of the right atrial muscle preparations. In order to assess whether the 
positive chronotropic effect of EKE was mediated through stimulation of beta adrenergic 
receptors , the right atrial muscle preparations were pretreated with propranolol (111M), a 
non-selective beta-adrenergic receptor blocker. This treatment caused an almost complete 
abolition of the positive chronotropic effect of EKE (Figure IIA). 
In addition, to investigate if the cardio-stimulatory effect of EKE involved activation of 
the cholinergic receptors, the right atrial muscle preparations were pretreated with 
atropine sulphate (1 11M). This pretreatment did not modify the effect of EKE on the rate 
of myocardial contraction (Figure IIA). In order to assess whether the positive 
chronotropic effect of EKE was mediated through modulation of noradrenaline release 
from junctional stores, the right atria were pretreated with reserpine (5 11M) to deplete 
junctional noradrenaline stores. However, this treatment did not significantly alter the 
positive chronotropic effects of EKE (Figure IIA). Involvement of the voltage-operated 
calcium channels in the chronotropic effect of EKE was also investigated. The right atrial 
muscle preparations were pretreated with nifedipine (111M), a voltage-operated calcium 
channel blocker. Nifedipine caused a significant reduction but not abolition of the 
positive chronotropic effect of EKE (Figure IIA). 
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The effects of EKE on the force of myocardial contraction were evaluated in rat isolated 
electrically-driven left atria. EKE significantly and concentration-dependently increased 
the force of myocardial contraction (positive inotropy) in a rat isolated left atria. 
Pretreatment of the left atrial muscle preparations with propranolol caused almost a 
complete inhibition of the positive inotropic effect of EKE (Figure lIB). In addition, 
pretreatment of the left atrial muscle preparations with nifedipine, caused a significant 
decrease but not an abolition of the positive inotropic effect of EKE (Figure lIB). 
However, pretreatment of the left atrial preparations with reserpine and atropine did not 
change the positive inotropic effect of EKE (Figure lIB). 
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Figure 11. 
-+- EKE 
-3f_ . + Nifedipine 
........... + Propranolol 
-+- + Atropine 
-+- + Reserpine 
Concentration-dependent response curves showing the cardio-stimulatory effects 
of EKE (2.5-40 mg/ml) on the rate (A) and force (B) of myocardial contraction in 
the absence and presence of atropine (1 /J.M), nifedipine ( 1 /J.M), propranolol (1 
/J.M) and reserpine (5 /J.M). Values are means ± SEM, (n=8; for each 
concentration). p* <0.05 by comparison with EKE alone. 
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4.4 Cardiotonic effects of APE 
The effects of APE on the rate of myocardial contraction were evaluated in rat isolated 
spontaneously-beating right atria. APE induced a significant and concentration-dependent 
(12.5-400 mg/rnl) decrease in the rate of spontaneous contractions (negative chronotropy) 
of the right atrial muscle preparations. In order to assess whether the negative 
chronotropic effect of APE was mediated through stimulation of cholinergic receptors, 
the right atrial muscle preparations were pretreated with atropine sulphate (1 flM) , a 
cholinergic receptor antagonist. Pretreatment with atropine sulphate did not modify the 
cardio-inhibitory effect of APE on the rate of myocardial contraction (Figure 12A). 
The effects of APE on the force of myocardial contraction were evaluated in rat isolated 
electrically-driven left atria. APE significantly and concentration-dependently decreased 
the force of myocardial contraction (negative inotropy) in a rat isolated left atria. 
Pretreatment of the left atrial muscle preparations with atropine sulphate did not alter the 
negative inotropic effect of APE (Figure 12B). 
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Figure 12. 
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--+-APE 
-~, + Atropine 
Concentration-dependent response curves showing the cardio-inhibitory effects of 
APE (12.5-400 mg/rnl) on the rate (A) and force (B) of myocardial contraction in 
the absence and presence of atropine Cl/lM). Values are means ± SEM, (n=8; for 
each concentration). p* <0.05 by comparison with control 
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4.5 Effects of APE on the positive inotropic effects of noradrenaline and 
calcium. 
The effect of APE on the concentration-dependent positive inotropic effect of 
noradrenaline was evaluated in rat isolated electrically-driven left atria. Firstly, a 
concentration-response curve for noradrenaline was established in the absence of APE 
(Figure 13A). The left atrial muscle preparations were then pretreated with APE. APE 
significantly antagonized the noradrenaline-induced positive inotropic effect in a 
concentration dependent manner (100 and 400 mg/ml) (Figure 13A). Similarly, APE 
, 
antagonized the calcium-induced inotropic effect also in a concentration-dependent 
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Effects of APE (l00 and 400 mglmJ) on the positive inotropic effects induced by 
noradrenaline (A) and CaCh (B). Values are means ± SEM, (n=8; for each 
concentration). p* < 0.05 by comparison with noradrenaline (A) or CaCh (B) 
and p* <0.05 by comparison with 100 mg/mJ APE. 
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4.6 Cardiotonic effects of PAE 
The effects of P AE on the rate of myocardial contraction were evaluated in rat isolated 
spontaneously-beating right atria. PAE induced a significant and concentration-
dependent (25-400 mg/rnl) decrease in the rate of spontaneous contractions (negative 
chronotropy) of the right atrial muscle preparations. In order to investigate whether the 
negative chronotropic effect of PAE was mediated through activation of cholinergic 
receptors, the right atrial muscle preparations were pretreated with atropine sulphate (1 
IlM), a cholinergic receptor antagonist. Pretreatment with atropine sulphate did not affect 
the cardio-inhibitory effect of PAE on the rate of myocardial contraction (Figure 14A). 
The effects of PAE on the force of myocardial contraction were evaluated in rat isolated 
electrically-dri ven left atria. P AE significantly and concentration-dependently decreased 
the force of myocardial contraction (negative inotropy) in a rat isolated left atria. 
Pretreatment of the left atrial muscle preparations with atropine sulphate did not change 
the negative inotropic effect of PAE (Figure 14B). 
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Concentration-dependent response curves showing the cardio-inhibitory effects of PAE 
(25-800 mg/mJ) on the rate (A) and force (B) of myocardial contraction in the absence 
and presence of atropine (111M). Values are means ± SEM, (n=8; for each 
concentration). 
p* <0.05 by comparison with control. 
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4.7 Effects of PAE on the positive inotropic effects of noradrenaline and calcium. 
The effect of PAE on the concentration-dependent positive inotropic effect of 
noradrenaline was evaluated in rat isolated electrically-driven left atria. Firstly, a 
concentration-response curve for noradrenaline was established in the absence of P AE 
(Figure 15A). The left atrial muscle preparations were then pretreated with PAE. PAE 
significantly reversed the noradrenaline-induced positive inotropic effect in a 
concentration dependent manner (200 and 800 mg/rnl) (Figure 15A). Similarly, PAE 
inhibited the calcium-induced positive inotropic effect also in a concentration-dependent 
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Effects of P AE (200 and 800 mg/rnl) on the positive inotropic effects of noradrenaline 
(A) and CaCh (B). Values are means ± SEM, (n=8; for each concentration). 
p* < 0.05 by comparison with noradrenaline (A) or CaCh (B) 
and p* <0.05 by comparison with 800 mg/rnl PAE. 
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4.8 Cardiotonic effects of HCE 
The effects of HCE on the rate of myocardial contraction were evaluated in rat isolated 
spontaneously-beating right atria. HCE induced a significant and concentration-
dependent (10-160 mg/ml) decrease in the rate of spontaneous contractions (negative 
chronotropy) of the right atrial muscle preparations. In order to assess whether the 
negative chronotropic effect of HCE was mediated through activation of cholinergic 
receptors, the right atrial muscle preparations were pretreated with atropine sulphate (1 
11M), a cholinergic receptor antagonist. Pretreatment of the atrial preparations with 
atropine sulphate elicited a complete abolition of the negative chronotropic effect of HCE 
(Figure 16A). 
The effects of HCE on the force of myocardial contraction were evaluated in rat isolated 
electrically-driven left atria. HCE significantly and concentration-dependently decreased 
the force of myocardial contraction (negative inotropy) in a rat isolated left atria. 
However, pretreatment of the atrial preparations with atropine sulphate exhibited partial 
blockade of the negative inotropic effects of HCE, with complete inhibition of the effects 
of the three lower concentrations and significant inhibition but not complete abolition of 
the last two higher concentrations (Figure 16B). 
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Concentration-dependent response curves showing the cardio-inhibitory effects of RCE 
(10-160 mg/ml) on the rate (A) and force (B) of myocardial contraction in the absence 
and presence of atropine (1IlM). Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with control and p* < 0.05 by comparison with RCE alone. 
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4.9 Effects of HCE on the positive inotropic effects of noradrenaline and 
calcium. 
The antagonistic effect of ReE was evaluated on the concentration-dependent positive 
inotropic effect of noradrenaline in rat isolated electrically-driven left atria. Firstly, a 
concentration-response curve for noradrenaline was established in the absence of ReE 
(Figure 17 A). The left atrial muscle preparations were then pretreated with ReE. ReE 
significantly antagonized the noradrenaline-induced positive inotropic effect In a 
concentration dependent manner (40 and 80 mg/.ml) (Figure 17A). Similarly, ReE 
antagonized the calcium-induced inotropic effect also In a concentration-dependent 
manner (40 and 80 mg/.ml) (Figure 17B). 
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Antagonistic effects of HCE (40 and 80 mg/ml) on the positive inotropic effects of 
noradrenaline (A) and CaCh (B). Values are means ± SEM, (n=8 for each concentration). 
p* < 0.05 by comparison with noradrenaline (A) or CaCh (B) and p* <0.05 by 
comparison with 40 mg/.ml HCE. 
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4.10 Cardiotonic effects of SBE 
The effects of SBE on the rate of myocardial contraction were evaluated in rat isolated 
spontaneously-beating right atria. SBE induced a significant and concentration-dependent 
(25-400 mg/'rnl) decrease in the rate of spontaneous contractions (negative chronotropy) 
of the right atrial muscle preparations. In order to investigate whether the negative 
chronotropic effect of SBE was mediated through activation of cholinergic receptors, the 
right atrial muscle preparations were pretreated with atropine sulphate (111M), a 
cholinergic receptor antagonist. Pretreatment with atropine sulphate did not affect the 
cardio-inhibitory effect of SBE on the rate of myocardial contraction (Figure 18A). 
The effects of SBE on the force of myocardial contraction were evaluated in rat isolated 
electrically-driven left atria. SBE significantly and concentration-dependently decreased 
the force of myocardial contraction (negative inotropy) in a rat isolated left atria (Figure 
18B). Pretreatment of the left atrial muscle preparations with atropine sulphate did not 
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Concentration-dependent response curves showing the cardio-inhibitory effects of SBE 
(25-400 mg/ml) on the rate (A) and force (B) of myocardial contraction in the absence 
and presence of atropine (lflM). Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with control. 
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4.11 Effects of SBE on the positive inotropic effects of noradrenaline and 
calcium. 
The effect of SBE on the concentration-dependent positive inotropic effect of 
noradrenaline was evaluated in rat isolated electrically-driven left atria. Firstly, a 
concentration-response curve for noradrenaline was established in the absence of SBE 
(Figure 19A). The left atrial muscle preparations were then pretreated with SBE. SBE 
significantly inhibited the noradrenaline-induced positive inotropic effect in a 
concentration dependent manner (100 and 400 mg/.rnl) (Figure 19A). SBE also inhibited 
the calcium-induced inotropic effect in a concentration-dependent manner (100 and 400 
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Effects of SBE (100 and 400 mg/.m]) on the positive inotropic effects of noradrenaline 
(A) and CaCh (B). Values are means ± SEM, (n=8; for each concentration). 
p* < 0.05 by comparison with noradrenaline (A) or CaCh (B) and p* <0.05 by 
comparison with 400 mg/.m] SBE. 
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CHAPTERS 
5.0 IN VITRO VASCULAR EFFECTS OF EXTRACTS. 
This chapter will describe the following; (1) vasorelaxant effects of various extracts 
evaluated on endothelium-intact and endothelium-deprived aortic rings; (2) the role of 
endothelial-derived relaxing factors in the vasorelaxant effects of the various extracts; (3) 
the role of calcium and potassium channels in the vasorelaxant effects of various extracts 
and (4) the effects of various extracts on the spontaneous-myogenic contractions of the 
portal vein. 
5.1 Vasorelaxant effects of EKE. 
The vasorelaxant effects of EKE were evaluated in endothelium-intact aortic nngs 
precontracted with methoxamine hydrochloride (lOIlM), an alpha-1 adrenergic receptor 
agonist to establish a cumulative concentration-response curve for EKE. EKE induced an 
endothelium and concentration-dependent (10-160 mg/ml) vasorelaxation in intact aortic 
rings precontracted with methoxamine hydrochloride (Figure 20A). 
5.1.1. Role of the endothelium 
In order to assess the role of the functional endothelium in the vasorelaxant effects of 
EKE, tests were conducted in denuded-aortic rings precontracted with methoxamine 
hydrochloride. When contraction reached a stable plateau, a cumulative concentration-
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response curve for EKE was re-established and compared to that of intact aortic rings. 
The removal of endothelium significantly inhibited the vasorelaxation induced by EKE 
(Figure 20A). 
5.1.2 Role of endothelial vasodilators. 
To examine the role of nitric oxide in the vasorelaxant effects of EKE, endothelium-
intact aortic rings were pretreated with L-NAME (100 11M), a nitric oxide synthase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. L-NAME 
significantly inhibited the vasorelaxation induced by EKE (Figure 20B). 
To examine the role of prostacyclin in the vasorelaxant effects of EKE, endothelium-
intact aortic rings were pretreated with indomethacin (10 11M), a cyclooxygenase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. 
Indomethacin significantly inhibited the vasorelaxant effect induced by EKE (Figure 
20B). 
To assess the involvement of cOMP in the vasorelaxant effects of EKE, endothelium-
intact aortic rings were pretreated with methylene blue (20 11M), a guanylate cyclase 
inhibitor before the contractions were induced by methoxamine hydrochloride. 
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EKE concentration (mg/ml) 
Figure 20. 
-+- EKE + Denuded 
~ EKE + Intact 
~ EKE 
- .... + L-NAME 
-+- + Methylene blue 
-Xi- + Indomethacin 
Concentration-dependent vasorelaxant effects of EKE (10-160 mg/.ml) on rat 
endothelium-intact and denuded aortic rings, precontracted with methoxamine in the 
absence (A) and presence (B) of L-NAME (lOOflM), indomethacin (lOflM) and 
methylene blue (20flM). Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with EKE+ intact (A) or EKE alone (B) 
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5.1.3 Role of calcium and potassium channels. 
To evaluate the role of calcium channels in the vasorelaxant effects of EKE, tests were 
conducted in intact-aortic rings precontracted with high (K+ SOrnM). EKE induced a 
significant and concentration-dependent vasorelaxation in the endothelium-intact aortic 
rings precontracted with high (K+SOrnM), (Figure 21). 
To evaluate the role of potassium channels in the vasorelaxant effects of EKE, the test 
was conducted in intact-aortic rings precontracted with low (K+ 20rnM). EKE induced a 
significant and concentration-dependent vasorelaxation in the endothelium-intact aortic 
rings precontracted with low (K+ 20rnM). Pretreatment of the aortic rings with 
glibenclamide, before precontracted with low (K+20rnM), did not modify the 
vasorelaxant effect of EKE (Figure 21). 
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Figure 21. 
......... K+20mM 
-~. K+ 80 mM 
-+- K+ 20 mM + glibenclamide 
Concentration-dependent vasorelaxant effects of EKE (10-160 mg/.ml) on rat isolated 
endothelium-intact aortic rings precontracted with high K+ (80 mM) or low K+ (20 mM) 
concentrations in the absence and presence of glibenc1arnide (3/-lM). Values are means ± 
SEM, (n=8; for each concentration). 
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5.2 Vasorelaxant effects of APE. 
The vasorelaxant effects of APE were evaluated in endothelium-intact aortic rings 
precontracted with methoxamine hydrochloride (lOIlM), an alpha-1 adrenergic receptor 
agonist to establish a cumulative concentration-response curve for APE. APE induced an 
endothelium and concentration-dependent (5-160 mg/.rnl) vasorelaxation in intact aortic 
rings precontracted with methoxamine hydrochloride (Figure 22A). 
5.2.1 Role of endothelium. 
In order to assess the role of the functional endothelium in the vasorelaxant effects of 
APE, studies were conducted in denuded-aortic rings precontracted with methoxamine 
hydrochloride. When contraction reached a stable plateau, a cumulative concentration-
response curve for APE was established and compared to that of intact aortic rings. The 
removal of endothelium completely abolished the vasorelaxation induced by APE (Figure 
22A). 
5.2.2 Role of endothelial vasodilators. 
To examine the role of nitric oxide in the vasorelaxant effects of APE, endothelium-
intact aortic rings were pretreated with L-NAME (100 11M), a nitric oxide synthase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. L-NAME 
significantly reduced the vasorelaxant effect of APE (Figure 22B). 
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To examine the role of prostacyclin in the vasorelaxant effects of APE, endothelium-
intact aortic rings were pretreated with indomethacin (10 11M), a cyclooxygenase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. 
Indomethacin significantly inhibited the vasorelaxation induced by APE (Figure 22B). 
To assess the involvement of cGMP in the vasorelaxant effects of APE, endothelium-
intact aortic rings were pretreated with methylene blue (20 11M) a guanylate cyclase 
inhibitor before the contractions were induced by methoxamine hydrochloride. 
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Concentration-dependent vasorelaxant effects of APE (5-160 mg/.ml) on rat 
endothelium-intact and denuded aortic rings, precontracted with methoxamine in the 
absence (A) and presence (B) of L-NAME (lOOIlM), indomethacin (lOIlM) and 
methylene blue (20IlM). Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with APE+ intact (A) or APE alone (B). 
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5.2.3 Role of calcium and potassium channels. 
To evaluate the role of calcium channels in the vasorelaxant effects of APE, studies were 
conducted in intact-aortic rings precontracted with high (K+ SOmM). APE induced a 
weak but significant and concentration-dependent vasorelaxation in the endothelium-
intact aortic rings precontracted with high (K+SOmM) (Figure 23). 
To evaluate the role of potassium channels in the vasorelaxant effects of APE, 
investigations were conducted in intact-aortic rings precontracted with low (K+ 20mM). 
APE induced a significant and concentration-dependent vasorelaxation in the 
endothelium-intact aortic rings precontracted with low (K+ 20mM). Pretreatment of the 
aortic rings with glibenc1amide, before precontracted with low (K+20mM), caused a 
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Figure 23. 
Concentration-dependent vasorelaxant effects of APE (5-160 mg/.ml) on rat isolated 
endothelium-intact aortic rings precontracted with high K+ (80 mM) or low K+ (20 mM) 
concentrations in the absence and presence of glibenclamide (3 11M). Values are means ± 
SEM, (n=8; for each concentration). 
p* < 0.05 by comparison with K+ (20 mM). 
133 
5.3 Vasorelaxant effects of P AE. 
The vasorelaxant effects of P AE were evaluated in endothelium-intact aortic rings 
precontracted with methoxamine hydrochloride (lOjJ.M), an alpha-l adrenergic receptor 
agonist to establish a cumulative concentration-response curve for PAE. PAE induced an 
endothelium and concentration-dependent (50-800 mg/.ml) vasorelaxation in intact aortic 
rings precontracted with methoxamine hydrochloride (Figure 24A). 
5.3.1 Role of endothelium. 
In order to assess the role of the functional endothelium in the vasorelaxant effects of 
P AE, tests were conducted in denuded-aortic rings precontracted with methoxamine 
hydrochloride. When contraction reached a stable plateau, a cumulative concentration-
response curve for P AE was established and compared to that of intact aortic rings. The 
removal of endothelium significantly inhibited the vasorelaxation induced by PAE 
(Figure 24A). 
5.3.2 Role of endothelial vasodilators. 
To examine the role of nitric oxide in the vasorelaxant effects of PAE, endothelium-
intact aortic rings were pretreated with L-NAME (100 jJ.M), a nitric oxide synthase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. L-NAME 
significantly inhibited the vasorelaxation induced by PAE (Figure 24B) . 
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To examine the role of prostacyclin in the vasorelaxant effects of PAE, endothelium-
intact aortic rings were pretreated with indomethacin (10 11M), a cyclooxygenase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. The 
vasorelaxant effect of P AE was not affected in the presence of indomethacin (Figure 
24B). 
To assess the involvement of cOMP in the vasorelaxant effects of PAE, endothelium-
intact aortic rings were pretreated with methylene blue (20 11M) a guanylate cyclase 
inhibitor before the contractions were induced by methoxamine hydrochloride. 
Methylene blue significantly inhibited the vasorelaxation induced by PAE (Figure 24B). 
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Concentration-dependent vasorelaxant effects of PAE (50-800 mg/.m1) on rat 
endothelium-intact and denuded aortic rings, precontracted with methoxamine in the 
absence (A) and presence (B) of L-NAME (lOOIlM), indomethacin (lOIlM) and 
methylene blue (20IlM). Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with PAE + intact (A) or PAE alone (B). 
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5.3.3 Role of calcium and potassium channels. 
To evaluate the role of calcium channels in the vasorelaxant effects of P AE, studies were 
conducted in intact-aortic rings precontracted with high (K+ SOmM). PAE induced weak 
vasorelaxation in the endothelium-intact aortic rings precontracted with high (K+SOmM) 
(Figure 25). 
To evaluate the role of potassium channels in the vasorelaxant effects of P AE, 
investigations were conducted in intact-aortic rings precontracted with low (K+ 20mM). 
PAE induced a significant and concentration-dependent vasorelaxation in the 
endothelium-intact aortic rings precontracted with low (K+ 20mM). Pretreatment of the 
aortic rings with glibenclarnide, before precontracted with low (K+20mM), significantly 
inhibited the vasorelaxant effects of P AE (Figure 25). 
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Figure 25. 
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Concentration-dependent vasorelaxant effects of PAE (50-800 mg/.ml) on rat isolated 
endothelium-intact aortic rings precontracted with high K+ (80 mM) or low K+ (20 mM) 
concentrations in the absence and presence of glibenclamide (3/lM) . Values are means ± 
SEM, (n=8; for each concentration). p* < 0.05 by comparison with K+ (20 mM). 
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5.4 Vasorelaxant effects of HCE. 
The vasorelaxant effects of HCE were evaluated in endothelium-intact aortic nngs 
precontracted with methoxamine hydrochloride (lOI1M), an alpha-l adrenergic receptor 
agonist to establish a cumulative concentration-response curve for the extract. HCE 
induced an endothelium and concentration-dependent (10-160 mg.mr!) vasorelaxation in 
intact aortic rings precontracted with methoxamine hydrochloride (Figure 26A). 
5.4.1 Role of endothelium. 
To investigate the role of the functional endothelium in the vasorelaxant effects of HCE, 
the test was conducted in denuded-aortic rings precontracted with methoxamine 
hydrochloride. When contraction reached a stable plateau, a cumulative concentration-
response curve for HCE was established and compared to that of intact aortic rings. The 
removal of endothelium significantly inhibited the vasorelaxation induced by HCE 
(Figure 26A). 
5.4.2 Role of endothelial vasodilators. 
To examine the role of nitric oxide in the vasorelaxant effects of HCE, endothelium-
intact aortic rings were pretreated with L-NAME (100 11M), a nitric oxide synthase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. L-NAME 
significantly inhibited the vasorelaxation induced by HCE (Figure 26B). 
139 
To examine the role of prostacyclin in the vasorelaxant effects of HCE, endothelium-
intact aortic rings were pretreated with indomethacin (10 11M), a cyclooxygenase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. 
Indomethacin significantly inhibited the vasorelaxation induced by HCE (Figure 26B). 
To assess the involvement of cGMP in the vasorelaxant effects of HCE, endothelium-
intact aortic rings were pretreated with methylene blue (20 11M) a guanylate cyclase 
inhibitor before the contractions were induced by methoxamine hydrochloride. 
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Figure 26. 
Concentration-dependent vasorelaxant effects of RCE (10-160 mg/.rnl) on rat 
endothelium-intact and denuded aortic rings, precontracted with methoxamine in the 
absence (A) and presence (B) of L-NAME (lOOIlM), indomethacin (lOIlM) and 
methylene blue (20IlM). Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with RCE + intact (A) or RCE alone (B). 
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5.4.3 Role of calcium and potassium channels. 
To evaluate the role of calcium channels in the vasorelaxant effects of HCE, studies were 
conducted in intact-aortic rings precontracted with high (K+ SOmM). HCE induced a 
significant and concentration-dependent vasorelaxation in the endothelium-intact aortic 
rings precontracted with high (K+SOmM) (Figure 27). 
To evaluate the role of potassium channels in the vasorelaxant effects of HCE, studies 
were conducted in intact-aortic rings precontracted with low (K+ 20mM). HCE induced a 
significant and concentration-dependent vasorelaxation in the endothelium-intact aortic 
rings precontracted with low (K+ 20mM). Pretreatment of the aortic rings with 
glibenclarnide, before precontracted with low (K+20mM), did not cause any change in the 
vasorelaxant effects of HCE (Figure 27). 
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Concentration-dependent vasorelaxant effects of RCE (10-160 mg/.rnl) on rat isolated 
endothelium-intact aortic rings precontracted with high K+ (80 mM) or low K+ (20 mM) 
concentrations in the absence and presence of glibenclamide (3/lM). Values are means ± 
SEM, (n=8; for each concentration). 
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5.5 Vasorelaxant effects of SBE. 
The vasorelaxant effects of SBE were evaluated in endothelium-intact aortic rings 
precontracted with methoxamine hydrochloride (10I1M), an alpha-l receptor agonist to 
establish a cumulative concentration-response curve for the extract. SBE caused an 
endothelium and concentration-dependent (10-160 mg/.rnl) vasorelaxation in intact aortic 
rings precontracted with methoxamine hydrochloride (Figure 28A). 
5.5.1 Role of endothelium. 
In order to assess the role of the functional endothelium in the vasorelaxant effects of 
SBE, the test was conducted in denuded-aortic rings precontracted with methoxamine 
hydrochloride. When contraction reached a stable plateau, a cumulative concentration-
response curve for SBE was established and compared to that of intact aortic rings. The 
removal of endothelium significantly inhibited the vasorelaxation induced by SBE 
(Figure 28A). 
5.5.2 Role of endothelial vasodilators. 
To examine the role of nitric oxide in the vasorelaxant effects of SBE, endothelium-
intact aortic rings were pretreated with L-NAME (100 11M), a nitric oxide synthase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. L-NAME 
significantly inhibited the vasorelaxation induced by SBE (Figure 28B). 
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To examine the role of prostacyclin in the vasorelaxant effects of SBE, endothelium-
intact aortic rings were pretreated with indomethacin (10 j.lM), a cyclooxygenase 
inhibitor before the contractions were evoked by methoxamine hydrochloride. 
Indomethacin significantly reduced but not abolished the vasorelaxation induced by SBE 
(Figure 28B). 
To assess the involvement of cGMP in the vasorelaxant effects of SBE, endothelium-
intact aortic rings were pretreated with methylene blue (20 j.lM) a guanylate cyclase 
inhibitor before the contractions were induced by methoxamine hydrochloride. 
Methylene blue significantly inhibited the vasorelaxation induced by SBE (Figure 28B). 
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Concentration-dependent vasorelaxant effects of SBE (10-160 mg/.rnl) on rat 
endothelium-intact and denuded aortic rings, precontracted with methoxamine in the 
absence (A) and presence (B) of L-NAME (100IlM), indomethacin (lOIlM) and 
methylene blue (20IlM) . Values are means ± SEM, (n=8; for each concentration). 
p* <0.05 by comparison with SBE + intact (A) or SBE alone (B). 
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5.5.3 Role of calcium and potassium channels. 
To evaluate the role of calcium channels in the vasorelaxant effects of SBE, the test was 
conducted in intact-aortic rings precontracted with high (K+ SOmM). SBE induced a 
significant and concentration-dependent vasorelaxation in the endothelium-intact aortic 
rings precontracted with high (K+SOmM) (Figure 29). 
To evaluate the role of potassium channels in the vasorelaxant effects of SBE, the test 
was conducted in intact-aortic rings precontracted with low (K+ 20mM). SBE induced a 
significant and concentration-dependent vasorelaxation in the endothelium-intact aortic 
rings precontracted with low (K+ 20mM). Pretreatment of the aortic rings with 
glibenc1amide, before precontracted with low (K+20mM), did not have any effect on the 
vasorelaxant effects of SBE (Figure 29). 
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Figure 29. 
Concentration-dependent vasorelaxant effects of SBE (10-160 mg/.ml) on rat isolated 
endothelium-intact aortic rings precontracted with high K+ (80 mM) or low K+ (20 mM) 
concentrations in the absence and presence of glibenc1amide (3flM). 
Values are means ± SEM, (n=8; for each concentration). 
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5.6 Effects of various extracts on the contractile activity of rat isolated 
portal vein preparations. 
The effects of various extracts, EKE, APE, P AE, HCE and SBE on the rhythmic, 
myogenic-spontaneous contractions were evaluated in rat isolated spontaneously 
contracting portal veins. The relationships between the extracts and adrenergic, 
cholinergic receptors and calcium channels were also tested. 
5.6.1 Effects of EKE on myogenic-spontaneous contractions of portal vein. 
The effects of EKE on the myogenic spontaneous contractions were investigated in rat 
isolated portal veins. EKE concentration-dependently increased the myogenic 
spontaneous contractions in rat portal vein preparations. EKE at a concentration of 40 
mg/.m1, caused tonic contractions (contracture) in the rat portal vein preparations (Figure 
30A). 
To investigate whether the effects of EKE on the myogenic spontaneous contractions 
were mediated through activation of alpha-1 adrenergic receptors, the portal vein 
preparations were pretreated with prazosin Cl/-lM), an alpha-1 adrenergic receptor 
blocker. The effect of EKE on the myogenic activity was not affected by this prior 
treatment with prazosin (Figure 30B). 
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To test the involvement of voltage-operated calcium channels in the effects of EKE on 
myogenic activity, the portal vein preparations were pretreated with nifedipine (lj.lM). 
Nifedipine significantly reduced the stimulatory contractile effect induced by the higher 
concentration of EKE, (40 mg/.rnl) (Figure 30B). 
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Contractile effects of EKE (10 and 40 mg/ml) on rhythmic, myogenic spontaneous 
contractions of rat portal veins in the absence (A) and presence (B) of prazosin (1~M) 
and nifedipine (3~M). Values are means ± SEM, (n=8; for each concentration). 
p*< 0.05 by comparison with control and p* <0.05 by comparison with EKE, 40 mg/ml. 
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5.6.2 Effects of APE on myogenic-spontaneous contractions of portal vein. 
The effects of APE on the myogenic spontaneous contractions were investigated in rat 
isolated portal veins. APE induced concentration-dependent biphasic effect on the 
myogenic-spontaneous contractions of the rat portal vein preparations. The biphasic 
effect of APE consisted of an initial slight and transient increased contraction of short 
duration, followed by a secondary, longer-lasting relaxation of the rat portal vein 
preparations (Figure 31A). 
In order to investigate whether the initial stimulatory effect of APE involved activation of 
voltage-operated calcium channels, portal vein preparations were pretreated with 
nifedipine (1IlM), a calcium channel blocker. Pretreatment of the rat isolated portal vein 
with nifedipine (lIlM) completely inhibited the contractile phase induced by APE. 
(Figure 31B). 
In addition, to investigate whether secondary, longer-lasting venorelaxation were 
mediated through activation of cholinergic receptors, the portal vein preparations were 
pretreated with atropine sulphate (1IlM), a cholinergic receptor antagonist. However, 
pretreatment of the isolated portal veins with atropine sulphate, did not alter the 
sustained, long lasting venorelaxation induced by APE (Figure 31B). 
152 
50 A 
* 25 -~·Control --




~-- * -~-- * -"! 
* -100,..l---...----.--~-...;::===f 
5 B 
-~·Control -~ 0 - -+-APE400 C1) 
C) 
c 








, , , 
"' ............ 
~-- .... 
-.-. + Atropine 
-100 
0 3 6 9 12 15 
Time in minutes 
Figure 31. 
Contractile effects of APE (100 and 400 mg/ml) on rhythmic, myogenic spontaneous 
contractions of rat portal veins in the absence (A) and presence (B) of atropine (lIlM) and 
nifedipine (3IlM). Values are means ± SEM, (n=8; for each concentration). 
p*< 0.05 by comparison with control and p* <0.05 by comparison with APE 400 mg/ml. 
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5.6.3 Effects of PAE on myogenic-spontaneous contractions of portal vein. 
The effects of PAE on the myogenic spontaneous contractions were investigated in rat 
isolated portal veins. P AE induced concentration-dependent biphasic effect on the 
myogenic-spontaneous contractions of the rat portal vein preparations. Similar to APE, 
the biphasic effect of P AE consisted of a significant, initial slight and transient increased 
contraction of short duration, followed by a secondary, longer-lasting relaxation of the rat 
portal vein preparations (Figure 32A). Pretreatment of the rat isolated portal vein 
preparations with nifedipine (lIlM), or atropine sulphate (lIlM), did not show any 
significant effect on the biphasic effects induced by PAE (Figure 32B). 
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Contractile effects of PAE (40 and 160 mg/rnJ) on rhythmic, myogenic spontaneous 
contractions of rat portal veins in the absence (A) and presence (B) of atropine (lIlM) and 
nifedipine (3IlM). Values are means ± SEM, (n=8 ; for each concentration). 
p*< 0.05 by comparison with control. 
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5.6.4 Effects of HCE on myogenic-spontaneous contractions of portal vein. 
The effects of ReE on the myogenic spontaneous contractions were investigated in rat 
isolated portal veins. In contrast to APE, PAE and SBE, ReE did not stimulate, rather, it 
induced a significant and concentration-dependent longer lasting venorelaxation in the rat 
isolated portal vein preparations (Figure 33A). 
To investigate if this effect was mediated through cholinergic receptors, the portal vein 
preparations were pretreated with atropine. Pretreatment of the rat isolated portal vein 
preparations with atropine sulphate (l/-lM) significantly inhibited the venorelaxation 
induced by ReE (Figure 33B). 
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Contractile effects of HCE ( 40 and 160 mg/rnl) on rhythmic, myogenic spontaneous 
contractions of rat portal veins in the absence (A) and presence (B) of atropine (lflM) 
Values are means ± SEM, (n=8; for each concentration) . 
p*< 0.05 by comparison with control and p * <0.05 by comparison with HCE, 160mg/rnl. 
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5.6.5 Effects of SBE on myogenic-spontaneous contractions of portal vein. 
The effects of SBE on the myogenic spontaneous contractions were investigated in rat 
isolated portal veins. SBE induced concentration-dependent biphasic effect on the 
myogenic-spontaneous contractions of the rat portal vein preparations. Similar to APE 
and P AE, the biphasic effect of SBE consisted of a significant, initial slight and transient 
increased contraction of short duration, followed by a secondary, longer-lasting 
relaxation of the rat portal vein preparations (Figure 34A). Pretreatment of the isolated 
portal veins with atropine or nifedipine did not significantly change the biphasic effect 
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Contractile effects of SBE (40 and 160mgl,ml) on rhythmic, myogenic spontaneous 
contractions of rat portal veins in the absence (A) and presence (B) of atropine (1/lM) and 
nifedipine (3/lM). Values are means ± SEM, (n=8; for each concentration). 
p*< 0.05 by comparison with control 
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5.7 Summary of Results. 
• All crude ethanolic extracts exhibited hypotensive effects both in acute and 
chronic studies. 
• All extracts demonstrated potent bradycardiac effects in chronic studies. 
However, these extracts did not exhibit significant effect on heart rate in acute 
experiments. 
• Apart from EKE, all the other extracts exhibited negative inotropic and 
chronotropic effects on rat isolated left and right atria. On the other hand, these 
extracts antagonized the positive inotropic effects induced by noradrenaline and 
calcium. 
• EKE, induced positive inotropic and chronotropic effects on rat isolated left and 
right atria, respectively. 
• The extracts also demonstrated potent vasorelaxant effects involving both 
endothelium-dependent and independent mechanisms in rat isolated aortic rings. 
• Apart from HCE, all extracts induced biphasic contractile effects in rat isolated 
portal veins. However, at higher concentration, EKE induced a tonic contraction 
in a portal vein. 






The aims of the present study were to investigate the cardiovascular effects of some 
medicinal plants, namely Ekebergia capensis, Persea americana, Helichrysum ceres, 
Sclerocarya birrea and Hypoxis hemerocallidea in vivo and establish their possible 
mechanisms of actions in vitro. To establish the mechanisms of the antihypertensive 
actions of these plants, we evaluated the direct effects of the various test extracts on the 
rat isolated cardiac and vascular preparations .. The extracts exhibited hypotensive effects 
in vivo, cardio-inhibitory and vasorelaxant effects in vitro. We suggest that these plants 
exhibit their antihypertensive actions via the reduction of the total peripheral vascular 
resistance by directly dilating the blood vessels through both endothelium-dependent and 
independent mechanisms and through the reduction of cardiac output by directly 
inhibiting the rate and force of myocardial contractions. Thus, observations of the study 
suggest that crude extracts from Ekebergia capensis, Persea americana, Helichrysum 
ceres, Sclerocarya birrea and Hypoxis hemerocallidea, would have the potential to 
provide cheap and accessible source of traditional medicine for the treatment of 
hypertension and other associated cardiovascular disorders. 
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6.2 Hypotensive effects 
The acute effects of various plant extracts on the MAP, heart rate and myocardial 
contractility were evaluated in male anaesthetized Wistar normotensive rats. Group A 
extracts, namely, EKE, APE and PAE caused significant but transient reduction in MAP, 
with no significant effect on the heart rate (See Figure 6). The transient effects may 
suggest that the active principles in group A extracts are rapidly biotransformed or 
metabolized or may be acting on some systems with a mode of action rapidly reversible. 
In contrast, group B extracts, namely HCE and SBE induced significant and progressive, 
long-lasting reduction in the MAP with no significant effect on the heart rate. This may 
suggest that the active principles in group B extracts could act on some systems with a 
mode of action slowly reversible or that the active components are slowly metabolized or 
the extracts could have some toxic effects. The present findings have also been observed 
with other plant extracts (Tahri, Yamani, Legssyer, Aziz, Mekhfi, Bnouham, and Ziyyat, 
2000). The acute hypotension elicited by these test extracts may be attributed, in part, to 
their vasorelaxant and cardio-depressant effects (described in detail later), which might 
have resulted in decreased total peripheral vascular resistance and cardiac output 
respectively. As described already in 1.4, maintenance of the normal blood pressure is 
dependent on the balance between the cardiac output (CO) and the total peripheral 
resistance (TPR). The cardiac output and the total peripheral resistance set the mean 
arterial pressure (MAP) since they determine the average blood volume in the systemic 
arteries over time and it is this blood volume that causes pressure (Vari and Navar, 1995). 
In hypertensives, therefore, the antihypertensive drugs work by altering the balance 
between these two factors to bring down blood pressure towards normal. It is important 
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to recognize that when heart rate or stroke volume increases, cardiac output increases as 
well and so does systolic and the corresponding mean arterial pressure (Bertram, 2004). 
The observed acute hypotensive effects of the test extracts, therefore, could be mediated 
by their direct effect on the blood vessels and cardiac muscles resulting in decreased 
total peripheral resistance and cardiac output, respectively and hence hypotension. This 
suggestion is corroborated by the observations that these extracts except EKE, elicited 
potent negative inotropic effects in vivo (See Table 2), which could have resulted in 
significant reductions in cardiac output. On the other hand, all extracts exhibited 
vasorelaxant effects in rat isolated aortic rings in vitro (described in details later), which 
might have caused an acute reduction in the total peripheral resistance, resulting in 
overall reduction in mean arterial pressure. Furthermore, the long term effects of the test 
extracts were evaluated in Dahl salt sensitive-rats (DSS, a genetically hypertensive rat 
model) for six weeks. The results demonstrated that each of the test extracts prevented 
the development of hypertension., DSS-untreated rats progressively and significantly 
developed hypertension and increased heart rate during week five (See Figure 7). The 
long-term antihypertensive effects of the test extracts may be attributed to the presence of 
bioactive compounds in the test extracts which may be directly acting on the 
cardiovascular system or indirectly influencing other systems that regulate the functions 
of the cardiovascular system. 
Several chemical constituents have been identified and isolated from extracts of 
Sclerocarya birrea, Persea americana and Helichrysum ceres. These compounds include 
a wide spectrum of polyphenols, tannins, triterpenes and saponins with a large variety of 
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pharmacological actions (Ogbode, 1992; Eromosele, Eromosele and Kuzhkuzha, 1991; 
Galvez et al., 1993). Moreover, saponins have been reported to stimulate nitric oxide 
release from vascular endothelial cells to cause smooth muscle cell relaxation 
(Fitzpatrick, Hirschfield, Ricci, Jantzen and Coffey, 1995). Similarly, plant-derived 
polyphenols including flavonoids which are abundant in these plants have been 
demonstrated to relax blood vessels in an endothelium-dependent, nitric oxide-mediated 
manner (Fitzpatrick, Hirschfield, Ricci, Jantzen and Coffey, 1995; Rice-Evans, Miller 
and Paganga, 1996; Andriambeloson, Stoclet and Andriantsitohaina, 1999; Ruang et al., 
1999). The hypotensive effects displayed by SBE, PAE, and RCE can, therefore, be 
attributed to the presence and bioactivities of these compounds. 
Furthermore, flavonoids, saponins and tannins, which are also present in SBE, P AE and 
RCE, have been demonstrated to possess angiotensin converting enzyme inhibitory 
activity (Lacaille-Dubois, Franck and Wagner, 2001). Inhibition of angiotensin 
converting enzyme is currently considered to be a useful therapeutic approach in the 
treatment of hypertension (Lacaille-Dubois, Franck and Wagner, 2001). Angiotensin 
converting enzyme (ACE) inhibitors block the conversion of the inactive angiotensin I 
(Ang I) to the active pressor molecule angiotensin II (Ang II) (Lacaille-Dubois, Franck 
and Wagner, 2001). Angiotensin II is the most important humoral factor in the renin 
angiotensin system (RAS), which mediates inositol triphosphate (lP3) production and 
calcium mobilization which cause vasoconstriction, aldosterone stimulation, and 
sympathetic nervous system activation (Burrell and Johnston, 1997). Therefore, the 
presence of flavonoids, saponins and tannins in these extracts, with angiotensin 
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converting enzyme inhibitory activities might have offered a long-term cardioprotection 
in Dahl salt sensitive rat model. Methanolic and aqueous leaf extract of Persea 
americana, containing tannins and flavonoids have been demonstrated to elicit inhibitory 
effects on the binding of angiotensin II to AT1 receptors (Liu, Hsu, Tsai, Chan, Liu, 
Thomas, Tomliso, Lo and Lin, 2003). The AT1 receptor is the major physiological target 
of angiotensin II (All) in the cardiovascular system (Lacaille-Dubois, Franck and 
Wagner, 2001). Inhibition of the binding of angiotensin II to AT1 receptors is presently 
considered as a novel strategy in the search for new antihypertensive therapy (Liu et aI., 
2003). This is because, in spite of their therapeutic efficiency, angiotensin converting 
enzyme inhibitors are not highly effective in lowering angiotensin II levels since other 
enzymes, such as chymase, are able to synthesize angiotensin II (Reilly, Tewksbury, 
Schechter and Travis, 1982). In fact, chymase-dependent angiotensin II production is 
upregulated in human diabetic kidney and diseased blood vessels (Huang et ai., 2003; 
Doggrell and Wanstall, 2004). 
Since the presence of these major compounds in Sclerocarya birrea, Persea americana 
and HeIichrysum ceres, has been reported (Liu, Hsu, Tsai, Chan, Liu, Thomas, Tomliso, 
Lo and Lin, 2003; Ogbode, 1992; Eromosele, Eromosele and Kuzhkuzha, 1991; Galvez 
et ai., 1993), it is possible that these compounds contributed significantly in the long-term 
cardioprotective effects of these extracts. 
On the other hand, the hypotensive effects of Ekebergia capensis may be attributed to the 
presence of triterpenes and other active compounds. The major triterpene reported in this 
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plant is oleanolic acid (Sewram et aI., 2000). Moreover, Somova et ai., (2003), reported 
the beneficial effects of oleanolic acid and other triterpenes in preventing the 
development of salt-sensitive, insulin resistant hypertension in genetic Dahl rat model of 
hypertension. In addition, oleanolic acid and other triterpenes have been reported to 
possess antioxidant, anti hyperlipidemic and hypoglycaemic properties, all of which play 
an important role in the prevention and control of hypertension (Somova et ai., 2001). 
Similarly, the hypotensive effects of Hypoxis hemerocallidea may be attributed to the 
presence of some bioactive compounds such as phytosterols (Mills, Cooper, Seely and 
Kanfer, 2005). Phytosterols exist in several forms but the most abundant ones are b-
sitosterol and stigmasterol which are present in Hypoxis hemerocallidea (Mills, Cooper, 
Seely and Kanfer, 2005). Phytosterols have been reported to possess some beneficial 
cardiovascular properties (Jones, MacDougall, Ntanios and Vanstone, 1977). Recently, it 
has been reported that b-sitosterol and stigmasterol induce the synthesis of prostacyc1in in 
vitro (Awad, Smith and Fink, 2001). Prostacyclin is a potent inhibitor of platelet 
aggregation and causes vasodilation of blood vessels, suggesting the possibility that the 
phytosterols present in APE may have offered protection against the development of 
hypertension in experimental animals. Thus, it may be suggested that the hypotensive 
effect of APE could be related to the presence and bioactivities of the b-sitosterol and 
stigmasterol which might have lead to the increased synthesis of prostacyc1in thereby 
reSUlting in vasodilation and hence hypotension. 
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Therefore, the observed antihypertensive effects elicited by various ethanolic extracts 
from the five studied plants may be attributed to the potential of the major active 
compounds present in these extracts to induce vasorelaxation, thereby lowering total 
peripheral vascular resistance and to suppress myocardial contractility, resulting in 
reductions in cardiac output and hence, hypotension. The long-tenn antihypertensive 
effects, on the other hand, may be related to the inhibitory activities of the active 
compounds contained in the extracts on the renin-angiotensin system or/and other 
systems that may be directly or indirectly influencing the cardiovascular systems. 
6.3 Positive inotropism and chronotropism 
The present study has demonstrated that ethanolic leaf extract of Ekebergia capensis 
(EKE) exhibits a concentration-dependent, selective positive inotropic effect with little, 
but significant effect on spontaneous heart rate (See Figure 11). The study has also shown 
that the positive inotropic and chronotropic effects of EKE are not affected by 
pretreatment of the atrial preparations with reserpine (See Figure 11). Reserpine depletes 
junctional noradrenaline stores, thereby discarding the ability of noradrenaline release in 
response to stimulation (Salzmann, Bormann, Herzig, Markstein and Scholtysik, 1985). 
Therefore, the study has shown that positive inotropic and chronotropic effects of EKE 
are not mediated through modulation of noradrenaline release from junctional stores 
since its effects were not affected by prior treatment of the atrial preparations with 
reserpine, suggesting that activation of the sympathetic nervous system does not play an 
important role in the inotropic and chronotropic effects of EKE. 
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The study has also shown that the positive inotropic and chronotropic effects of EKE is 
not affected by pretreatment of the atrial preparations with atropine sulphate, a 
cholinergic receptor antagonist (Arunlakhshana and Schild, 1959) (See Figure 11). It is 
generally known that activation of cholinergic receptors in the myocardium induces 
negative inotropic and chronotropic responses (Landzberg, Parker, Gauthier and Colucci, 
1994). However, in some specific cases positive inotropic responses have been reported 
(Caulfied, 1993; Bohm, Giersschik, Schwinger, Uhlmann and Erdmann, 1994; Landzberg 
et al. , 1994). In addition, studies have demonstrated that acetylcholine elicits a positive 
inotropic response in isolated cardiac tissue of some species (Endoh and Blinks, 1984; 
Tajima, Tsuji, Sorota and Pappano, 1987 and Eglen, Montgomery and Whiting, 1988). 
Acetylcholine mediates its effects through stimulation of cholinergic receptors, meaning 
that the myocardium consists of two cholinergic components. One, which mediates 
stimulatory and the other, which mediates inhibitory effects. (Landzberg et al., 1994). 
However, the present study has provided evidence that the positive inotropic and 
chronotropic effects of EKE are not mediated through activation of cholinergic receptors, 
since its effects were not affected in the presence of atropine sulphate. 
In contrast, the study has demonstrated that pretreatment of the atrial preparations with 
propranolol almost completely abolished the inotropic and chronotropic effects of EKE 
(See Figure 11). Propranolol is a non-selective B-adrenergic receptor blocker (Hoffman 
and Lefkowitz, 1990). In the presence of propranolol, the positive inotropic and 
chronotropic effects of noradrenaline are inhibited (Hoffman and Lefkowitz, 1990) (See 
Figure 9). In this respect, since the positive inotropic and chronotropic effects of EKE 
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were completely abolished after blockade of myocardial B-adrenergic receptors, it may be 
suggested that the positive inotropic and chronotropic effects of EKE are mediated 
through a noradrenaline-like mechanism. Therefore, the study has demonstrated that the 
positive inotropic and chronotropic effects of EKE are mediated through B-adrenergic-
dependent mechanisms. 
In addition, pretreatment of the atrial preparations with nifedipine (an L-type Ca2+ 
channel blocker), partially, but significantly reduced the positive inotropic and 
chronotropic effects of EKE, suggesting the important role of the voltage-operated 
calcium channels in the cardio-stimulatory effects of EKE. It is widely accepted that 
cardiac contraction is to a great extent regulated by the concentration of cytosolic Ca2+ in 
cardiac muscle cells (Fabiato, 1883). The influx of Ca2+ into the cardiac cells during 
depolarization initiates the process of myocardial contraction. Thus, the present 
observation suggests that the cardio-stimulatory activities of EKE, besides B-adrenergic 
mechanism, are also mediated at least, in part, through activation of L-type Ca2+ channels 
causing an influx of calcium and subsequent positive inotropy and chronotropy. 
However, involvement of other mechanism (s) in the cardio-stimulatory effects of EKE 
cannot be ruled out. 
Considering that the positive inotropic effect of EKE was accompanied by positive 
chronotropism, it may be suggested that other mechanisms are partially involved in its 
effects. One of the mechanisms may include non-adrenergic mechanism like 
phosphodiesterase III inhibition, which would probably result in increased cAMP levels 
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and subsequent positive inotropy (Sys, Boels and Brutsaert, 1987). Moreover, it is 
reported that all inotropic mechanisms involving cAMP go along with a positive 
chronotropic effect (Gilani, Janbaz, Aziz, Herzig, Kazmi, Choudhary and Herzig, 1999). 
This speculation is supported by the fact that EKE, besides inducing positive inotropic 
effects, it also caused some chronotropic effects. 
In the present study, we have demonstrated that ethanolic leaf extract of Ekebergia 
capensis causes a concentration-dependent inotropic action with little chronotropic effect 
in isolated rat electrically-driven left and spontaneously-beating right atria respectively. 
We have also demonstrated that these effects are mediated through B-adrenergic receptor 
stimulation and calcium channel activation. We have also shown that its inotropic and 
chronotropic effects are not mediated through the release of noradrenaline from 
junctional stores. These observations may suggest that EKE may posses bioactive 
components which interact with the B-adrenergic receptors and calcium channels and that 
these two components may act synergistically to bring about the overall cardio-
stimulatory effects of EKE. 
The present study has demonstrated that Ekebergia capensis may posses a potential 
cardioinotropic principle, which may provide beneficial effects in conditions of cardiac 
heart failure or ventricular dysfunction. Positive inotropic drugs have therapeutic value in 
congestive heart failure (Erdmann, 1989), however, the current available cardiotonic 
drugs have major disadvantages that limit their clinical use. For example, cardiac 
glycosides like digitoxin have narrow margin of therapeutic safety, mainly due to 
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potential arrhythmogenesis (Paker, 1988), while inotropes involving increases in cyclic 
adenosine monophosphate (cAMP) levels, like sympathetic stimulants and 
phosphodiestrase (PDE) inhibitors (Siegl, 1986), induce tachycardia, which is unwanted 
side effect in this mechanism of action. Therefore, EKE may provide a cheap source of 
safe treatment of hypertension complicated with heart failure. The presence of a 
triterpene, oleanolic acid and perhaps other triterpenes, may contribute to the positive 
inotropic and chronotropic effects of EKE. Moreover, oleanolic acid has been recently 
reported to possess positive inotropic and chronotropic activities in guinea-pig isolated 
atrial muscle preparations (Somova, Mipando and Shode, 2004). 
6.4 Negative inotropism and chronotropism 
In the present study, the negative inotropic and chronotropic activities of ethanolic 
extracts prepared from the leaves of Persea americana (PAE), Helichrysum ceres (RCE) 
and stem-barks of Sclerocarya birrea (SBE) and corm of Hypoxis hemerocallidea, 
'African Potato' (APE), respectively. The study has demonstrated that all extracts (PAE, 
RCE, SBE and APE) elicited significant and concentration-dependent negative inotropic 
and chronotropic activities (See Figures 12, 14, 16 and 18). The study has also shown that 
pretreatment of the atrial preparations with atropine sulphate did not affect the negative 
inotropic and chronotropic effects induced by PAE, APE and SBE (See Figures 12, 14 
and 18). Atropine sulphate is a cholinergic muscarinic receptor antagonist 
(Arunlakhshana and Schild, 1959). In its presence, the negative inotropic effect of 
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acetylcholine is inhibited (Brown and Taylor, 1996) (See Figure 10). Acetylcholine is a 
neurotransmitter released by the parasympathetic nervous system and mediates its action 
by stimulation of the cholinergic muscarinic receptors (Brown and Taylor, 1996). 
Therefore, the fact that the negative inotropic and chronotropic effects of PAE, APE and 
SBE persist even after blockade of the cholinergic receptors, suggests that the negative 
inotropic and chronotropic effects of these test extracts are not mediated through 
activation of cholinergic receptors. This finding suggests that these extracts exhibit their 
cardio-inhibitory effects through some different mechanisms. 
There is a possibility that these test extracts may exert their effects directly on the 
myocardium or there could be other non-specific mechanisms through which they induce 
their cardio-inhibitory effects. Moreover, these test extracts were found to antagonize 
beta-adrenergic receptor agonist noradrenaline-induced positive inotropic actions in rat 
isolated left atria in a concentration dependent manner (See Figures 13, 15 and 19). This 
finding may provide evidence for beta-adrenergic receptor inhibitory potential of these 
test extracts. Thus, the test extracts may have a direct betal-adrenergic receptor blocking 
action, since betal-adrenergic receptors mediate the positive inotropic effects of the 
catecholamines (Hoffman and Lefkowitz, 1990). 
On the other hand, these extracts significantly antagonized the concentration-dependent 
positive inotropic effects induced by calcium in a concentration-dependent manner (See 
Figures 13, 15 and 19). Contraction of the cardiac muscle is to a large extent regulated by 
cytosolic Ca
2
+ levels in the cardiac cells. The influx of Ca2+ into the cardiac cells during 
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depolarization marks the process of excitation-contraction coupling. Therefore, by virtue 
of their antagonistic effects on the positive inotropic effects of Ca2+, these extracts appear 
to possess calcium antagonistic component (s) which might interfere with calcium influx 
at the cell membrane of the myocardium thereby, inhibiting myocardial contraction. 
Thus, the cardio-inhibitory effects of these extracts might well be related to inhibition of 
voltage-dependent calcium channels. 
In contrast, pretreatment of the atrial preparations with atropine sulphate significantly 
reduced the negative inotropic and chronotropic effects of HCE with a complete abolition 
of the effects of the three lower concentrations, suggesting that HCE mediates its cardio-
inhibitory effects partly, through activation of cholinergic receptors (See Figure16). 
However, the negative inotropic effect of the highest concentration persisted in the 
presence of atropine sulphate. This partial inhibition would suggest that besides 
activation of cholinergic receptors, HCE involves other mechanism (s) through which it 
mediates its cardio-inhibitory effects. However, the possibility that at this concentration, 
HCE competed with atropine sulphate for the cholinergic receptors cannot be ruled out. 
Furthermore, in separate experiments, HCE significantly reduced the concentration-
dependent positive inotropic effects induced by noradrenaline and calcium chloride (See 
Figure 17). We can, therefore, speculate that HCE may interact with adrenergic receptors 
and calcium channels to elicit its cardio-inhibitory effects. Therefore, it is likely that the 
negative inotropic and chronotropic effects of HCE are mediated by muscarinic receptors 
most likely M2 receptors (Caulfield, 1993). This is because it has been reported that the 
173 
negative phase of muscarinic receptor stimulation is mediated by M2 (Caulfield, 1993; 
Landzberg et al., 1994). The other possible mechanisms may involve its antagonistic 
actions on betal-adrenergic receptors and calcium channels. 
6.5 Vasorelaxant effects of various plant extracts. 
In the present study, we investigated the vasorelaxant effects of group A extracts (EKE, 
APE and PAE) and group B extracts (HCE, SBE) in rat isolated endothelium-intact and 
endothelium-deprived aortic rings precontracted with methoxamine hydrochloride (Ul-
adrenoceptor agonist). All the test extracts from each group significantly induced 
vasorelaxant effects in a concentration-dependent manner in endothelium-intact aortic 
rings precontracted with methoxamine hydrochloride (See Figure 20, 22, 24, 26 and 28). 
Removal of the endothelium significantly reduced, but not completely abolished the 
vasorelaxant effects of EKE and P AE from group A and HCE, and SBE from group B 
extracts, suggesting that the vasorelaxations induced by EKE, P AE, HCE and SBE are 
mediated by both endothelium-dependent and endothelium-independent mechanisms 
(See Figure 20, 24, 26 and 28). In contrast, the removal of the endothelium completely 
abolished the vasorelaxant effect of APE, from group A extracts (See Figure 22), 
suggesting that the vasorelaxant effect of APE involves predominantly the functional 
endothelium-dependent mechanisms. 
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6.5.1 Role of endothelium-derived relaxing factors. 
Since the extracts induced both endothelium-dependent and endothelium independent 
relaxations in the rat isolated-aortic rings precontracted with methoxamine, an attempt 
was made to investigate what endothelium-derived vasorelaxing factors contribute to the 
vasorelaxations induced by the test extracts. Pretreatment of the endothelium-intact 
aortic rings with L-NAME, a non-selective nitric oxide synthase inhibitor (Rees, palmer, 
Hodson and Moncada, 1989), significantly reduced but not abolished the vasorelaxations 
induced by the test extracts from each group (See Figure 20, 22, 24, 26 and 28), 
suggesting the important role of nitric oxide in the vasorelaxant effects of these extracts. 
The endothelium is a dynamic organ that plays an important role in the regulation of the 
vascular tone, structure, and function (Vanhoutte, 1989). The endothelium regulates the 
vascular tone by sensing various physiological stimuli and triggering release of multiple 
vasoactive substances, including nitric oxide (Behrendt and Ganz, 2002; Gibbons, 1997). 
Nitric oxide, enzymatically synthesized from the amino acid L-arginine, was first 
discovered in the vascular endothelium (Furchgott and Zawadzki, 1980). Endothelial 
nitric oxide plays an essential role in the control of vascular tone and structure (Luscher 
and Vanhoutte, 1986; Vanhoutte and Mombouli, 1996). The vascular tone plays an 
important role in the regulation of arterial blood pressure. A reduced production of nitric 
oxide by vascular endothelial cells is closely associated with endothelial dysfunction, 
which is proposed to be an important factor in cardiovascular diseases, especially in 
development of atherosclerosis and hypertension (Busse and Fleming, 1996). Moreover, 
endothelium-dependent vasorelaxation is reported to be impaired in human and 
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experimental hypertension (Luscher and Vanhoutte, 1986). Decreased bioavailability of 
nitric oxide, results in decreased vasodilation, thus causing an increase in vascular 
resistance and hence increased blood pressure (Luscher and Vanhoutte, 1986; Behrendt 
and Ganz, 2002; Panza, 1997). Moreover, endothelial dysfunction is closely associated 
with reduced bioavailability of nitric oxide. Owing to the importance of blood vessels for 
the function and regulation of the cardiovascular system, blood vessels are the major 
target for pharmacotherapy in patients with cardiovascular risk factors including 
hypertension (Luscher, Spieker, Noll and Cosentino, 2001). Therefore, the development 
of vasodilators with the ability to restore the bioavailability of nitric oxide in the vascular 
system can present a novel strategy in the search for drugs of hypertension and its 
associated cardiovascular diseases (Yin, Kang, Choi, Kwao and Lee, 2005). 
The present study has demonstrated that the vasorelaxant effects of various extracts 
(EKE, APE, P AE, HCE and SBE) are dependent on the synthesis or release of the 
endothelium-derived nitric oxide, since the vasorelaxant effects of these extracts were 
significantly reduced in the presence of L-NAME, an inhibitor of the enzyme which 
catalyses synthesis of nitric oxide (nitric oxide synthase). 
Pretreatment of the endothelium-intact aortic rings with methylene blue, a non-specific 
guanylate cyclase inhibitor (Mayer, Brunner, Schmidt, 1993; Kawada, Ishibashi, Sasage, 
Kato and Imai, 1994) caused a significant reduction in the vasorelaxations induced by 
each of the test extracts (See Figure 20, 22, 24, 26 and 28), confirming a predominant 
role of endothelium-derived nitric oxide in the vasorelaxations induced by these extracts. 
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The relaxation of vascular smooth muscle mediated by nitric oxide involves a sequence 
of steps. Nitric oxide is formed in the endothelium by activation of nitric oxide synthase. 
Once formed, the nitric oxide diffuses out of the endothelium with some entering the 
underlying vascular smooth muscle where it binds to and activates soluble guanylate 
cyclase (Furchgott and Vanhoutte, 1989). Soluble guanylate cyclase is an intracellular 
second messenger for nitric oxide in the target tissue, where it catalyzes the formation of 
cGMP (Arnold, Mittal, Katsuki and Murad; Lucas, Pitari, Kazerounian, Ruiz-Stewart, 
Park, Schulz, Chepenik and Waldman, 2000). Increases in cGMP subsequently lead to 
protein kinase C phosphorylation and smooth muscle relaxation (Furchgott and 
Vanhoutte, 1989; Nathan, 1992). In the present study, the role of cGMP on the 
vasorelaxant effects of various extracts was investigated. The endothelium-intact aortic 
rings were pretreated with methylene blue, an inhibitor of guanylate cyclase. Methylene 
blue significantly reduced the vasorelaxations induced by each test extract, suggesting 
that cGMP signal pathway plays an important role in the nitric oxide-dependent 
vasorelaxant effects of the tested extracts. Therefore, the fact that both L-NAME and 
methylene blue significantly reduced the vasorelaxations induced by the extracts clearly 
indicates that the active components contained in these test extracts act on the vascular 
endothelium via nitric oxide synthase/cGMP pathway. 
However, besides blocking guanylate cyclase, methylene blue also inhibits nitric oxide 
synthase at even higher potency than guanylate cyclase (Mayer, Brunner and Schmidt, 
1993). Furthermore, methylene blue stimulates the production of superoxide anion, which 
inactivates nitric oxide (Furchgott and Vanhoutte, 1989). Both these actions can decrease 
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the tissue nitric oxide levels, so that the observed effect of methylene blue on the 
vasorelaxatons induced by these test extracts could also be due to changes in nitric oxide 
rather than cyclic GMP levels. However, its overall effects on the vasorelaxations 
induced by the test extracts generally suggest a predominant role of endothelium derived 
nitric oxide. 
The possibility that endothelial vasorelaxing factors derived from cyclooxygenase 
pathway; Prostacyclin (PGh) released from endothelial cells (Jaffe, Levin, Weksler and 
Marcus, 1982), participated in the vasorelaxant effects of the test extracts was also 
evaluated. In this respect, pretreatment of the endothelium-intact aortic rings with 
indomethacin, an inhibitor of the cycloooxygenase, significantly reduced but not 
abolished the vasorelaxant effects of HCE, APE, EKE and SBE (See Figure 20, 22, 26 
and 28), suggesting that these extracts, in addition to nitric oxide synthase/cGMP 
pathway, mediate their vasorelaxant effects via cyclooxygenase pathway probably, 
through the release of prostacyclin. In contrast, cyclooxygenase pathway does not seem 
to play an important role on the vasorelaxant effect of P AE, since in the presence of 
indomethacin the vasorelaxant effect of this test extract was not affected (See Figure 24 ), 
thus excluding possible involvement of prostacyclin, another endothelial vasodilator, in 
the vasorelaxant effect of P AE. 
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6.5.2 Involvement of calcium and potassium channels. 
Involvement of calcium channels in the vasorelaxant effects induced by the test extracts 
was evaluated in the endothelium-intact aortic rings precontracted with high K+ (80mM) 
concentrations. In this study, RCE, EKE and SBE induced concentration-dependent 
vasorelaxations in the intact aortic rings precontracted with high K+ (80mM) 
concentration (See Figure 21, 27, and 29), suggesting the participation of calcium 
channels in the vasorelaxant effects of these extracts. 
The contractile responses induced by high K+ (80 mM) or increases of CaCh in KCI-
depolarized muscles are due to the influx of extracellular Ca 2+ through L-type voltage-
sensitive channels (VOCs), (Godfraind, Miller and Wibo, 1986) and have been used to 
provide a simple means of studying drugs with possible Ca2+ -entry blocking properties 
(Cauvin, Loutzenhiser and Van Breemen, 1983; Godfraind, Miller and Wibo, 1986). 
Calcium channel blockers inhibit noncompetitively the contractions which are induced by 
K+ depolarizations (Godfraind and Kaba, 1969). In this study, RCE, EKE and SBE 
induced concentration-dependent vasorelaxations in the intact aortic rings precontracted 
with high K+ (80mM) concentration. Since high K+ produces smooth muscle contraction 
by promoting Ca2+ entry through the voltage-sensitive Ca2+ channels, which are readily 
activated by membrane depolarization (Godfraind and Kaba, 1969), the vasorelaxant 
effects of RCE, EKE and SBE against high potassium-induced contractions can be 
visualized as blockade of Ca2+ channels. Therefore, the vasorelaxant effects of these 
extracts on the high K+ -induced contraction indicate that these extracts may interfere with 
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Ca2+ influx on the membranes of the vascular smooth muscle cells. In contrast, P AE and 
APE induced weak or mild vasorelaxations in the aortic rings precontracted with high K+ 
(80mM) concentration, thereby, (See Figure 23, and 25), excluding the involvement of 
calcium channels in their vasorelaxant effects. 
In the present study, the role of potassium channels in the vasorelaxant effects of the 
various test extracts was investigated in the endothelium-intact aortic rings precontracted 
with low K+ (20mM) concentration. In this study, each of the test extracts induced a 
concentration-dependent vasorelaxation In the endothelium-intact aortic rings 
precontracted with low K+ (20 mM) (See Figure 21, 23, 25, 27 and 29). However, PAE 
and APE induced the vasorelaxations more effectively in aortic rings precontracted with 
low K+ (20mM) than those precontracted with high K+ (80 mM) concentrations. This 
observation is similar to those found with potassium channel openers such as those of 
benzopyrane group (Edwards and Weston, 1993; Hamilton and Weston, 1989). 
In the vascular smooth muscle cells, Ca2+ is required to activate nitric oxide synthase in 
endothelial cells in order to transform L-arginine to L-citrulline and produce nitric oxide 
in a reaction dependent on a Ca2+-calmodulin interaction (Bredt and Snyder, 1990). 
In addition, activation of K+ -channels results in hyperpolarization of the endothelial cell 
membranes, providing a driving force for entry of Ca2+ which in tum activates nitric 
oxide synthesis and subsequent vasorelaxation. Therefore, besides activation of the nitric 
oxide synthesis, the opening of potassium channels also appears to be a possible 
mechanism for the vasorelaxation induced by the test extracts. It is reported that any 
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substance that selectively relaxes the contractions induced by low K+ «30 mM) is 
considered as a potassium channel opener and such experiments allow to distinguish 
potassium channel openers from calcium channel blockers (Hamilton, Weir and Weston, 
1986; Kishil, Morimoto, Nakajima, Yamazaki, Tsujitama and Takayanagi, 1992). In the 
present study, APE and PAE exhibited weak vasorelaxations against high K+-induced 
contractions, but selectively and significantly relaxed the low K+-induced contractions, 
suggesting that potassium channels play an important role in their vasorelaxant effects in 
rat aortic rings. 
It is conceivable that nitric oxide and prostacyclin are not the only endothelial mediators 
released from the endothelium in response to the various tested extracts in the present 
study, considering the fact that vasorelaxant effects of these test extracts were not 
completely abolished in the presence of L-NAME and indomethacin. Recently, it has 
been suggested that the remaining part of vasorelaxation induced by acetylcholine that is 
resistant to nitric oxide synthase inhibition is mediated through the release of 
endothelium-derived hyperpolarizing factor (EDHF) that acts ultimately by opening 
potassium channels (Hamilton and Weston, 1989; Edwards and Weston, 1993). 
Potassium channel openers are relatively a new class of drugs comprised of a diverse 
group of molecules with a wide range of potential therapeutic uses (Quest, 1992). The 
compounds open K+ channels, causing membrane potential hyperpolarization through the 
increase in K+ efflux, thus causing a decrease in the cellular free Ca2+ and smooth muscle 
relaxation (Quest and Cook, 1989; Nelson and Quayle, 1995). Different types of K+ 
channels are expressed in vascular smooth muscle cells (Kuriyama, Kitamura and 
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Nabata, 1995) and agents that block these channels are useful tools for examining the role 
of a particular K+ channel. In the present study, pretreatment of the endothelium-intact 
aortic rings with glibencl ami de, a selective blocker of ATP-sensitive K+ channels 
(Buckingham, Halmiton, Howlett, Mootoo and Wilson, 1989; Frank, Puschman, 
Schusdziarra and Allescher, 1994), did not affect the vasorelaxant effects of EKE, HeE 
and SBE (See Figure 21, 27 and 29), suggesting that ATP-dependent K+ channels do not 
play an important role in their vasorelaxant effects. However, glibenclamide significantly 
reduced the vasorelaxations induced by P AE and APE (See Figure 23 and 25), suggesting 
an important role of ATP-dependent K+ channels in the vasorelaxant effects of these two 
extracts. 
It is reported that the vasorelaxant actions of K+ channel opening agents in smooth 
muscle tissues are lower at high K+ (>35mM) than low K+-induced contractions (Ito, 
Kanno, Suzuki, Masuzawa-Ito, Takewaki, Ohashi, Asano and Suzuki, 1992). In the 
present study, the highly significant vasorelaxant effects of APE and PAE demonstrated 
in endothelium-intact aortic rings precontracted with low K+ (20mM) than of high K+ 
(80mM) also supports the possible involvement of KATP channel activation in the 
vasorelaxations induced by these test extracts. 
6.6 Effects of various plant extracts on portal vein. 
In this study, the effects of the test extracts on the contractility of the rat isolated-
myogenic- spontaneously contracting portal vein were evaluated. EKE displayed biphasic 
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effects on the myogenic-spontaneous contractions of the portal vem, with low to 
moderate concentrations causing an initial significant increase in contractions, followed 
by venorelaxations. However, the higher concentration (40 mg/.ml) induced a significant 
and sustained tonic contraction, which was not accompanied by venorelaxation (See 
Figure 30). Studies have reported that the contractile activity in a portal vein is 
essentially due to alphal-adrenergic receptor activation (Han, Abel and Minneman, 1987; 
Maramatsu, Ohmura, Kigosh, Hashimoto and Oshita, 1990). However, pretreatment of 
the rat isolated portal vein with prazosin, an alphal-adrenergic receptor antagonist (Han, 
Abel and Minneman, 1987 and Maramatsu et al., 1990) did not affect the tonic 
contractile effect of EKE (See Figure 30), suggesting that its tonic contractile effect in a 
rat portal vein is not mediated by activation of alphal-adrenergic receptors. In contrast, 
pretreatment of the portal veins with nifedipine (a voltage-gated Ca2+channel blocker), 
significantly reduced the tonic effect induced by EKE (See Figure 30), suggesting that 
EKE induces its tonic contractile effect in a rat portal vein partly, through activation of 
the voltage-gated Ca2+ channels. 
The structural and pharmacological features of the portal veins offer convenient 
preparation of venous smooth muscle, which possibly models the pharmacological 
reactivity of blood vessels (Bourreau, Lambert and Steyn, 1988). Spontaneous phasic 
contractions in a portal vein are thought to result from depolarizations stimulated by 
spontaneous transient inward currents (STIC) and influx of Ca2+ through voltage-gated 
calcium channels (Burt, 2003). Influx of Ca2+ through voltage-gated Ca2+ channels 
following depolarization may then stimulate Ca2+ induced Ca2+ release from intracellular 
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stores of the portal vein causing a contractile response (Burt, 2003). Therefore, the fact 
that nifedipine significantly reduced the tonic contractile effect of EKE in the portal 
veins, suggests that the test extract induced the tonic contractions, in part, by activation of 
the voltage-gated calcium channels thereby causing an influx of Ca 2+ and the subsequent 
contractile effect. 
Additionally, it is suggested that inhibition of the Ca2+ -dependent ATPase results in 
prolongation of the time required to restore the resting cytosolic Ca2+ level after 
contraction and this slows the rate of relaxation resulting in sustained tonic contraction 
(Choi and Eisner, 1995). It may be possible, therefore, that EKE exerts some inhibitory 
action on the Ca2+ -dependent ATPase, thereby resulting in prolongation of cytosolic 
Ca2+ level, and thus, maintaining the tonic contraction. On the other hand, APE, P AE and 
SBE exhibited biphasic contractile responses in rat isolated, myogenic-spontaneously 
contracting portal veins, with an initial, transient increase in contraction followed by a 
sustained and long lasting venorelaxation (See Figures 31, 32 and 34). Pretreatment of 
the rat isolated portal vein with nifedipine (lIJ.M) completely inhibited the contractile 
phase induced by the highest used concentration of APE (400 mg/.rnl), but did not affect 
the contractile phase induced by PAE and SBE (See Figures 31, 32 and 34). These 
findings suggest that the initial contractile effect of APE could be mediated through 
acti vation of the voltage-gated calcium channels while the effects of P AE and SBE do not 
involve these channels to induce contractions in this tissue. In addition, pretreatment of 
the isolated portal veins with atropine sulphate, did not alter the sustained, long lasting 
venorelaxations induced by the highest concentrations of APE, P AE and SBE, (See 
184 
Figures 31, 32 and 34), thus discarding involvement of cholinergic receptors in their 
mechanisms of venorelaxation. 
In contrast, without causing any initial contraction, RCE induced a significant and 
concentration-dependent venorelaxation in the rat isolated portal veins (See Figure 33). 
Pretreatment of the rat isolated portal vein preparations with atropine sulphate, 
significantly inhibited, but did not abolish the venorelaxation induced by the highest 
concentration of the test extract (160 mg/.m!) (See Figure 33). This observation indicates 
that RCE may induce venorelaxation in portal vein via stimulation of cholinergic 
receptors. 
The overall effects of these test extracts in a portal vein suggest that these plants could 
provide a source of novel drugs for the treatment of portal hypertension. Portal 
hypertension is the most common complication of chronic liver diseases . This syndrome, 
defined by a pathological increase in the portal venous pressure, is characterized by an 
increase in the pressure gradient between portal vein and inferior vena cava (Ratti, Pozzi, 
Bosch, 2005). The portal pressure gradient is the result of the interaction between portal 
blood flow and the vascular resistance that opposes the flow (Ratti, Pozzi, Bosch, 2005). 
Thus, portal pressure gradient can originate from an increase in intrahepatic vascular 
resistance, an increase in hepatic blood flow or from a combination of (Ratti, Pozzi, 
Bosch, 2005). There are mainly two types of pharmacological approaches towards the 
treatment of portal hypertension: by reducing portal blood flow by using vasoconstrictors 
or portal vascular resistance by using vasodilators (Navasa, Bosch, Rodes, 1991). 
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On the basis of the findings demonstrated by the present study, it is clear that these plants 
may provide a cheap source of treatment for portal hypertension. Thus, EKE due to its 
potent contractile effects demonstrated in isolated portal veins, may be used as a source 
of vasoconstrictor agents to reduce portal blood flow, one of the factors that increases 
portal pressure. On the other hand, due to their potential to induce long lasting 
venorelaxations, the other extracts (APE, P AE, SBE and HCE), may provide a source of 
vasodilator agents, which would be used to reduce portal vascular resistance, another 
causal factor for portal hypertension. In addition, these extracts with potent venorelaxant 
effects, may represent a novel strategy to treat portal hypertension, by reducing hepatic 
vascular resistance with the advantage of avoiding a further decrease in liver blood flow, 
but of improving liver perfusion (Loureiro-Silva, Cadelina, Iwakiri and Groszmann, 
2003). 
6.7 Conclusion. 
The present study has demonstrated the potential of the ethanolic extracts from five 
different selected plants to reduce blood pressure. All the tested extracts exhibited 
antihypertensive effects both in acute and chronic studies. However, of the five extracts 
only HCE demonstrated potent heart rate lowering effect (bradycardia) in the acute 
experiments while in chronic experiments, all tested extracts demonstrated the potential 
to lower heart rate. 
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The present study has also demonstrated that apart from EKE, all extracts exhibit 
negative inotropic and chronotropic effects on the rat isolated electrically-driven left and 
spontaneously-beating right atria respectively. The negative inotropic and chronotropic 
effects of ReE were shown to be mediated through activation of the cholinergic 
receptors. We speculate that the extracts might exert some inhibitory effects on the beta-
adrenergic receptors and the voltage-gated calcium channels, since they antagonized the 
positive inotropic effects of noradrenaline and calcium. In contrast, EKE was shown to 
exhibit positive inotropic and chronotropic effects which have been shown to be 
mediated by activation of the beta-adrenergic receptors and voltage-operated calcium 
channels. 
This study has also demonstrated that all tested extracts have vasorelaxant effects on the 
vascular smooth muscles of the rat isolated aorta. Apart from APE, all extracts exhibited 
both endothelium-dependent and endothelium-independent vasorelaxations. APE was 
shown to exhibit an endothelium-dependent vasorelaxation. Vasorelaxant effects of these 
test extracts were demonstrated to involve the activation of endothelial vasodilators, 
opening of potassium channels and blockade of calcium channels. 
The study has also demonstrated the biphasic contractile effects of some of the tested 
extracts in rat isolated portal veins, except for EKE and ReE. These extracts induced an 
initial and transient contractile effect followed by a sustained and long lasting 
venorelaxation. On the other hand, ReE induced venorelaxation in the spontaneously 
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contracting portal vein, the effect of which was mediated by activation of cholinergic 
receptors. EKE, on the contrast, induced tonic contraction at higher concentration in the 
rat isolated spontaneously contracting portal veins. This effect was shown to involve 
activation of voltage-gated calcium channels. 
Taken together, these findings suggest that, these plant extracts exert their hypotensive 
effects through their cardio-suppressant actions causing a reduction in both stroke volume 
and cardiac output and through their potent vasorelaxant effects causing a reduction in 
the total peripheral vascular resistance. Thus, a combined decrease in cardiac output and 
total peripheral vascular resistance results in hypotension. 
The present study has provided the mechanistic basis for the use of Ekebergia capensis, 
Persea americana, Helichrysum ceres, Sclerocarya birrea and Hypoxis hemerocallidea 
in the management of hypertension and other cardiovascular disorders. Therefore, crude 
extracts from these plants can be recommended for an additional and rational therapy of 
hypertension, as a cheap and accessible source of treatment of hypertension and other 
associated cardiovascular disorders. 
6.8 Short Falls 
The following are some of the short falls of the present study; 
The doses used in the present study were determined based on the preliminary work in 
our laboratory. There was no work on the toxicity of the plant extracts. Therefore, there 
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may be a possibility that the observed effects of the extracts were partly due to the toxic 
effects of the extracts. 
During acute and chronic studies in rats only a single dose was used. Use of a series of 
doses would be ideal to asses whether the effects of the extracts may be dose-dependent 
or not. 
Pharmacological studies were only done in vitro. Pharmacological studies should have 
been conducted in whole animals in order to confirm the in vitro results, since there are 
possibilities that the in vitro studies may provide false results when applied to the whole 
animal studies. 
The study does not justify use of ethanolic extracts, since traditional healers usually 
administer aqueous extracts to their patients. 
6.9 Future work and recommendations 
1. Further work will be devoted to isolate and structurally identify the active 
ingredients in these extracts. 
2. Since none of the acti ve compounds reported to be present in these plants were 
tested for their cardiovascular effects in this work, future work will be devoted to 
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screening the isolated compounds of these extracts and probably compare their 
effects with the available synthetic compounds. 
3. Since it is a common practice that traditional healers combine more than one plant 
to formulate a herbal medicine, in future we will investigate the combined effects 
of these extracts in the treatment of hypertension. Furthermore, efforts will be 
made to compare the cardiovascular effects of these ethanolic extracts to those of 
aqueous extracts considering that traditional healers normally administer aqueous 
extracts to their patients. 
4. Many factors may contribute to the long-term beneficial effects of the test extracts 
on the cardiovascular system. For instance vascular smooth muscle cell 
proliferation is essential factor involving the formation of atherosclerotic plaques. 
Therefore, since nitric oxide plays a major role in vascular smooth muscle cell 
proliferation the effects of these extracts and their isolated active ingredients on 
vascular smooth muscle proliferation will be carried out in vitro. Future work will 
also investigate whether the extracts may induce actual production of nitric oxide 
and cGMP in vitro. 
5. It is generally accepted that the kidney exerts a dominant role in controlling blood 
pressure. Taking this into account, future work will investigate the effects of 
these extracts on the renal function. 
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6. At present, nothing lS known regarding the pharmacodynamics of these test 
extracts. Therefore, future studies on the possible degradation or chemical 
modification of the test extracts in the body will be necessary to confirm the 
relevance of the in vitro studies described by the present study. 
7. Toxicological studies of these extracts will be conducted by a dye-reduction 
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Some in vitro and in vivo cardiovascular effects 
of Hypoxis hemerocallidea Fisch & CA Mey 
(Hypoxidaceae) corm (African potato) aqueous 
extract in experime_ntal animal models 
JAO OJEWOLE, D R KAMADYAAPA, CT MUSABAYANE 
Summary 
T his sUidy WlI!> uuderml en (0 inveslig a t e some cardionls -
('ulnr ctTe-cts of Hypo:"';_, h em erocufliilell Fisch & C ,\ \lc~ 
(Il~' po. id:le'C:1C) corm (.-'\ fden n PO[!ltO) aq .. e-ous extnlcl ill 
"'''pcrint ("oIAI >lnil1l:11 rHtr:l dij!ms. The cffee( of the corm 
>lIIUCQUS e"tl">,ct ( ,\I'E ) un m~ot:"r"iJlI c"nln.ctilt~ perform-
:U1Cl' I,a" e' .. Ju>I(cd on guine~,-pig isolatf'd atria l 1I\ .. "clo: 
Slril»' ;11 "iln' ; \ Iwrca the .>'Illtihypcrtc.n s ive (hypulen~h'e) 
effe<-I of Ihe plant e'Ct,' :Ict ,,~'s e"3minecl in hyp e ,'t cnsiyc 
Da.hl salt-sensitin~ mts ;1/ l'ivQ, \l>E (25--t00 m glml) pro-
duced concentration-depemlent, igllificant (p < O,U5--(J,OU I ) 
negati, c inulrupk ant! "ega.tin: ebrQnolrOI>ic.: effe .... " on 
I!llinca-pi~ isolalL-d electrically uriv"n len, alld spuntan~­
ous ly he:uilll>!. righl alrial muscle IJrep:trations, respedi, d~ . 
)lon'o\'H, .\['E reduced or abolished, in. :t co ncenlratioll -
rlependent Illanner, the positin: in.otropic and cbronotrollic 
,-es[>onsc"; o r g uine.a- I,i::, is olated atrial mu!>cle slrips induced 
hy fl o radr" n:llinc (:-.- \, 1- 100 f-I.;\I) and calciulIl (Ca" , 5-&0 
III \1 ), T h e II cg nrtve i n o rropic and i:hronotl-opic effect. o f 
.\PF. on g ulne n. pig nrrial muscle strip..~ v-ere noc modified bv 
e'''genf)lI~ a dmilliStration of atropine (ATR. '.5 )( 10"-2,5 
" 10 ·' \1) to the bach nuld. ~PF: .\! . 0 ~ignifi('nntl\' reduced 
(p < 0.0:">-0.(01) or a bolis hed In a cOllCCnCrlltlon-dependclIl 
manner, the rh) chill ie', "1)()I][lll\eOUS, myogenic (onrtal'lions 
of p(,rtal, o:ins i.solale.1 r ... .1 .... n,ts , f'urthcrmvre. APE c>'Iu,e d 
dose- related Lrans ient but Significant Ip < 0 .0:;....0.001 ) ,~"uc-
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lions in the "ystemic arterilll blood p,'es$ur(' ano h ean n H I!S 
of the h:, perl"llsiv nt is used, 
Although' the e:\'Jl('t m~chnllisms of th4' c:u'djodepre~"""t 
and the fran jenr hypotensive tantihype,·tensh'CJ action 
of ~'E could nM he esra\)li"hec:1 in the pres ent stu(h, we 
ccxclul.l" the in\ oh emcnl of the cholinergic Syslem: 's ince 
the " .. inlCt's c:'IrdiQ"ascuht" cfTeclS were resistanl 10 atro-
pine 1}I'etrc:Umcrll., Ho\\ l'~· e.-. the rcsult~ of this laboratory 
animal Slutl~' indicaled that . \.PE caused brudYcllrtii>l an;' 
btief h) (,o(~'Il~ion in the mammalian e-:l.perim;ntal nh.dd,.; 
used . These observations lend to suggesl thul the herb rnll,' 
be used as II natural supplementory "emed)' in sOlne cas.; 
of c"lrdiac d~·sfunctions and in essential hyperten.<iiol1_ The 
findings of this experimental animal study lend phllnnaco-
I'ogiclll SUllfl(>l1. [0 the folkloric. anecdotal uses of the Afri.c :1 n 
potato in the management and/or control nf cc.-Iain cardiac 
dysfunctions and essential hypertension III some rur:.tl ('(lIIl-
munities of southern . ~fri£-a, 
( ·a m l m'r. .. ·J.'nIlI"./r ! IJO,t, . I ; I hf) I ?l 
T he !loral h k" jiv.:rsiLy of , o ulh .\ fricn ha< pr<l\'ided IR lr tr::rJ i. 
lional hcalth rmlclilioncrs w ilh an imprc s,~i ve fl" ,)1 I } f 'nil(\l l:aI 
phurmn.::) ' Ih,m \ hich p l unt.~ at ' ';":Ic ' let! 11.. , r 'm <.:<1 i ' ,,_ alld/ o r 
>I.' ing,nod icn LS W prC1l3l'C herbal m.:Jieincs ( phywm t: lido",. ) 
for ,-, pkiIH' r:. .,r hu man J bordcr. _ \Vc hav' Io;:ccnt h <': ';:J1n m"d 
S0n1C II I Ihe commo nl) ~ct! :-- 'uth A rrica n mcdKm~u p lanLS I;,)' 
111<: 11 c hcmk 11 cvn:;l illlc nl" and ph;Ul11UC(. It.g io:~1 ul: l j\'ilie s_ " in 
un ei'tl ,rl tIl ,,,'t;lh lr ,,h a "c i 'ntilk hll.o.; ,,, It lf the i, 1\)1(';l l)l"ic. c lh-
noml:dil-al \I~C". O n..: ~lI(;h c ,-arnp lc i;. I '; 'l}IJx i.1' In.'m(·rocat/!d l'c{ 
d':' i ~ch &. ',0\ Pl.le ) ) [ ramil ) _ 11)p<." iclac .... =1 pn:vklu~ l y k",,,, ·n 
~ I ~l f Jo.xi.· rplI{Jeri. 
Thi: southcm, rrkan 'mi md ' m cdicinal plant' is a tuber-
('U~. perenn i.J1 herh w ith long. s u .. "'p-sh a pcd I"u\'",~ anJ y' lIll\v. 
star-"h apcd Ilo \\'c rs, T he 1')I'oaJ and s lig htl) hui!) lea\ <!;; o f /I 
hCi'Ilt'r(x :CII'III:le a UI'C arra ng ed o n.: :Jbo vc th e (,111<:" tn Ibnn t ilt , , 
dblinc l groups "r Io.: ovc~ s pr-cod ing o utwnnl. ' from th~' <;(" n tro: ,.f 
th\! f'b J1l. w h ik l he h rig ht :- <.:'11 m \', Star.,;h:'l pc d rlc)\n" l's :.U'I,: b<" 'IK' 
, 'n I" og_ .. h.:ndc, stalk. _' Tho.: Lutx:n"lI~ r", ' L,t~. o.:k I co ml ) ,, ( t ho.: 
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herh. p(lplll:lrl~ klhl\\'l) as 'Afric:m pOl.3ll1· . j" widdy u...;eJ in 
",'ulh.:m. lrinm lruJilional m~'dkine us a r.:med) fix an arrllY 
vf" human J.ittncnts. Tr..wili,'naJ hC"J.lcrs hllvt: u,,;cu the corm as 
I1wlhl (isi/,ulu uord. ll1o.!:lfI ing 'm<:dicinc ') for cc'mur;.:;;., and 
now, the humbk African rmtm ha.~ bo..:en claimed to be an 
' amazing plant medi in.: ' in \.h.: ligh l against \aric'u m,xkm 
human oilmcnL~ ,;uch a. I IlV! AIDS-rcialctl Ji~::tSe,,- arthrilis_ 
,uppic nu, h) pcf1.':llsi,m. diubo..:tL'S mdl ims. cancer, flS<.~ria"i~. 
ga.~t ric and Ju.,oenal ~al cer', tul"l<o'I'Cu.!ns;s. unna.!"y tr..lct infec-
li \Il~, asthma. and ",Hne centra.! 11Cl .... OUS system disNders. 
l:spccialJ} cpilcp:$) :In I chih.II K!(,.j cl1nvu lsi' U1S .""· 
Pre i"us slllJic~ in nur lah""ll[nt"ics have inJica!.:.! thal 
U1': com, r H h,.' m':I'IJ~·{/llide(.J P,'S~S$\;~ ,lI1ti-in lblll trH1WI") . 
h) pogl> t'l..:mIC and ,' ll1a ph:trma ... :\ll~'gical prop ' l1io:, .. ". Tlte 
pr~''''l:nl s.tud~ was. pr~'mrt.:d by the d:um (If .. ;..)mc tr'dlti1 Ir>nal 
health pmctil il.\ners in K\\uZulu-).IUlullhtll decucl i ol1~ und infu-
, lOll!-. or :\(rio.:an rotalU JI\: cll'c..:li\ C n.:medics for tho.: manago:-
mo.:nl anJior (;\'nll'l,1 ufh)lx'ncllsi("O(l ~mJ S('Il IO: ,·an.!iac J.i~\rd.:rs 
The c,">re 'li m ,)1' this Sllhi), \\'J$, therer no. 1\ im' ';;Iigalc tht· 
cardiac and :.ullilrypc:l"l~nsi \·c (h}pol.Cn.<i\"c) <:11<:<;(" (11'11 Itcme-
1"I)C,dlidclI ';(>1"111 ulI='\ ~ cxtract in I a.bllnu,,,), expo.:rimcmal 
animal paradigm ... . 
Materials and methods 
·nlc.: cxperirncnc..uJ prllLvo.:,)1 lI,.o:d in lhis SluJy \\ IS appn}\ cu b) 
thc r::thic~ Committe-: (,l' the U nfvcrsily \11" Durt un-\\'c$lyillc 
and cOnl(.mls to the G!IId~' 10 rho! ('ar,;: mull ',·" ol .·fnimals in 
Resl:llrclJ and reaching. 
Plant material 
FrO: 'h :'orms <If If hememc,.lhdt!!(1 were rurcha.~..:d from a fhlit 
"I"S" ak",!! W(',;t Sln:e! in Durban. Kwal:ulu- atal , hd\\'c 'n 
June ilnd :"-h1' .:mhcr 20n. ' 11'0: c"nns wert: icienli li ed hy " m[ II 
Baijnalh 11"'I'mcr chief hl"onnmi"I /l:Urm.nr ,I' th~ (Ini\"er,;i l"- of 
Durban- WC,I' ilk's Dcpanm,'nt o f BO I ;ln~ ) U' 11'1".- , "I' H.~p~',\·i,~ 
lu:menlcallidea Fisch & CA M) Ifiunily: I IY[)I.")-.;idae.:u-:I 
:\ voucher spceimL'n ll f the planl has bc.:cn depo,iled in Ihe 
l ni ' <:r,ily's HN:III) Dc.pal101cnlal Hc.rh~lJ·ium . 
Prepllraoou of cm'm aqueous extt'act 
()11~' "ilogr..trn tIl' If h~f/le"(J('(I!JidO!<:I fresh ;;I)rrn, \Y:I~ '\;"h~'d 
\\ .il11 J i":li lkJ \\:llc r. CUI into ~J1lrdlt.::t picc<;s aoJ (!mund in a 
\Varin.!; t:(lIlUlh.,.-eiul hll!'lldcr. The ll1ilkd C,,,'1l1 \Va~ ""aked in 
11\)\ dislilkd waler and ':"l'..I<.:1 '<I l\\'ic~'. O il !:a,'h t><:Ca.o:iml with 
2,5 lilr!:, ,)1 Iwl distilled" ale ' (al9f)-IO() "'I f"1" I ? 1\( \1I~. T he 
~l1mbin<:tI \:\lnu:t ~1Iubk,.; "L' rC cl'no:.:nU~IlCli l,1 Jr'H1L''''' tlnde l' 
'Ju cd pr.:s-<;urc in a l'\IUlry ,,',aroralo!" al 70 = I 'C: Th..: r..:su l1-
ing crude aqueous cxlmel wa.' freer\: dried. fInal!} gi\' ing 78 g 
\ 7.N% ) kid I of" d;u;" hmwn. pm\ def) . ,IY U"<I I~ ·.'\ lra 'll"l;"idul' 
{t\ ('E). \\,ilhQur a ny further puri ficut ion. :l.I iquot portions o( lhe 
.\1'1". \\"cr·~ m.:ighc.:d :md di ';'-i\I!vc.:J in dist ilkd \\:1I.:r 'al room 
(en"p<'''ltUl'' I I,'r usc lin cach d3~ pf OUr .:xp.:rimc:nl~. 
Aoimal material 
I k~tith), malt: I )unUn-l/anky guillcn-rig..; «( <JI 'W "'m ..· •. ltu, 1 
\\'cighing ,iOO l\' ~50 g and 11<:<1 1111) , nUlllo! ;Jli UI I.. ll1,tk \'\ 'IStnr 
rJL..; \It'al1u.\' ih'n " ~x}(: lI-l'1 \"cighing. :i50 t{"; 300 l:? \\'~ I'\: lIS"':U . 
T he anim;ili; WCI"(' kqll :lIld mail1laincd under !aoor::lI1f)' (:011-
u iltons ..,1' kmpenltllt'<:, numidil) and lighL anJ wac :llIo\\"d 
lree acct:s..-; t" 1(,(,..1 (s lamJal1.l pdl!::l diel) and \~ at>!!" lid ilhitllm, 
All the animal;; \\'cf\l fa~led f{)r 16 nour,;. hUl ~ld l allowed free 
:Ie-cess to W::lll;r h ·thre th.c COmm'::l1ccm lit of ollr expt! ri l11<.:nls . 
Juinea-pig L~"lmed alli:ll muscks were used ror th.:: ill v itm 
c\'uluation {"If the ctTcCL~ of A PE on myncard ial cnntr ... ctillly: 
\ hcrea.'I rUI isnlnted /"'<'t1..11 \ eins \\ CI"C u,;ed to examin.:- the 
, ' i\S1xlih.1I,'ry enect~ I,f the extract. Droll ~nl l-sensi ljve nl!~ wcr.: 
used fi)r lht! in \'il'o IlIn!, ligatioll!>f the! h~ !loten,i~'e (:Jnlih~ pcr-
lensivd el1i:<;t or PF.. 
Isolated. mUsCle experiments 
GlIill<!(J-pi:: iSQ/(,lecl dl!ctricuJ(r dr;v<!1/ left, (llId spon l({//.cI1uslj' 
hemill!: rixht. atrial muscle prcpnrntiOJlx 
The guinca-pigs "crc s:lc rificcd h~' stunn ing and cx=suina-
lipn. Th.; len ~nd right alrial muscles M' mc an.im b weI" iso-
lOlled and mounted as prcYi()u:-:ly dc.o: rihed h;.- (~icw(>lc .··' The 
i.:~o lalcJ I-It atrium Ill" ll<.:h guinea-pig was impaled on n Ih in 
platinum wirt' ckctrode and suspended under an applied r.:sling 
tcnsil1l1 or 1.0 g in " 30-1111 \ 'go Basik l1fg"', balh '( !llmni " g 
Kl'\:bs- I knscleil ph:- ;;i"l()gic~1 ,,,,Iuli'ln 1,'(" cn ll1pO~ilk,tl. in 
g/ lilre: NnCI. 6.92: KC I. (J,3~ ; 1'<u11J'O,. 0.15: NaHC(),. 2, IU: 
MgCl, . 0. 11: ea ·1.. 0,26; and gll""e. LUU pit ndju; led 1\> 
7.tl m:lint:dn"d :11 J~ + 1"(' (iI1d ConLinuou ' Iy a('rat·li \\'iu, car-
bog "11 (95% n , + 5%, CO, gns miXllU"u). f-:al.:h let\ alrial lnll :><:k 
preparalillfl. \\ as Icl·tTicall~ dri'l!n with '4t1,m: \\'o.-'l! pub'l!s 1)( 
5-1l"I.~~~ tlur:1li,111 a t " rrequ~~nc) of' 3 I-Iz anu a s upr'lma imal 
vil hag' , \f" Ij\ I.: It' I () \'olls. uc li\¢t..:d by an SRI ~limuliltor. 
T Ill: srx'"ta.tle')lI~ ly b.:ating. right a1Jium tI t" cach animal \Va" 
abl,) ~cl up unucr thc >(tm,' ph}'siulvgical L'XpcriOlcnwl cpndi-
Ii,)n:; and allo\\"ed 10 Ix'at !,'\Xmtnn<:t)u:-;Iy. T\\" i~)latcJ e b :lri-
call~ tlrh.::n len atriaf mu~ch.: s l1'ip5 und "-\'o is(1 1mcd $pOllla-
ncou..;ly I;l:ating rig.ln :ttrial muscle preparaLions were :thvu\.:; 
set up at a Limc (onl.: u..;cJ a" l lll: [1.:5.1.. und Ihe (,ther the (.'Onl;',1 
preparal}, n) to HUm\" f(',(" ehll1lgc.,; in the atria l li$,.~u..: scn~il i il'. 
("he Htrbl rllu"clc pn.!I"Jrntion,; \\ ere len to '<.luilihrak' ror ,~5 In 
flO mill ldunng which lim' th.: ha llimg physiol"giC;J1 sllluli 111 
was chan!!,.:.! <:"\CI": 15 min) be I on: thc> \\e l"l.: challcl1gl:d "ilh 
PE Of ll.n~ or Ul<' 1-.;f(:rCIIC: drugs u~u. The lC~l at rial I11lL,l'IC 
pl'\:~pilrJ.li\)rl:- Wen; ltcuku with SCl)ucl1liaHy applieJ graded 
cvncenl r.:tU\.~Il.$ uf APt:: and/ur Ih . rd-;;;n.:nce ag(lniSl. drugsuscd. 
",lll.·lca ' Ihe control atrial l11u~ck sU'tp wcn.; lrCakd wim dis-
!illcd waH.:r (0. 1 .. 0.4 mil onl). '111e dccu;caU) pn.)Voked and 
~Ixl!ll.anc(>u;,. ~·ilnlr.ICI ions {) f Ihi! au;al muscles.. u.< well ,IS the 
PF. - :Ufd n:tcrcn 'C :.I£pnist drug-indm,-<:d r..:~'P<lI\.';":s "flhe :lIl'inl 
rlmsclc preparations \\"':re recorded i~O Il)elriL'Ully by mean,; \)r 
Ug.) Basile !(lfCt:-Jisplaccmt:nl tnms.Jucc.:rs lind pen· writing 
Ol"mini (",'orders (mmld 7(70). 
Rill i~'(J{tl(t!rf portlr/l'l!'in prt:pmYlliolls 
T he ral~ '.\'CTC sacrificeJ by stunning and e:o;sanguin:ui(1n . The 
uhdom<:n ,)1" c' en rat was quickly opo.! l1cd bv m id lin ... illci~ inl1 
and Ihe in le.-;( incs \\'cn~ pullcd u.<;ide, rh~ /"'<H~I \ ein "r ead, rlll. 
\\ illl an ill .~JfI1 length o r llppm"imatel\ 20 mnl. wu,; can:I'lI l!\' 
clcam:d Cret: ('of ,,\(Ir::l.IJeous ('o)nllc cli "~ a nd f:lIlv li'Mles. and 
(hell rCIlli"'I\"ed (r. ni Ihe an imal, baeh isolated 1';' rta 1 ve in was 
~lI,;p..:llded unlil' r ,lll !lpplieLi r~'slln~ lell~i"Jl <Jf 0.5 g in a 3(}-rnl 
l ig\.l B,~~ ik orgml balh cl.)J1l.ain ing K rcbs-I lctl~c lt:it pny.s io logi-
2) 7 
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cal ;:ollltion (pH adjustc.:l I.( 7...1 ) maintained at ;i-l. ;x. 1" (' and 
e 'nl inu() u~ly aerated with carnogen, Tw j isulUlcd VCI1I.'1lS tissue 
prcpamti()n.;; (one cOnlwl lind the Olh<!r i\PE- <I r r.:fc re nt.:.: drug,-
treated (l;!.<I) were lIh""uys ~I up in unJc:r \0 OI(\)..C all,'"wKI.: Ii.lr 
dmn£,·s in t is.~I \(; scnsitlvn;, t '0 1111'(11 ~enOU5 m uscle strips " en; 
Irct.!.ed with d istil k d water ')Illy Hhc "chicle in whi h APE nnd 
n..°ti.:'~nu: druss "'",re di,:solvt:d ), .( he venous t i"Suc pn,:par ..lliol1." 
"l~r0 allo\>" ,d 10 equ ilihril te r I 45 to 6() m in (during \\ hkh timc 
the bath ing ph:;; i )I, 'gical Sf ·lul ion wa. ... chang..:d ,'vcr) 15 min ) 
he ltH'" th.:.' we/'I." chalkng,l'd with ,\1'1 "'T (10:' u( lhe n ·r.:n:m:..: 
<i.ru~s usnL '!lIe APE- ami I'\.'rCI'.:n~'c urug -imluced n,:;.p0n~..:~ of 
the \ CIl,JU!< sfTIol,Jlh muscle p n:par.lt i(H)s were, '<:l'n.ktl i':,. m~tri­
call)' b} m..::ms ,.f! Igo na~ i k fu rc.:-d i",pl:.lccme nl 1I1111 ~lu..:<!r" 
and pen-writing G.:mini n:c. lrd.:~ t010dd 7070). 
\Vholc animal cxprrimcu ts 
SYSittll1h' arterial hifl(){/ prt!,",'urtts ((lid h"arl rifle,' of 
tlTlue.<llu.tised ra t~ 
:VI,.I.: hYl'cl1cnsh'':, y 0Lmg adul! ()~Ihl :al\-:i-:n~iti\'c nils \\'cig:h-
ing 150 to 3110 g \\'tOre u~d . ~d{>n: lh..: eunH11enCClllcm ,)1' l'lIr 
c:-(\I:rim..:nlS. th ... <Ulimals W\.'I''': placed ... n .j·".o salin" " at.: ,- ami 
normal lo..H.l (slandanJ petkot dil't) liJr si'C t.,l e ight "" .. -I;" (dlll'-
iog whic:h lim\.' lh..: art,;rial bkx.d PI"C;,:':Uf,: vi' Lhe allinial:; rL'So;; 
tl ) b..:t \\'ecnI70lf 25 and 11l6113[J mrnllgJ. R' IS wilh an .ut e rial 
hlooJ prcssur..: oi' ]70/ 120 mmllg and ab,,,''; ,'CI" "on~iJcr..:d 
II he hypcncnsi, rand u,.,.:d in th is study. 
Each ,'f lhe anim,als \\ a;, 'lIl:;t<."sLhdi~o;;J \ ith inlr.l! .:riwl1 'a.1 
inJcction ot' (l,1 1 g'-kg or Ibpanal I $,),liUlll 5-':lh) I-t I-m.:thrl-
hutyl )-2- thinh::u'hiLurme j , ' n 1<! right timmral "..: in of each nil wa:' 
c!l(1nulall!u f with :1 s m ull PlliYlht.:nc cann ulu) rllr the admini::lm-
l inn of the plan t ¢xlrtlCt :\110 t'\! rCTt.:nce Jrug". In .)I'd"r to) mi l1l-
mise lht pwblcm o r' hlood coagu lation, heparin (500 Ir\l! t#kg) 
"!L\ l rlLraVCnollst: 8llnl lrUStcr 'd I th.: an imnl :Ulct flush 'J in 
\\ ilh 0,2 miDI' 0,1)".10 " / \' sodIum dtlnride M.lmion, rh..: I'[t 
(;arutiJal'u: r~' of .:a<:h rat "'I." aL' . cannul.alt.:u and ":OI1lH:ell'J 
(" ,I fO Lir-chann.:i Gra.:.s p"IY:?I'<lph 1~lr ~: l<l.:m ic a rterial I'>kll)U 
pr.:s,ur..: recurding. 11",: Lraeh..:a ('1' cudl rat was L:.Illfl Ibtcd 1(\1' 
artificial re"11iraliol1, bUl lhe animal W'l.~ .tll()\\ ",d l(' brc~lf.h<! 
spontaneously, T hc tal's hI) r t.:ml1<:ral.un.: wa.~ maillt:lincJ al:;6 
;::; 1' <': with an iJ1\.'an.ks..:ci1t lamp 1)lac.:d l'''<: r its ahdllm..: n. 
,'\.! Icr a 20-mi" sl.ahilisulio n p..:.l'iod. the li)'litCmi ' at1..:l"in l 
hl.)o(l pressur\! (s),st(>lic, Jia..,;",tk and m-:a n arterial prcssur..:s) 
m'1,1 he>lrt I'ale ,,1' caeh rat wo;;re rnca.~lJn:d and rCCl)rded, The 
"Ile"ls of "'PI:. flnd ,)tllL;r dmgs [::tcc~ Ichol inc (0,5 .j ,O f.tg!kg 
il) anu l1onld rc l1:lline 10_.:\ 4 .0 ~(g , kg iv)J 011 systemic ancti.J..I 
ok)(,.1 Plt"SUI C :lnu he:m ralc~ (calculated Ir l)l11 the " ('(i limb 
k ad II recording at a fast p~lpcr spc",d ,,1' 25 mm/~e~) wcre 
r('cor'lkd by mc:\n~ .,( fI tt)tJl'- l~h:II'flC I (iras." polygraph n:c,)I'I1c.· 
(m~l{kl 7" 11), In som <: 1'1' 111 nilS, the IT~ pot 'ns i\'<! (d,,'pr<::i our) 
..:lli.:el "I' : \ 1'1-: r:!.:: 00 mgf" g i\') was C'(111111 11CU ntler iltl'llp i-
n i:;llli , ,,, Jp ·tr..:a lrnCIIl (If Ihe rats Wilh atropine sulpha!' ( 1.5 
mgikg ip) 18 lO 24 holtl~ hd'1r": us 'l. Rec<lu,,;c I'E :Jn u o ther 
drugs uS<.:u in lhb s tu uy \\'L'l'C uis""-II\ n l in d is tilled " ·atcl', raL .. 
Ir..:alcd wilh Ji~t.ill~J waler 13 m l/kg tV) alone ,'ere uSt.:J as Cull-
In,l animal Ul1(kr thl." ,:al'l'll: c\;paim':l'Ital cnnli il i, ms. 
l)1"u gs used 
f he t'(\~k1\\·ing (:'Hl)r~i IOl.l" an ... 1 drucs \\'~1"C uscJ : II Ju,,,'nh.Tt) .. 
,,,!lideo eor11l "4uCOU: e,[ract IA I'I-: ), aCL'l~ Ir.:h"l inc c: hll'ride. 
~llropillc • u lphat '. (- i-u()radrcn:.dine h ufllchlmiJc. ( J )-pw-
pmll~lk'i 11>Utl.ldlluridl:'. <':;'lldum t'h luridc. potU5sium ehl!'ride 
and Trapana l I~dium 5-:;10':' H l-mdhyltll'lyll-2-thiororhiw-
nllc I, /\11 Jrug:< ~\:;re d issolveu in disti lled waler..:a h day ClL lht.: 
b"1;innin!: ur' ,Ill!" CAp -rim,;nls. Drug conc\!nu~ui( ns anu d l$l~S 
qUIlted in th..: I.;XI rdel" to the sall ' . except APE, .md J om,i..: final 
organ-bath c0tlccnmtliQI1s in the in l'iflrJ ':Xpcrllll<."IlLS, 
Data analysis 
F 'pcrimcillal Jaw (Ih laincu Cn rn lc~ 1 guinea-pig iso laLl."u atria. 
rat isol'lh.:d po rta l \ cin and anac, thcti:.:cd h:'pcn'I\.:;I\'\!' mI." 
tf'l!iILt.:d with APE alonc. a.~ well as thuse ohtain·d frtl/l1 d istll l 'd 
"atcl~ llt:1tcJ c<.mLruL isolated all·itt. r onal v..:in and anaes-
l hl."liscd rats were pouled and .: :\q::'l'c~~cd :L-'; ll1ean~ (:t SF f), 
Slauslical comparis 111 or lh.: Ji n~renc.:s OelW':en fhe .\ PE- :UlJ 
r...:icrcncc dntg~lre :llcd ICSI m eans, lind distilled wat.:r-In:ateu 
Co,m-o l means, \HIS pcr/onncd \\ith <JraphPad InStat s0llwan: 
(vt!r~ion '.00. (jr.:lphP:ld s~' lh;,al " SUIl Diecl1. ·ali fo rnia. l 'S l 
u~i ng nne-way llnuJysis ,)f' variance (ANOVA: 95%, c,-,nfidem;" 
imcl, "I). t" llo,\\;d by I u"~'y-K mnler multipk t:')!l1parj~on lcsl 
Values ,\£'" -: (I 0 5 wen:: taken to imply sLatls tical ~igJli lkanCt: , 
Results 
Isolated muscle experim en ts 
G uillea-pig i,~nltlfed. eieclrlcltJlytfrlvell left. 1'II11I ,I:poJ/t"ne-
ollsl), bentillg right atrial fllllSelf! prl!J)rtrtlfitW$ 
SequenLial aJmi nisu'utions 1n lht: l'ath lJu id or ,.,.Ia ti"..:!, Ie,\\, 
It> high C011Cel1muions of APE (25-400 I1lgitnl) ~ i l:!IlUi~.mtl) 
rcau 'd (p ""- 005 (l,lIO.l ) or al>Cllish~'d (h~ f( ,!'Co;; of contrac-
t i in S (l( guinea-pig. iwlmcJ dcclricnlly dri en lett ulr ial muscle 
pr,'pardt iuns in :.l c<..>Dccntration-rcl.ttcd manner (F ig, I). Tilt! 
o"'gativc in<>lro pi<.: d kcl (If.!\PE vn these m L,dc s trips, wa .. nlll 
alle'lcu P: pri,'r e:-u.'go.:l1C'ltS administration ~ f ;lU'opine l t d R, 
7. - 10 '-.:p '" 10" M ) to th.:: hath t1uid. 
At lhe samo:: concentration runge, APE also s ign i fican ll~ 
n:d I ed I.P < 0,05- 0,00 I) t)t aUQli' hcd lhe miL: •• 1' cuntr.l{;-
tions ojf ~uin..:a- pig is<,lated, s"XlIlLMentrsly beating right atrial 
mU::ick pl"CfKuTllions ill ~I conct!Jllral i"n-depcntlen( manner 
F ig. 2t. ~ljl1el1tial admtni~'tratiIH1 $ to the hUlh fluid of high 
(;<) nc.:nlmlioll$ or APE (> 400 mg/ rnl) always pn:,t1U('IlU ear-
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FIQ, 1. E!1e~ls of graded concentrations of APE on 
gumea-plg Isolat ed, electrically driven left atrial mus-
cle ~trips. Each value represents the mean (:t: SEM) 
of eight to 1 0 observations, while the vertical bars 
den a t.!., standard errors of the means (.p < 0.05; up < 
0.01 ; p < 0 .001 vs control). 
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diac arrl\vthmi,t,,; in Lh<:. r rl1usde strips. II"w<:\ cr. the I'1cg:llivt: 
chr"'Hlln~pic ci!ect of A Pt-, was nol anwgonis..:d b:r alre'pine. 
which rclluo:d o r ab.,lishcd the ne!,\ativc chmlllllropic .::nCr.:1 of 
.lcctdch"linc (ACh. 7.5 ~. I (I - 3.5" 1 0" \\ I) l\ll ~i\; ulher such 
t11us~h:: pn:pamlions cxamiJ11.!d. i"PI: significantly rCdth.:cd tp 
< (t.ns (l.OU I ) r ah,\lishcd. like prnpronol<ll (10 " 10 ' I'v!). th..: 
P{)~ili\c inolropi.: m u chrollPllYlp C cffCCl~ of noradrenalin' 
(" !\ . I- I on ~I .1) un ,111 th'" ,.[her 'ight i. (l laled mrirtl I11U:<C!c 
:ilrips tc,.·t<:d. rhe ·:".:[I';)C{ :1 1,,0 ~igni fic::,ntly fp '" n.OS-U (10 I 
inh ibilc or "holish..:d cah;iu01·inuuceo (C,,'· .. - .+11 noM I p,,;.i-
th..: inou,opi • CUIO chI'''' vln 'P'I<: n.:spon~,· ''''I ,III tI,,: l.lher nil\\" 
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Fi g. 2. Effects of graded concentrati ons of APE 
on guinea·p ig isolated, spontaneously beating right 
atrial muscle stri ps. Each value represents the mean 
(:t SEM) of eight to 10 observations, while the ve·rtical 
bars denote standard errors of the means (*p < 0.05; 
' . p< 0.01 ; "'p < 0.001 vs cont rol). 
z . 
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Fig. 3. Ef1ects of APE (400 mg/ml) on rhythmic, myo-
genic , spontaneous contractions of rat isolated portal 
veins. Each point represents the mean (:t SEM) of 
eight. to 10 preparat ions, while the vertlca.1 bars de-
note standard errors of the means • 
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Rllt is(I /llIeri porlal I'erll 
&:'-!u"'nlial aomini:!tt\l.tions lei th.: bath l1uid of ro.:l4lti ... ..:Iy low Il> 
hid1 "om;cntr.Llions or APE (25 ·IOf) mg/ m l ) alwi.1)s induccd 
c, ;-;'cenlr.Lti\.n-Jqx;nJem .. bi phas i...: dlccl.s ( Ir\ lh..: ampl iluJc :mu 
IT..:qucnC) Old,.: rh) hmic. myogenic: contraction: ·.,rthe raJ. i:;..· ... 
lal . .:d porw..! \I.!in~ . The h iphas ic c(l"ct Ill·odu.:cd hy APr..always 
(;,msi;;teJ "ran initial ~Iight but signilkant (I' < O.O-) C<llltru • 
li.on (stil1'lulali,ln) "I' short d JrnLi,..,[1. foHnwed 0) a ~c .moal}. 
!tmg.c:r·la~ling. and significant (p "- O.1l5- <J .O(l I ) n.;luxntion 
ItnhibHion) of" tho: vascular muscle prcp:rr()ti,)I1 ( l"ig. 3). /\1 the 
NUllC .... l neentrutinn mn;;c. A PI:'; .. b(1 IOhibtt(",{j <'r ab,)Ij "hcd in 
" ,:nm:cntrtliion-d ' Jx:nd 'J)\ tl1 :.um.:r. I.-ontrnctions uf th.: VC Il Ul!, 
nm~ck P"Ci'lUrClli('n;; indu cd by nl lr drcnal inc (I I 00 j.l~,ll or 
I)!*l,~ium (" 1llf\1). 
\ Vtw!e lI !lima l e.xln"rim ents 
:rs1emic arler'i,,1 b /o (l(/ p reJ.'SII res ({li d /rellrf TITle:> of rats 
A,·ut..: illtravcJlnu.., :Idminisl t"at ions of i\pt: (25--.+00 mg/l;g i\ J 
illt" ~H\nc~llldise(t hyp 'ftcllsiv\: L)nhl ~tlt-sen:itivt:' raL" [,rll' 
Olll: '0 ,iI.l!\l:"rl!lalcJ. signilicanl n.:ducliuns (p < 0.0:5 (l.UO I) in 
l.h.: ~) slcmiL- :.uiai;,1 hl<'uJ prcs.,>un: and h.;art mll::s ,)f the ral~ 
I r"b lc I). '1'1)(' lr ..lI1"icn t 11) IX'lellsi"" (a lHihypalcm;ivc) effec t 
of Ih..: ' \.trae( pcrsisted tor !';Cven I I 45 min. dep nding ()n the 
. P[ O,',s.: aOl'ninis lcn:t1. Furthe mmrc. th.: cx t r".lCI dCls<,:-cl ' p<..'t1d-
I:nlly inh 'h ih:U or a/1olish(:d th.: prcss\lr ..:Ilee(." of' n,'raclretUl.linc 
\0 .5 --1.0 J,.lg. : k~ iv I on "yst~mic art.erial blood pl'cssur" and heart 
rat..:::; of the al1iJ1lut~. Pn~lrculmenlllr Lhe anaesthetised. h~ pcr-
tcnsi\ c 1'".11...," iLn ~lr(Jpinc "wphatc. ( 1.5 mglkg ip. 18 Il,24 h" urs 
1,<:\,.1'1: US<.: I abolish·J (I" murkedly rcdu(;cJ.thc o t:prc$s()r 'n;; 'IS 
"j' u,;etyl 'h" l im: (1I.5-1 .11 ~lgikg iv) elll lhe SYS\<'111 ic un..:riul 
[,1.",,1 prL~urc and h¢'Jrt \'Ill.;'';. I I"wc\ cr, the oJ 'prc~or ..:Ilbcls 
of A PI: rJn s~ lit 'mic arkt;al bt.}I)lI p"","'\.~un: and h...:an flIt·~ ,,1' 
the nils wen: I1N ani:cted b) prclreCllmem 01 (h<, ;;mima.b wilh 
aU'npinc <;u lphule. 
Discu$sion 
The rO:"'\.I I~ ,thtnillnl in this $ludy show thai n~lative l ) 1,\\" to 
h igh conccntraJiuns \If II 11I:! ltIeroo:ullidl!1l corm ':l.tmct pr(l-
d\lccd dl)~c-rekllcd. ~ig,lIitic;.lt.ll rcdllClj~Hl$ (I' < O.()5- 0.0(J I ) in 
~ystcmic atlaial blu<..J prc:"sure und lleun nitc~ "r LlIl: arlac,,,," 
tl1'lisee!. h) P('I1~rlJiiv r,\t· \ls~d. \Vhile biomt:dic.ll lit.:r..Llu,'t.' 
aix'un . wilh inionn"lion n the ~h<.:mb1r)' and some ph:umu .. 
c.)loilh.-.iI propcrLic~ of African p'HalO ':XlrdctS.' ,. t''' ,: there i~ 
rcl 'lli, dy litlle inf\.rmatilln 0[1 the cardiov;t . .;cular effects of Ihe 
herb in human." · iulJ uthc;J' mammals." 
A llh,)ug.h lhe I~t\::ei:«: I11c(;hanism or th ..: cardinva.,culaJ· 
e Ili:t:ts "f A Ihcan )X'lat.o ill ~"irro and in VI1'O is still ohs lire . i I 
i:s kaT lhlln ih.: ro.:suil . vf til.: pJ\:SCnt stUd) that the «ru:tliuJc-
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pr":-S:'lll'lt anu hypot<!nsive c.!ICt'l.s 01':\ I'E are high I)' unlikely In 
k m~'titaled \, i" the cho linergic m"dmnism, Uur o ns(!rllulion in 
the ill \,1110 is. 'l au:d atrial mils":!.: preparatio ns indkulillg lhat 
the ncg;J1i',,: iflOlr('pi ' :1I1d <.:hrl norropic efrcCL~ of :\PI' wen.~ 
11\ I mo di fied b) b:uh-arp li l!d :llmpinc IUl1her but[f\!s~'S the 
hyp,ltil':,; is of n n-c holincrgic mcdi:ltio ll, 
l'he a nlllgll nism of thl! p.")s ili\~ in tropic :md chnmo-
In..pic cn~t-'tS of nnrnd.rennl inc by PE on is( .rUled :w 'ia If 
gui nea-pig;, ":<'llld, in purt al kaSL h<!: taken In suggc" l (). 
:.tJrt:noci:pli.Ir blod.::lt1e, H'''wvcr. the inh ihihlr;. dlecl" , •• APE 
, .n e .l;· - imlm;cd tl<ISili.c i\1I)U'opic and cl1JlJnutmpic I\':~p\lrlsc:, 
nr Ih<." guinea- pig isoi.alt:d Ulriu) luusdi: stri.p:: \\llulJ lend Il' 
:.uggest a Iloo-sp<.:clfic ,paMl'lOtYlic action If Lhe' plum <:.'\lI'ad 
.'n tho.: 111),><:arJium, Inhi hiti"l1 or n nu.lI\:Il11lin<.: - <In\! 1"'las-
siurn-indlllXd Ctll1tr-,J ,tion;" I.,f th<'" ral isnlm,,1 !'Illial \ 'inl> h~ 
\ PI: \~':>ukl al",) appear to $UplXlrt lh<: Ilon-sp.:cilic. "pasllloIYlit: 
hYrNhc,i ~, 
I'h.: .. b"cn illi 1n lh:u rel..t livd) hil,!h n~n":l'nt rali,\ns ."r i\PE 
('~ .. 00 rng'tnl) lL<;ua ll~' induLl: d c::lTdia' aJTil:-Hl1lli a.' in iSll lal<.:d. 
'r""t(\I)e<~llsly hemin!! right :lIrial m usc les o( guin<:a-rigs is ill 
..:"n",)!UlIlce \\ illl the finding ,If Ker '. who r<:poncd \ elll1i~ular 
ladl) I."ll"dia ,L~ an 'Hh .. 'r"" ' fJi:CI of 'hrOllic inil",li,)n o(i\ Ji-iC:l11 
1>"1111" ICtt, In lho.: Ist,lme i r<>nal \'cil1 \'il~":lIl:u' :'m(\()lh mus..:k 
II cd. A PE \V,'u lu "PI:X;~II' Itt ..:h~mg,,, lhc ph) s icat "I<.I lC func-
lions or Lh..: muse!..: tellS' l1l.:mhrall<; pllll'ntial~, pmlwhly h~ 
h) pcrpolari~ing tll.: ... -.:11;; (If ll", j;<;(\I:n ~u hl(~ld \"o.:<.~c1 ,;tnps, TIlL' 
c'J.rJiodepre"anl dlcl'l" \II' tl • herh extract arc, t hcl"Cft1ft:. like!: 
w I.l<.' partl) mcJialcd th rou::;h (I. f) ,-adrcnoccplt1r h lod;adc, (2. 
Ji~t.:l adion (I n <;,mlr.:u:tilc mll\.:hinc.') lit" tho.: m y,) 'ardn,IIH, ("'t 
inhibitinn (, ( C,,: !lux: antV"r 14) illl<.:ri<:rCI1C': \\ it.h Il.cmbrllm: 
nl(>l~iliSl l l ion 0[' Ca' m:cu"u III maintain lIomml <':(lnU~I,:\ i"n" uf 
Ihe 1"I1)\ 'h.:.ardiun1.~ : 
('O';\7.C": t!1 [II: nose'" cd, in th.:ir :>ludics ,10 pharm,u':(I\"i-
n'lic cilld l.~arJin\'~cu l ar .. ' I)'ct'{ - ()f hypoxP"iJ .: and r<'(I IX:wl in 
~ 'h" 'mil hJ.b,:l<m,;, that pure h} 1 ,'(os·iJ" Jlrmllt,;~:~ nt' ..:arJh va:,-
<: ul.ar dled, wh<.:rcw; pun: ro 'perot caused m"deralc, lJan ,;ic nl 
in Tca,,-:~ in cunhac lllltput. ';'lrokc vnlume and , 'a,:.:ular pressure 
with,'u t an .nnea""" ill hC<Jn f"J.lc fi r fi llin g pr~..;~un::, The im 'csti-
g,aIOr!i, Ihcrd~lrL ~ugg,:sl.:d t ll ;11 r,,,,pcn)1 in n:a'\cu mj ( caniiaJ 
c,)Jlu'adi.lil), "nlC ui~LTqrJIll·i\.'$ t-':lw,'cn {HIJ' r<.:sult", and the 
(indi llg~ of Cu..:t.tct: el ai." 111<1) be Ill<: to \ I ) :-pc.:i"" Ym"imi' lIl 
(f;1L~ and guim:~I-pigs \ s balxH,lns l. lmu en the n lC\ Ihal "'-' llS.:tl 
a crud..: :I11U>;.,lUS CXU';Jel ()C t\ Inc;!n PU!:It(l in our' "tutly, '.\ h<.:l'I::L" 
(\)CUCC tt l a/," used pure hyp()"\:o.~idc and nl' perot. 
rh.: e,(I':1 rnl'ci1iUll!itll thrnugh w hi<.:h lhc pl!ult extra':l lICt:" 
I J.:pn:s:;:-; stcmi..: ; ,lentll hlood pI)l!s.,;urc in the L'xrcrimenl:11 
lJlim',lI m lUI:! usc..! In this .,; tu~jy is unknnwll al prCSCr1l , III 
ph) s i~'tugk-.t1 parl,ml.:":, how\:\ I.:t', the h~ ll\lh:n"i t: ~ 1I"'Cl <Ii' APf" 
is likd) ( I) 1:1..: tluo: , in 1'.111 at Icu$\., tn ;\$ va:;ou il ;lti.lry ili: lion (iL,; 
main, ~ ' ': \>IId''f} .:fk<.:t t)n ral 1 ~\.l 1<:1l 'J POtu! veins), lh rt\ ug h 
\dl ich m Ule it rnJl>abl~ tlcLs ll> ucc rc,l:ic \ a$cull1r r'si,aa nce, 
In th i~ \\:1:- , APE m;!~ lx r..:JUl.:i Hg [nlnl flCdplll.:ral f''''''' I''I1"" 
.TPR ) in lite an:ac ~lho.:li!«: tl r.1b<, Simi la.rly. Lt., .: din~d canlit l-
dc pn;"S:lJ11 dTcc{ 1.'1' (h.: APE rna) kat! If' a n:duc{i, >n In car-
di; l.: OlilrUI ~ CO. via ..I mark,-,j rcJu\.· tion in the he"" ralC, I. he 
,;,'ll1bineJ r~Juclil)f1S in {hI: I"J>R :Old CO \\tHlld "\'h~ '1l1..!nt ly 
''''',1U t ~1 a fall m S) ~ It:mic arterial bk~ .• J prcssurc -- s il"';': ,,,",cri.t! 
bll,,,J pr.;;. -,,' e is <l pr, ,.JUCl II' cal'diuc <J lIlpUl and L"la i p<.'T1ph-
en!i t'l:!-ISlH lU':C., 
T he !! hl!mcrvcal/idca conn has bco::n I'<!p0l1cd l() con· 
lain ph)t(lsl~r'lls ( mainl) j3-siinstero lj and ~o m<.: sLerolins: , . 
I h,wcl'.:r, Ill': .:h.:mkaJ ..:nnslilUCI1l.!S )1" the C{lI1n thUI j,;fart: 
n:sp<)n:<ible I;)T the nhscn ",d cardiodep"e ..  sll.nl. anu hypotens ive 
d ll!c{s vf API: in Ollr stud) iw'arc still unknowll, ,I\\though the 
exact chemical c mpound,s r<.::>pt'nsihlc r r th<." cardk1delm!.-
",lilt ani h) r('l.:nsjyc tTee ls of / \ friean p<')talC'l tiqucoLl :': t!)<tT:.lct 
still rl!mainis ~ p<!'ctl lat ive, <!'x pc r imt!nl=al evid.::ncc oblllincd il1 1ho.: 
pre;;"nt lahnrmof) animal s tudy ;IlJi.:atL':' lhullhe h.:rh p<'ls;;e 'se:-; 
'af'cll(ld<~pn,:.'~lfIl (iJraJYl';lHl ic ) (Uld IrYP',t'-"fLsivc pro pcI (ic~, 
In "ummm). 111~: findings of (hl:; c'(po;:rim..: t11U1 anilllal study 
I 'nd llh"rmu 'u lugk'lll :>lI P IXIr\ lil liJ lldori<.:, Ilnet.:tltlwi. ..:lhn,,· 
m::uical l1St:~ ,). African potatu a~ " lluLUru! SUppk lllCl.llUry 
n; n\<:u> in Ibo:: mall ,lg\;m~nt antil(lr ~''(1I1 U''1 1 or \.;crtai ll .... anlial: 
d~"tunl'li •• n~ <Ind c,scntial h) r..:rtcn$i~l n in ~'m(; nlrlll ('ommu-
nilie.> l>f" Lllhcrn .. \ f'rie~, 
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Cardiovascular effects of Persea americana 
Mill (Lauraceae) (avocado) aqueous leaf extract 
in experimental animals 
JAO OJEWOlE, DR KAMAOYAAPA. MM GONDWE. K MOOD LEY. CT MUSABAYANE 
Summary 
The cardiovascular effects of Per~''''u umericu."u Mill 
Cl.auraceac) aque.ous leaf extrAct (rAE) have been inve.-
tigated in some experimental anilnal paradigms. The 
effects of PAL on. myocardial contractile performance 
was evaluated Oil guinea pig isolated atrial muscle strips, 
wltile the vasodllatory effects of the plant extract were 
examined on isolated portal vcln5 and thoracic aortic 
rings of healthy normal Wistar rats in vitro. The hypo-
tensive ( .. nti~rten5h'e) effect of the 1)lanl extract was 
exa milled In healthy nonnotensive and hypertensive Dahl 
salt-sensith .. e rars in vi.,..,. 
P american" aqueous lea f extract (25--800 mglml) 
produced concentration-dependent, significant (p < 
0.05-0.001), negative Inotropic and negative chronotropic 
,,(fects on glainea pig isolated e1ectricDUy driven left and 
spontoneou~ly j).,ating right atrial muscle preparatio·ns, 
respe.ctlvely. 1\10reover, PAE redu.ced or abolislLed, in a 
concentration-dependent manner, tile positive Inotro-
pic Dnd chronotropic respon es of guinea pig isolat-
ed atrial mUs<:le strips induced by noradrenaline ( A. 
10·'°-10" M), and calcium (Ca"', 5-40 mM). PAE (SO-SOO 
rnglllll) also significantly reduced (p < 0.05-0.00 I) or 
abolished. in a concenrnltlon-depcndent manner, the 
rhythmk. spontaneous., myob>enic contractions of portal 
veins isolated from healthy normal Wistar rats. L·ike 
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IIcetylwoline (ACh, )o-"-lQ4 M), the plaltt extract (25-
800 mg/ml) produced cotlcentrlllion-~lated relaxations 
of isolated endodtelium-containing thorade aortic rings 
pre-eontracud with noradre.nallnc. The vaJiorcla"ant 
effects of PAl!: in the Isolated, cndothellum-Inuct aortic 
rina:s were markedly inhibited or annulled by NG-nitro-
L-orginine methyl ester (L-NAME.. 10" M), a mtrlc oxide 
syntlta5e Inhibitor: Furthermore. PAt: (25-400 mg/kg h i) 
caused dOlle-related. transient but significant reductions 
(p < 0.05-0.00]) in the systemic arterial blood pressure 
snd heart rates of the ao.aestbetlsed normotensive and 
hype.-tcnslve rau used. 
In conclusion, the results of this labot'story animal 
study indicate tbat 'PAE caused bradycardia, valtorelax-
auon and hypotension in tbe mammalian experimental 
models used. The. vasorelaxant aelion of PAE was codo-
tbeliun. der)endell', and was therefore possibly depen-
dent on rbe synthesis and release of nilric oxide (.NO). 
The vuserelaxant effects of 'PAE appeared to contribute 
significantly to the hypotensive (antihypertensh-c) effc.<:u 
of the plant extract. However, Lbe findinas of this study 
tended to suggest: that P american" leaf could be u~d as 
a natural supplementary remedy in ~entlal by~rten­
sion and certain cases of canUae dysfunctions 10 some 
roral Africa eommuluties. 
In our eurrem pbannaCO-chemieal exploration of African 
medicinal plants, we haY<: examined in our laboratories some 
of the frequently used South African medicinal plant! for 
tbcir chemical conslitu=ts and phannacological actions.' " 
m an attempt lO establish a scientific basis for their folk-
loric. elhnomedical uscs. One of such cotn'l'Ionly used 
African medIcinal plants is Persea americana MIll (flllnily: 
ulllmCeae). 
, p. anJcncano.. othen.vise k.no\.VJl a..c; the avocado pear~ 
MeXIcan a\locado and so on. is a medium-sized.. sinRIe. 
lIlenuned.. terrestrial , eroet, perennial, deciduous, everg~1l 
t ree 15-20 m in heiGht. Although 3 native ofCenlml Am(.'lica 
(Mexico), P americana is now found in most tropical and 
68 CARDIOVASCULAR JOURNAL OF SOUTH AFRICA. Vol 18, No. 2. March/April 2007 
subtropical countries of the ",'Orld. The branches are fissured 
and grey. but the t\O.~gs nre green and smooth. The 15- 25-
em long and 10-20-cm broad leaves with well-developed 
jX:tiole:; are ~pirally arranged. often cluStered near lhe branch 
ends. narrowly to broadly elliptical or obovate. and are 
usually lXlimed at the t ip." 
The g.rcenish-yellow flowers a.re borne on bram:hed. 
compa<-"t panicles. which are shorter than UlC Icaves. The 
often pear.sha~ one-seeded fruits are variable in size and 
shape according to the variety. up to ) 8 em long and usually 
shiny and green. or brownish when ripe. The flesh is soft. 
oily. greenish or yellow surrounding one la.rg:e, loose round 
seed." The avocado is now cultivated commercially as a fruit 
crop in many cOUlltrics oflhe world. In many parts of Africa. 
the fruits of the avocado are much wught aftcr by humans 
and some animals as valua.ble foodsnrrr. Besides the oiL 
avocado fruit pulp coma.ins carbohydrates and more protein 
than any otller fruit. wbile ils conrents of viL'lmins A llnd B 
are high. " " 
In addition to the nutritional value of its fruit, ~ leaves 
and other morphological partS of P americana possess 
medicinal properties and are ~ idely used in trodi tional 
medIcines of many Afncan countries. For example, the fruit 
pulp is caren as all aphrodisiac and as an e mmenagogue 
in South Africa, '" while a hot-water eKtr.1ct of the leaves is 
taken orally as a diuretic and for hypertension in many "Vest 
African eountri.:.;." In some other parIS of the world. variOl! 
morphological parts of P americana have been employed for 
a wide range of human ailments . Products of the plant have 
been effectively u.~ed for the management, control and/or 
treatment ofnmenorrhoea, anaemia, insomnia . hyperlipidac-
mia, hypertension. diabetes mellitus. diarrhoea, dyscntery. 
gastritis. peptic ul~ bronchiris, cough, hepatitis, and so 
forth." " 
Pt:evious s tudjes on the avO<."ado have "hown thaI lear 
extracts of P olllerictma possess (I catalogue ofphnrmacolog-
ieal activi ties, including ana.lgesic, anti -innammatory, anti-
diabetic. hypoglycaemic. hypotensive and antihypertensive 
properties. ,,, •• T he present ludy was prompted by the elaim 
of some lraditional Iteallh pr.1ctitioners in KwaZulu-Natal 
lhat decoctions and infusions of avocado leaves are effeclive 
rcmedi.:.'S for the managen'lC1lI andlor control ofhypencnsion 
and cerlain cardiac disorders. 
The aim of the present study "''!IS. therefore, to investigate 
the cardiac. vascular and antihypertensive (hypotensive) 
cHeetS of P americaI/O aqueous leaf extract in experimental 
animal p;uadigms, with a view to providit)g a phum18cologi· 
cal justification (or otherwisei for the ethnomedical uses of 
the plant leaf in the management. control andlor treatment 
of essential bYI)ertcnsion and certain cardiac dysfunctions in 
some rural African communities. 
Materials and methods 
Theexperim..:ntal protOcol used in this study was approved by 
the ethics committee of tbe University of Durban-Wc:stviUe 
and confonns to the Guide to Ihe Care alld Usc o.fAllima/s 
in ReseQf'Ch and T(,-OcJling ." 
Plant ma.terial and preparation 
Fresh leaves of P ameriC<Jna were collected from a play-
growld behind WilIO\vpal'k Centre alon~ Umbilo Road in 
Durban, between lanu.ary and June 2003. The leaves were 
identified by Prof H Baijnath. the former chief taxonomist! 
curator of the Department of Borany, University of Durban-
Westville. as those of P americana Mill (family: Lauraccae). 
A voucher specimen of the plant has been deposited in the 
Botany Deparuneotal Herbarium. 
Roonl air-dried lcaves (I kg) of P americm.a were miUed 
in a Woring commerc ia.l blender. The IXlwdcred leaf W'dS 
macerated in distilled water and extracted twice. on ench 
occasion with 2.5 I of distilled WaLer a t room temjX:rantre fOr 
48 hours. with occasional shaking. The combined di tilled 
WIIter cxtrnclS """re concentrated (0 dryness at 60 ± IOC in 
a rOlary cvlllXlrntor. Frecze drying and solvent elimination 
under reduced pressure finally gave 2l.50 g (2.15% yield) 
of a light-hrown, powdery aqueous leaf extract. TIli s crude 
extrnci was used in our study wiUmut further purification. 
Aliquot portions of the residue from the aqueous extr.lct 
W~ weighed and dissolved in di stilled w-... ter for usc on each 
day of our experiments. 
Animal material 
Healthy male Dunkin-Hartley guinea pigs (Cavill porcel/us) 
weighing 300 50 g, and heallhy young adutl male Wistar 
rots (Rallus nOYVegic.L<) weighing 250-300 g ","'ere used. TIle 
animals were kept under labomtory conditions of tempera-
n.tre. humidity and light and .... 'ere allo",'Cd free access to food 
(standard pellet diet) and water ad [ihilum. All the animals 
were fasted for 16 hours, but allowed free access 10 watcc 
hefore the commencement of our experiments. Guinea pig 
isol:ued atrial muscles were used for the ilZ "lero evaluation 
of the effects ofthc aqueous ex:tract on myocardial contract il-
ity, .... llereas rar isolated portal veins and thoracic aortic rings 
were us.:.u to examine the vasorelaxant effecls oflhe extract. 
Normotensive (nonnal) Wi star, and hypertensive DaIll salt-
sensitive raL~ were used for the in vi~'O invcstigulion of the 
bYlXltensive (antihyperlensive) effect of the aql.leQUS extr.l.Ct 
Isolated muscle experiments 
Gu.inea pig muscle strips 
The guinea pigs were sacrificed by stunning and e.xsanguina-
tion. The left and right atrial muscl.es of the animals were 
isolawd and mounled as prt,'viously d~~ribcu by Ojewole." 
nle isolated left atrium of each guinea piS was impaled 
on a thin platinum wire electrode and suspended under 
an applied resting tension of 1.0 g in 3 30-ml Ugo Basile 
organ bath containing Krebs-Henseleit phys·iological solu-
tion (comlXls ition in mmolli. pH adjusted to 7.4: NaCl. 118; 
KCI. 4.7; Nal-l ,PO" 1.28: NaHCO" 25.0: MgCI, . 1.2; CaCl,. 
2.52; glucose, 5.:5:5) tn3inlained at 34 ± IOC and continuously 
a.crlt ted with caroOl;en (95% 0 , + 5% CO, gas mixrure). 
Each le n atrial muscle preparation W OolS electrically driven 
",ith square wave pulses of 5-ms duration at a frequency of 
3 Hz and 8 suprnmax imal voltage of 5-10 V. delivered by 
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an SRI stimulator. The spontaneously beating right atrium 
of the animal was also set up under the same physiological 
experimental conuilions a nd allO\\/ed to beat spontaneously. 
Two isolated electrically driven I..(t alrial rnusclc strips and 
two isolated spontaneously beating tight atrial muscle prepa-
rations were always set up at a time (one as the test, and the 
other as the control) to aUow for changes in the atrial muscle 
sensitivity. 
The atrial muse1e prepar:llions were left to equilibrate for 
45-60 min (during which time the physiological bath solu-
tion was changed every 15 min) before they """,re challenged 
with PAE or any of the reference drugs used. The tcS! atrial 
muscle preparations were treated with sequentially applied 
graded concentrations of PAE and/or rcfc:rcnce agonisl 
drugs used. whereas the control atrial muscle strips were 
r .... -alcd wilh volume., of distilled water (0.l - 0.6 ml) equiva-
lent to the volumes of bath-applied PAE solution used. The 
electrically provoked and spOntancous contractions of the 
atrial muscles. as wc.11 as the PAE-· ano reference agonis t 
drug-induced responses of the atrial muscle "",pamtions 
were rt:Cordcd isometrically by means of Ugo Ba£ile force -
displacement transducers and pen-writing Gemini recorders 
(model 7070). 
Rat porml veins 
The mt, were sacrificed by stunning and exsanguination. 'The 
abdomen of each rat was quickly opened by midline incision, 
and the intestines \vere pulled aside. The portal vein of each 
mL, with an in situ length of approximate ly 2 e111. was cleaned 
of exlraneous connective and fatty tissues and then removed 
from the :mimal. Each isolated ponal vein was suspended 
under an applied resting tension of 0.5 g in a 30-ml Ugo 
Basile organ bath containing Krebs-Henseleit physiologi-
cal solution. Two isolated venous tissue preparations (olle 
contrOl and the other P. .... E- or reference drug-treated test) 
were always set up in order io make allowances for c hanges 
in the venous lissue senSitivity. Control venous mu.<;cle 
strips were treated with distilled "'3lcr only (the vehicle in 
which PAE and reference drugs were dissolved). Thc vcnous 
tissue preparations were :lllowed to equilibrate for 45-60 
min tduring which time the phYSIological bath solution "' .. as 
changed every 15 min) befOTe Ihey werc challenged with 
PAE or any of the reference drugs used. The plant extraet-
(50-800 mglml) and reference drug-induced responses of the 
venous smooth mllscle preparations were recorded i~ometri­
cally by means ofUgo Basi.le force-displacement transducers 
and pen-writing Gemini recorders (model 7070). 
Rat thoracic aorta rillgs 
The r'<ls were sacrificed by decapitation. The descending 
tJlorocic aurta .of each normotensive rat was quickly and 
carefully cxei5ed and placed in a 'Petri dish filled with ice-
cold Krcbs-Henseleit physiological solution. The aorta was 
cleaned of extraneous fat and connec tive ti sslles and c ui 
into rings :lpproxim:ltely 3-4 mm in width. AU dissecting 
procedures w.::re carefully done to protect the functional 
endothelium from i"advertent damage. In some aortic 
rings, the endolheliaL layer was mechanically removed by 
Vpl 13N022007..".,.., tJ,Q 
gently rubbing the lumjnal surface three limes with distilled 
water-moistened colton wool , followed by six times with a 
smaJI, plastic tUbing. A pair of ral isolated aortic rings . .one 
with intacl functional endothelium. and thc other one wi_th 
endothelium denuded, were always set up in parallel Jor 
:lppropriate comparison. 
Each of the isolated cndothclium-containillg and endotbe-
liurn-denuded aortic rings was suspended tmde.r an applied 
resting tension of 1.0 g in a 30-ml Ugo Ba..,-ile organ bath 
containing Krebs-Henscleil physiological solution main-
tained at 36 ± I'·'C and continuously aerdl(,d with carbogen 
(95% 0 , + 5% CO,)_ Tile aortic tissue prepar.llions were left 
to equilibrate for 45-60 min (during which time the physio-
logical bath olution wa changed every 15 min) belore Lhey 
were challenged with graded concentrations of PAE or any 
of the reference drugs used. At the end of the o!quilibration 
period. the aortic ring preparations were initially contracted 
with both-applied noradrenaline (10" M). 
Endothelial integrity and s uec=l"ul reuwvlll of the func-
tional endothelium was assessed by the presence or absence. 
re..--pectively, of relaxant re;;ponse to acetylcholine pO" M). 
ACh-induced relaxation s 5% was taken as satisfactory 
removal of the functional endolhelial layer. Such endothe-
lium-dcnuded aorrie mliscLep.repardt.iol1s were used in this 
study. After the subsequenl wash-out and equilibration 
period of 30 min, cumulative dose-response curves were 
obtained with noradrenaline in aonic riugs WiUl and WIthout 
cndOlhclium. 
Subsequently. 20-min preLrcatmenl of the aonic muscle 
preparations with grdded concentr.llions of tile pl:lnt extract 
(25-800 mg/ml) wa carried oul betore Ihe next ewnuJa-
live additions of nOradre,nalinc (IO"-IO" M) 10 Ihe bath 
fluid_ After the addition of each NA concentration. a plateau 
response '"-"8$ obtnined before the addirion of the ","'Xl 
higher dose in all eases of cumulatl ely applied noradrena-
line concentrations. Consecutive dose- response curves were 
taken at 30-min inteTV'dls, during which lime the. physiologi-
cal bath solution was ch=ged three 10 five times unlil the 
tension developed returned to basal leve l. 
Following20-min incubation ofthcaorticring prcpamtions 
with the plam extrnet (25-800 mg/ml) , the arterial rel:lXaIlt 
effec t of PAE wa!; e.'tamined on endothelrum-containing and 
cndothelium-denuded a.ortic ring preparalions pre-contr1lctcd 
with sequenlially applied or cluoulatively administered 
noradrenaline (10"'''- 10'' M). The effect of th.e vehicle in 
which PAE and the reference drugs used were dissolved 
(distilled .... ater). W"as also tesled. After each challenge. the 
aortic rings were wasbed three 10 five tirues lWith fresh physi-
ological solulion and allowed to equilibrate for 30 min before 
they were challenged again with any of the reference drugs 
or PAE. The contnlClilc ancVOT relmulnt eiTects of !ill the 
reference drugs. as well as P. ... E-induced relaxations of the 
isolated aortic ring preparations were recorded isometrical Iv 
by means of Uga Basile force-displucemem transducers m>d 
pen-writing Gemini recordcrs (model 7070). 
Whole-animal experiments 
orrnotensive \Vislar and hypertensive Dahl ~ah-sensitive 
rats weighing 25(}-300 g were used. Before Ihe commence-
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ment of our C):pcrim~lIt s. the sail-sensitive rat "''Cre placed 
on 4% saline water and OOnTl81 food (standard pelleL diet) 
for six (0 eight weeks (during which time the a rte rial blood 
prcssureofthe animals rose to between 170/ 130 and 1901140 
mmHg). Salt-sensitive rats wi.th a rteria l blood pressure ~ 
170J 120 mmHg w<:!n: considered to be hypertensive and used 
in chis study. 
Eaeh of the nomlOtensive and hypertensive rats was 
anaesthet ised with intrapcrit.oncul injection of 0 .11 gI'kg of 
Trapana l ~ [sodium 5-etltyH I -mcthy lbutyl)-2- th iobarb itu-
.... "'te]. T he, tight femoral vein was cannulated with a small 
po lythcnc C'd nnula for the. adminiSlration of the plant exlmC[ 
and reference drugs. Tn order to millimise blood coagulation. 
heparin (500 WlitslKg) was intravenously administ.cred to 
the aOllnal. and flushed in with 0.2 ml of 0.9% w i", sodium 
chloride solution. The left carotid a rtery of each nil .... ".J.S also 
cannulated aud connected to a four-cnannel Grass pOlygraph 
tor systemic arterial btood -pressure recording . T he trachea 
of C!lch raL was cannulated for artificial respiration. but the 
animal w~ a l\ov,'(;d to breathe spontoneoU$ly. The rat's body 
temperarurc WdS maintained al 361°C wilh an inC'lndcs-
cem lamp placed over the abdomen. 
After 20 miD sl.abili sarion period systemi' a rterial blood 
pressure (systolic. diastolic and mean anerial pressures) 
and hearL rule of each raL wcrc mensured ancl recorded . 
'nlC effects of PAE and the reference drugs [acctylcholilt<: 
(0 .5-4.0 I-llt''kg iv) and noradrenaline (0.5-4.0 I-l.glkg iv)] on 
systemic a rteria l blood 'pressure and heart rales (calculnted 
from the ECG limb lead Il recording a t a fast paper speed 
of 25 m:mist:<:.) were recorded by means of a four-channel 
Grn..<s polygraph recorder (,model 79D). In some of the rats . 
the hypotensive (depressor) effecL OfPAE (25-400 mg/kg tv) 
was examined after aLropinisation [pretreatment of the rats 
with atropine sulph:llc (1.5 mglkg ip) 18-24 hOUTS be fore 
use] . Because PAE and o the r drugs used in thi s study 'were 
di 'solved in distilled wmer. rats treated w ith disti lled wa ter 
(2 mllkg iv) alone were used as con trol an imal under the 
same experimental conditions. 
Compounds and drugs used 
The rollowing compoullds and drugs were. used: P ameri-
cana aqueous leaf extract, acetylcholine chloride (Sigma. 
England): (-)-nOradrcmll ine hydrochloride (S.ig:ma. England); 
atropine sulphate (Sigma.. England) ; N"-nitro-l.-arginine 
methyl ester (L-NAME) (Sigma. England); Trapanal' [sodi-
um 5-ethyl-( l .methylbutyl )-2-thiobarbiturate) (Byk Gulden. 
KOllslanz.. Germany); (± }-propranolol hydrochloride (Sigma., 
England); calcium chloride and potaSSi um c hloride (Sigma. 
England). The drugs " ", rc disso lved in distiUed water each 
day a t tIle beginning of our experiments. Drug concentra -
tions and doses quoted in the text refer to the salts. except 
PAE. and dt:note fina l organ bath conccmmtion. in the i ll 
virm c.xperimenrs. 
Data analys.is 
Data obtained from rest guinea p ig iso lated atria. rdL iSO la ted 
porta l vein . ROnic ring strips. and anaesthetised normoten-
sive and hype rtensivc rats treated with PAE alone. as \Yell as 
V~ t B No 2 2007.W:to 70 
those obrained from distilled water-trea led control isolated 
atria, portal veins, aonic rings a nd Anaesthetised rats, 
were pooled and expressed as means (± SEM). Statistica l 
comparison of the differences bet:ween PAE- and reference 
drug-treal:ed test means. and distilled water-treated contml 
means. was performed with GraphPad loSt,tt SOfiWMC 
(version 3.00. GraphPad Software, San Diego. Califo.mia, 
USA) using one-way analysis of variance (ANOVA; 95% 
confidence intcrval), folk""'Cd by Tukey-Kramer multiple-
comparison test!.. Values or p s; 0 .05 wcre taKen to imply 
stntistical signi ficance. 
Results 
Isolated muscle experiments 
Guillea pig muscle preparatiolls 
Sequential adrninistrntions LO the bnth fluid of relatively 
low to high concentrations of PAE (25-800 mg/ml) signi fi-
cantly reduc ed (p <: O.05-<J.OOI) or aboli shed the force of 
contrac tions of guinea pig isolated electrically driven left 
atrial muscle preparations in a eoncentrntion-related manner 
(Fig. I). T he nesauvc inorropic c:ffcct ()f PAE on these muscle 
strips 'NUS not affccLed by prior exogenous adnnnlsrrarion of 
at ropine to the balh fluid . 
Fig. 1. Effects of graded concentrations of PAE 
(25-800 mg/ml) on guinea pig isolated electrically 
drIven left atrial muscle &trIps. Vehlcte (distilled 
water)-treated control preparations receIved the 
same volume of PAE solution only. Each point 
represents the maen of eight observations, while 
the vertical b8l'$ denote standard errors of the 
means • • p < 0.05; •• p < 0.01; ***p < 0.001 vs vehicle-
treated control. 
At the same concentrd.tion I'llnge. the plant eoctracl a lso 
significantly reduced (p < 0.05-0.00 I) o r abolished the rote 
of contractions of gwnea pig isolated SpOntaneously beating 
right lUrial muscle preparations in a conccntration-dependen l 
manne r (Fig. 2). However, the ncgative chronotropic effect of 
PAE on these muscle strips W;1S nor antagonised by atropine 
which reduced or abolished the negative chronotropic effcct 
of acetylcholine on six other spontaneously beating right 
atrial muscle preparations examined. PAE significantly 
redu~d (I' < 0.05-0.001) or abolished., like propranolol, [he 
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Fig. 2 . Effects of graded concentrations o f PAE (2.5-
400 mglml) on guinea pig Isolated spontaneously 
beating right atrial muscle aCrips. Vehicle (distilled 
waterrtreated control preparatIons received tile 
same volume of PAE solution only. Each point 
represents the mean of eight observations, while 
the vertical bars denote standard eJ'rors of the 
Means. 'p < 0.05; H p < 0.01 ; ".p < 0 .001 vs vehicle-
treated control. 
positive inotropic and chronotropic eJfects of noradrenaline 
on all eight other iso lated atrial muscle strips tested. The plant 
e"tf8CI also s ignificantly IF < 0.05- 0.00 I ) inhibited or abol-
ished calcium-induccd positive inotrOpic and chronorropic 
responses on "II orher nine atria l musc le ~rrips e.xnrnined. 
Rat portal vei1ls 
Sequcntial administrations to Lho bath fluid of relatively 
low to high concentrations or PAE a l .... 'a)'s induced cone en-
tralio n-<iependem, biphasie effeclS on the amplitude a.nd 
frequency of the rhythmic myogenic contractions of lhe rat 
isolated port'<ll vein . T he biphasic effecL produced by PAE 
always consisted of an initial slight but signiJicant (p < 0.05) 
contraction (stimulat.ion) of short duration, followed by a 
secondary longer-lasting and sigl1lficam IF <: 0.05- 0 .0(1) 
rela.xa tion (inhib ition) of the venous muscle preparations 
(Fig. 3). At the same concentration range, the pliUlt ex.lnlel. 
also i_nhibited o.r abolish ed in a cOllCentrarion-dependent 
manner, COntrd.cliollS of the venous musc le preparations 
induced by noradrenaline or pOIaSl;,ium. 
Rat aortic ring strips 
Cumularivo addition.,> of g,rad.ed concentralions of noradrena. 
line to the bath ~uid provoked conccntmtion«pendent 
contractiOns of both endorheli llm-comaining and endollle· 
liulI'I-denuded noml0tensive rat isolated aortic ring strips, 
wilh a maximum of 3.76 ± 0.30 g tension developed. 
Acetylcholine provok.ed concentration-re laLed, .;ignificam 
relaxations (p < 0 .05--0.00 I.) of endothcli.um-eont.ainiog 
aortic .ring prepamtlons pre-contracted with bath-app lied 
noradrenaline, but did nc t sign ificantly relax. IF > 0.05) 
endothelium-denuded aortic ring preparalions prc-eontmcrcd 
with balh-applied noradrenaline. 
L ike acetylCholine. PAE produced cOncCmrBlion-depend-
t Vol 111 "')2 2007 1iU,kJ 71 
Fig. 3. Effects ot PAE (800 mg/ml) on rhythmic 
myogenic spontaneous contractIons of rat isolated 
portal veins. Vehicle (dIstilled water)-treated control 
prepaJ'81ions received the same volume of PAE. 
solution only. Each point represents the mean of 
eight to 10 preparations, while the vertical bars 
denote standard errors of the means . • p < 0 .• 05; ~p 
< 0.01 ; n.p < 0 .001 vs vehicle-treated control. 
en!, significlInt relaxations (p < 0.05-0.00 I) or the endOlhe-
Iiu m-conl:aining aortic ring preparations pre-contracted. with 
noradrenaline (Fig. 4), but d id nOI re lax endothclium-<lcnud-
ed aortic ring preparations pre-contracted ,vjth bath-applied 
noradrenaline. Moreover, the p lant ex tract sh ift.ed cumula-
tively .admi nistered noradrenaline ,collCenmuion-rcspo n$e 
curves lO the righl in a non-par.dle! and non-competitive 
fashion. and suppressed NA-induced maximal oontT3Clions 
of endothelium-containing Bonic ring muscle preparations. 
Ten minurcs' prior incubation or the endotheLium-intact 
aortic ring tiSsues with L-NAME, a nitric oxidc synLhase 
inhibitor, inhibited or abolished PAE- or ACh-induced 
FIg. 4. Arterial relaXant effects of graded concen-
trations of PAE (50-800 mglml) on noradrena-
line (1G-5 M}-induced contractile responses o f 
endothelium-intact aortic rings from normal rats. 
Vehicle (distilled water}-treated control prepara-
t ions received the same volume of PAE solution 
only. Each point r9pf'ltlSents the mean of ei ght 
observations, willie the vertical bars denote' stand-
aJ'd errors of the means • • p < 0.05; - p < .0.01 , "'p < 
0.001 vs vehicle-treated control. 
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TABLE I. EFFECTS OF PAE ON SYSTEMIC ARTERIAL BLOOD PRESSUREA."'O I:IEART RATES OF ORMOTENSIVE 





Afi'" m"""1f:nI: (>;IE (25-400 mg/kg i.-; 
50 JOO 200 400 
Sysrolic 61' (nun I'I&) 1245 ± 4 .6 112 .5 4.4 91.6 ± 4 .6· 73 4 4 .1·· 58.5 :t 4 .0'·· 42.6 ± 3.4'" 
Mean BP fmm ~Ig) II 1.4 ± 4 . 1 98 .S :I: 4 .7 84 .3 ± 4 .8~ 66.5 :1: 4 .0" 514 ± 4 .1··· 38.4 ± 3. 1**· 
Diasoolic lrnon Hg) 9 4 .3:1: 4 .0 80.4:1: 4 .2 68.5 :1:4 .0' 56.4 :I: 4..3+' 44.3 ± 4 .3"" 31 .4 :::: 3.0··* 
Heart ..... <: (be,,'''''min) 396.6 ± 18 .6 .364.8 ± 18.2 332.3 ± 15.4' 302.8 ± 14.4"· 2835± 12.3"· 242.7 = 11.5+·' 
''P < 0.05: up < 0.01, ' . '" < 0.001 ' 'S cooU'OI. 
TABLE 2. EFFECTS OF" I' .. U; ON SYSr.EMIC ARTf; R(Al,. BLOOD PRESSURE KO HE. .... RT RATIl:S Or.' HVPERTENSIVK 
a ... rs. £.'\Ctl VALUE ItEPR€S€ '1'S Tff£ MEAN (± SEM) OF OBSERVATIONS FROM EIGHT RATS 
Curdia~,(L5cl,J",.. Hejon: rnannelll: 
.·lftt<r (reulmenf: PA E (25- 4()() mgik!; i ~} 
po.lT/meler cUIl/rol ~/ue.y 2 5 50 100 200 400 
Systolic BP (mmHgl IS8.2 6.4 173 .6 ± 6.6 156.4 :1: 6 .3' 140.6 ± 6.0'" 124.4 ± 4 .8 u • 10L I:l:4.S-u 
Mean BP (mmHg) 146.8 :>: 6 . 1 132.4 ± 6.4 120.6 ± S .S" 106.4:t S.2·· 92 .S ± 4.0"· 76.7 ±. 4.4'·' 
Diastolic (mm.Hg) 120.4 ± 6.3 106.4 :: -1 .0 Q1.3 ± 5 .1· 78 .S ± 4 .4'· 64.3 ± 4 ,2'·· 50.S ± 4 .0· .. • 
Hcan rotc (beats/m in) 424.6 ±20.4 39 1.4 o!:' IS.6 3 6.5 ± 16 .u· 3 18.2 ±IS ,2·· 286.4 ± 14.b··· 2.36.4 :J: I 2.5" r. 
.p < O.US; up < 0.0 I ; .... p < 0.00 I v. contTol . 
relaxations of Ihe endothelium-containin~ aor lic rings pre-
contracted with noradrenalinc. Ten lJ1inutc~' prior incuba-
tion of lhe aortic ring tissues With atropine sulphaLC also 
inhibiled or abolished acetylcholine-induced relaxarlons of 
the endothclium-contajning aorlie rin.g preparations pre-
contracted wirh noradrenaline. 
Whole animal experiments 
Acute imrnvenous administ.ralions of PAE illlo anaestheliset.i 
nonnotensive and hypertensive rats produced tran.sicnt, 
dose-relatcd. significaJll reductions (p < 0 .05-0.001) in me 
systemic anona! blood pressure and heart ratcs of tile nlls 
(Tables I. 2). The trallSiO:.-rlt hypoten:;ivc (ant ihyperrensi e) 
elreet of the plam extract persisted for 12- 85 min. depending 
on the PAE uose admlllistcn.~ Funhennore. the plant extrnct 
dose.-depend.ently inhibited or aboli shed lhe pres..<IOr elrcels 
of noradrenaLine on systemic arterial blood pressure and 
hear! nllCS o f the a.nimals. Pre.treatment of the nonnoten-
sive and hypertensivc rdl;s with 8Lrupine sulphate abolished 
or markedly reduced the dcpressor cffc.;ls of acetylcholine 
on systemic anerial blood pressure and heart rates of Ihe 
animals. Ho .... 'Cvcr. the depressor effects of PAE on blood 
pressure and heart rates "'ere nOI atT'ected by pre-treatment 
with atropine sulphate. 
Discussion 
Th.e results of lhis study indicated that the aqueous leaf 
extroci of P a/IJcn alia possessed c,u-diodcpressanl. vasore-
laxant and hypotensive (antihypertensive) effects in the 
experimental animal paradigms used. This ev idcnce was in 
agreement with tho! findinc~ of some of the earlier invesli-
gators who have reported vasorelaxanl" and hypolCnsive" 
elrocls of the leaf cxtract in experimental animal modds. 
Furch£ott and Zawadzki" first described the involve-
menr of the endolhelium-derived relaxing faCI!)r (EDRF). 
whieh WllS ubsequently determined 10 be mlric o,,iclc Or 
NO derivatives :>ynlhesised from guanidinc groups of L-
arginine. '".) ' Endothelium-dependent relaxation. which has 
becn demonstrated in many vascular prepar:uionl'., including 
some vein. arteries and microvascular vessels. O¢Curs in 
response to stimulation by a variety of substances. such as 
acetylcholine. adenine nucleotide",,"" thrombin. Subslance P.." 
calcium iOllophorc ,\.23187. b.radykinin and h.isulIllinc.'" TIle 
vasodilaultion cflCcls of endothclium-dependent sub IJlnces 
can be inhibited by several L--arginine analogueb. such 
as N-monomethyl-L-argini:ne (L-NMMA) and N"-nilro-L-
arginine methyl ester (L-NAME).·"~7 
Endothelial niLric oxide plays a vilal role in the cuntrol of 
vll~tor lone and structure.'''''' On lhe other hand vascu-
lar lon~ plays an imponanl role in Lhe regulalion of arterial 
blood pressure. The devclopmcol and maintenancc ofhypcr-
tension has becn sug,g&'ted 10 inllolve II. reduced endotheli-
um-dependenr vasodilator influence on the \'3soulaT tissue.'" 
Impainnent of endothelium~~ent v.lSCular rela.xation 
in hum.an and experimental hypertensiOn has been observed 
by LU$cher and Ya:nooutte." and the ability !)f nitTie oxide 10 
maintain vascular tone has been shown to be deficient in this 
condilion. "" Because NO is a potent vasodilaror. a delicienl 
production and/or release of endothelium-derived NO will 
result in diroinished vasodiIalor tone. thus allowing v3S(;ular 
resistance to rise, and this, in lum. willlcad to elevaled blood 
pressurc: :u.!1 
Relaxation of vascular smooth muscle by NO involves a 
series or Steps. Nitric oxide is formed in functional endolhe-
liwn by the ;!l,."l ivation ofnilnc oxide synthase (NOS). which 
uses L-arginine as a substrate. Once fonned. NO diffuses 
out of the endothelium. with some cnterillS the underlYing 
~8.scular smooth mu c1e where it binds to and activates solu-
ble guanyla\.e cyclase."" This enzyme catalyses the conver-
sion of glJanidine triphosphale (GTP) to cyclic guanidine 
monphos phale (cGMP). which in tum. causes relaxation of 
313(>\)7 6.2'J:III AM I 
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the vascular smooth muscle cells.'"~'-'''-'' 
In pathological cotlditio,'S of thc cardiovas uLar system, 
thc,re is u dysfunction in the integrity of the vascularendothe-
Uum with a subsequent reduction in the releose. bioavailabil-
II)' and/or acrion of ni[!"ic oxide." NO release and fUllction 
have becn shown to decrease in cardiovascuJa,· diseases. such 
as hypertension." atherosclerosis" and congestive heart fail-
ure.. " Therefore the developmenl of vasodilators which can 
'"'-'Store the level and integrity of NO in the vascular system 
wouJd potentially contribute to the treatment of these cardio-
vascular diseases.'" 
In the presellt study, the plant extract , like accty lchOli.llc. 
caused conccnmllion-d,cpendcnt rcla.xation of the normoten-
sive rat isolaied .:ndotheliurn-containinc aortic ring prepara-
lions pre-contracted with noradrenaline. This vasore1axant 
property would appear LO have conrribured. at least in part. to 
the antihypertensive (hypotensive) effect of the plant extr3<..-t. 
T he arterial muscle relaxant effect of the extract disappeared 
by removnl of the functional endothelium. 
Furthermore., pre-treatment of the clldothcltum-com:llin-
ing aortic ring pr<..-par8lions with L- AME. a nitric oxide 
synthase inhibit.or. inhibited or abolished the vasorelaxant 
effect of PAE. Taken together. these observations would 
appear to s uggest that the vasorcia.xam effect of the extract. 
like thal of ace tylchol ine. was dependent on the formation 
and/or synthesis and release o f cndot.hclium-dcrivud njtric 
oxide, since removal of the functional endothelial cells led to 
the absence of reiaxanL response to PAE in the endothelium-
denuded aortic ring preparations. These observations nrc in 
agreement witb the findings of Mart in el at .. ... 19narro tt/ <II .• " 
Kang e( ol .. ~" Baisch C/ ol.~' and Yin f!lol!' 
·nle p.resem study aJso suggests that the endothelium-
dependCfIl vasorelaxant e lTcci. of PAE could be mediated vi.11 
endothel ial 0 sil;.'TliI linl;: in tbe aortic tissue preparations . 
However. the release of endothelial NO and the opening 
of poUlSsium channe ls have also been implic<U.ed in the 
vasorelaxant effects of extracts from some Other medicinal 
plants .- ' 
Noradrenaline-induced contractjons of blood vessels ba e 
been sbown to be part ly due to calcium relea.'>c from intracel-
lular storage sit~ and partly due to th,c in nux orcxtnleeiluJar 
calcium into the ce ll via receptor-gated channels rollowing 
alpha, (cx,)-adrcnocepror acrivntion .. " In tbe present S1udy. 
endothelium-containing aortic r ings pre-conrracted with 
NA in Krebs-Henseleit sollltion with and without normal 
calcium concentra.tions were relaxed by exogenous additions 
of PA E or acetylcholine. Moreover. the non-pamllel shift of 
the noradrenaline concentralion-response Cllrvcs to tIle right 
by the plant <!:X..tr.lct seems to suggCSt a mechanism of non-
competitive a ,-adrenoceptQr blockade. This hypothesis is 
in consonance with the work of Abreu el al." on ethanolic 
extract of ./aI/Up/fO ~:ossyp;,folia linn in rats. 
The findings of the present study indicated that PAE 
induced vasorelaxation in no.rtnotensiv(\ nit isolated ponal 
veins and endothelium-containing aortic rings, and caused 
hypotcnsion in anaesthctised. normotensive a nd hypcrtcn Ive 
rollS . Although a,-ildrenoceptor blockade may ha e partially 
contnbuted to the hypotensive effect of the plant extraCt, 
the ex peri mcnta 1 evidence obtained in 1he pr=nt ~tudy 
tends to suggest that vasorelaxation might largely have been 
responsible for the hypotensive action of the plant extract. 
T his vusorelaxmll effcct of the cxtract was probably mediated 
through cndolhclium-dcpendcnt NO produ<..1ion and cGMP 
release, and not rdated to activation of vascular endothelial 
muscarinic receptors. 
Although the precise mechanism of thc hypol.Cnsive 
action of PAE could not he established in the present 
study, we excluded involvement of cholinergic mechanisms. 
However, a complicating factor In the imecprcUlLion of the 
data obtained in the hypotensive experiments ..... 'as the b,dCiy. 
cardia associated with the reduct ion in systemic a.n.erial 
blood pressure of the rats. Firstly. the reduction in heart rate 
could. on irs o,",,'l). have been the cawe of the hypolcnsion. 
Hov.·cver, based on the results obtained from the rat isolated 
aortic rinl;:s, it would seem unlikely that the fall in arterial 
blood pressure produced by P,'\E wns solely dependent 0 11 
reduc tion in heart rote. Secondly, the observed transient . 
sccondar-y reflex tachycardia accompanying the fall in arte-
rial blood pressure would probably suggest that the plant 
extract did not affect centra.! ca.rdiova5Cular celltres and/or 
brain cardiovascular receptors. The plant extracL may. then."'-
fore, also hnve had a din.'Ct drcct on Ihe sinus node of the 
heart. o r on the central nervous system control machinery of 
arterial blood pressure. 
P otncrlcmto has been reported to co ntain many bioac-
tive chemical CQl11pounds. inc luding polyphel\ulics. lIlrmins. 
coumarins. flavonoids, tritcrpenoids, phytosterols (espe-
cia lly /X>itosterol), biotin. <x-1.ooophcroL carotene, aseorbic 
acid, scopoletin., quercetin, oils. organic GeLds and inorganic 
substances s uch as cnlcium. rnagm::sium. zinc and phos-
phorus."· 1! Howcver. our present slate of knowledge of the 
chemical constituents of the lca.fexLr.lct is limited.lt is there-
fore impossible for u.~ at this stage to identify with cectainry 
the vasorelaxant llnd antihypertensive constituent/s or PAE. 
Although we speculate that one or more of the major chemi-
cal constituents of the plant (namely flavonoids, polyphc-
nols. tannins. coumarins (especially seapoletin and other 
coumarins). tritcrpcnoids and phytostcrols) may possibly 
have accounted for the observed cardiodepressant. vasore-
laxant and antihypertensive properties of the plant extract. 
there are no sufficient scientific data a t present tojustiry this 
speculaJion. However, the experimentaJ evidence obtained 
in the present siudy shO\o\'OO that P americana aqueous leaf 
extract produced signiticant cardiodepressant, vnsorelaxant 
and hyperensi e (antihypertensive) effects in the laboratory 
animal paradigms used. 
In COnclusion. the findings of the ~nt laboratory 
animal study lend pharmac.ological suppon LO the s uggested 
anecdotal ethnomedical lIseS o f P american(J aqueous leaf 
extract a.<; a natural supplementary remedy in lbt: manaSt:-
menl. control andlor treatment or hypertension and certain 
cardiac disorders in some rural Africa communities. 
The authors arc ,-r:ileful l!) Pruf H Baijnalh for the jdentification of ~rxi!U 
amerirwuJ learuS7C:d in thiS Study and 10 Or U Motend8 fOl' nc.r:tS6iSllnoe In 
the ex lnllction p rocesscs. 
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Pn::violl.o ob~c,.vatlon.< indicate (hat FiclIs rluJllningll 
(Blume) 1l-1o.mcc<'\cl stem-bark extracts may b" u<:cful ill II.., con-
rrol of d.inbetes mellitus. Accordingly. we invesrigated in some 
experimenral animal paradiglD' the c[fec l~ of F . thOlmingii stem-
bark ethanulic eXlTI\Ct (.1"1'£) on l'enal and cardiovascular func-
lions 'd' cornplicatjou$ of diabe(e~. Oral glucose to lernnce [MrS 
weee conducted in )<epal"'dtc grunps of Ilon-diabetic and STZ-
1 reared diabetic nUs given glucose land (0.86 g.kg- I • p.o.) after 
L8-h fast, followed by varinu« FTE dosres (6(), 12(). and 240 
mg.klCt). Rats treated with. deionized water (3 rnL.kg-' p.o .). or 
metfonnin (500 mg.kg- I p .o .) IICled "$ untreated and treated poo-
itive conrroL •• re.~pectively. Dlood glucose was monitored al 15-
m ill intervals for the Ii~[ hour, and hourly th.ereafte.r for 3 h.. 
Acute effects of FIE on kidney funct io n and m ean al~erinl blood 
preI:.,ure (MAP) were invesugared in anaurhelized rats chal-
lenged with hYpolonie saline a lier" 3.5-h equilibration for 4 h of 
1 h control 1.5 h trcatmeJ11. and 1.5 h reeove ry periods. FrE wn~ 
added 10 111£ infusal" during tbe treatment period. Chronic e(Ject~ 
of PrE wac studied in imlividoally caged rat< trented daily ""im 
PTE (120 mg.kg- I , p.o.) for (lve weeks. Cylotoxicity of PTE wu 
as .• <:.<:.Sed by dye-reduclion co loriulCrric (M'rT) assay on MOBK 
and LLCPK 1 kidllcy cell line.. expo~etl for 24 h. 411 h. and 72 h 10 
graded concemnllions of the extracl. Myocardial contractile per-
fonnancc .... V;.IS evalualtxi on J'u r i.sohtft'"..d 40ltrinl 1l1uscle siript;. FTE~ 
Addre.~s correspondence (Q ProJeSl<ot" c:r. Mu.<nbayane, D.is-
aipline of Human Physiology, We.LviUe Com pus. S chool of 
Medical Sciences. U ni vel . iry of KwaZulu- N:u:aI. Private Bag 
X5400 J. Durban 4000. S(}Orh Afdca: Tel.: (27) (31) 260 7975; 
Pox: (27) (31) 260 7132; E-mail: mu...3.bayancc@uk.zu .ac.7..a. 
Clnu.~ltbuYll ne@hol1'l1ai l. {""O ln 
like merformin, decreased blood glucose le"els in non-diabelic 35 
and STZ·diaberic Nits. Both acute and chronic PTE rrearment5 
did nol aIfecl renal function. In vit.ro Sltu.lic8 dcmonSI.r.llcd Ihlll 
PTE increased ]\IJOBK cell metabolic activ ity by an avcrage of 
15% (72 h), and LLCPKI microred the conouls . Acute intrave.. 
nO\L< infn..ion of FTB reduced the MAP from LJ9 ± I mmHg (0 40 
98 ± 4 mmHg. 11", MAP also was reduced throughout the five.. 
week experimenlal study perioll. FIE also produceu couccntrution-
dependent. negative inocropic ond chronotropic e(fecls on ml 
i,;ol .... ed. e lccnically driven left-. and spontaneously beating 
eight-. atrial mU:;cle preparation. • . Our cxpccimenta l iinding.. sug- 45 
gest thlll: FTE! possesses reno- and cardia-protective effecIs in 
di"bcle.~ mellitus . 
Keywurds Ficus thl)lln;ng;;~ elhanolic eXtTaC4 w3betos 
mellirus. renal an.d caniiova",clIl ar effecls 
INTRODUCTION 50 
We have previously reported tll3L Fi uS rhmmlJl8ii 
(Blume) [Moraceae) sLem-bark. eLhanoLic extract reduces 
blood glucose ill non-diabelic and diabetic rats after five 
weeks ex.posure.111 Because diabetes is often assochlled 
willl i lupaited. kidney function and cardiovascular disor- 55 
ders, appropriaLe goals in the control of diabetes mellilus 
llsing F. ,lIonningii should include nOl only re.gulaliltg 
blood glucose, but also the prevention or aUeviation of 
t.be.<:e complications. Accordingly. the current sludy W"dS 
designed to es tablish in some experimental a.nimal par,, - 60 
digms Lhe effecls of F. lhonningii bttrk ethanolic ex.rracts 
270 
:2 C.T. ::\!rLL~.abll)'ll:neel ~d_ 
(Fro) not ullly OU hlocl(! glucose. but aho relUll and car-
diovallcular function!>. Thus, the main pllTpose of the 
present study was to investigate the eff~ of sbort-ootm 
(a(lllle) and loug-Ierm (chronic) administruti.on of PTE on 
70 renal :fluid and electrolyte handling. ali well Il~ on bL{)()(} 
Ilressure in male WistaJ" rots. Available evidence. suggestS 
th:ll sOme hemal e tt'ftctS may iJ\t.erfere wjth the COnCCJ1-
tnlting and diluting mechanisms of tubular Ir:mspon pro-
cesses in the proximal tubule and dista.1 tubule ceUs and/or 
75 on other protein components of tubular cell mem-
bnmes.l:t.:.ll Tndeed, previ.ous studi¢;.", in ollr laboratories 
show thllt SOllle crude plant extrnC(, impair tile renal !:tan-
dliug of fluid and e1ectl'Olytcs.f4) Thus, we further sllccu-
h.lled !hat FTE influences tubular reabliorption Ilnd 
SO secretion by alterinlubuJar epilbelial cellI;' viability. 
Tbero:fore, the second I)bjootivc was to :I$S¢$S me cirects of 
FTIl l)ll cell viabiliry on previl)usly validated porcine prox.-
iOla! tubule and bovine distal tubule ceJlliIle.~. Celt cultl,lr~ 
syl;tems provide a good model ft)r the evaluation of cylO-
85 lOAicit)' of various compotUlds. We, lberofore. employed 
the eJlt.ensiveiy used in viltO cell culture te.cbniques oflhe 
proximal (LLC.PK 1) and distal tubule (MDnK) ceHsl$-71 
to study PrE-induced renal effects, 'The technique mimics 
the ill vivo state., as me'~ ceJllines UWlltain similar 010-
9() chemical function of levels of marker enzymes eiliibitcd 
by freshly lsoJa4,.'fJ cells.l lll We also assessed the effect. of 
FTE oil glomerular filtration rute (OPR), au i n.dicatOl: of 
rolla] tubulur fuuclion .f9•I()1 FurtllerltlQte. tbe ludy investi-
gated the influence of PTE. on blood pressure, a parameter 
95 associ;lted with the deteriotation afkKlney function in dia. 
betic patients .f l ll III un eHocl to shed more ligbt on the 
plausible me..:lumisJU(s) through whicb Fl'E IDUY lIl'fcct 
blood presslU'C. we ha c also lnve ligated Ill\!. effccts of 
FTl!! on myocaroilll ctn).tracLilit)' in vitro_ 
100 MATERlALSANDMETHOllS 
Pieces of Ficus tiwnnillgii Slem-barks were identified 
by Prof. H. Baijnatll, the former Chief Ta...oltouulIlICuta-
lor of tho University of Durb-.m-Westville'S Department of 
lOS Bot.<my. A vouella spe<:imen ·of me plaut bas been depos· 
ited 111. Ole University's B<Jl:lny Depa'ftmentlll HCf.'bariurn. 
The slctrl-oarks were Air-dried. at room tempcr.:ttu.re and 
milled into fille powder with a colU01cl"cJal blender. The 
powdered steUl-bark was mllce:rolcd iu95'U ethnnol f Of 24 b 
110 (Witll (lcc:\sio.ual shaking) and filteted. -11l¢ 1lltiate '>vas 
COl\ceuLra.red under reduced pressu.re ill a rolary evaporator 
at 60 ± I CC. Tbe «udc, powdery Firm!! thf)nningii \'lICit!-
bark. ethanoLic ex.tr<lCl (FTE) was used throvg}l()v\ this 
study without further purifiC'dlion. 
Animals 115 
Male WisG!n1ns (250-300 g OOdy weight) maintained 
under Jaooramry conditl()n~ of temperature., l\umidity. and 
12 llligbtl J2 h dark regime at me Biomedical Resource 
Unit, University of Kw.tZulu·Natal, were u.<;ed. TIle ruts 
were exposed to both fuod (Epol-diet 4700, Bpa). South 120 
Africa) and water ad libitum. Ethical clCllfl'Il1ce W8S 
obtained for this study from the l)njvcrsity of KWI\ZlIJu-
Natol's Bthie!! commitl.ee. 
Experimerua1 Design 
Oral glucose tolerance Ie I (001'1') studies were 125 
carried Qut ill male, .no1lt-di:lbctic.and troptoZcQlocill 
(STZ -treated diabeti.c Wistar rats (250-300 g body 
weigbt . In "jvo I'tudies (Ill rennl fU1:lctiml and l»O(Id pres-
sore were catTit..:1 Out in non-diabetic and StreplO:w(ocin 
(STZ)-induced diabetic rats. w hile the in vitro effect.~ of 130 
the lll:mt'$ extract were conducted onlddtley cell lines. 
LLC· PICl and MDBK. Etfects -of Fl"E on myoeMdi"I COll-
troclile perfonnanec were evaluated on t'dt iSQlaled atrial 
muscle strips. 
JmJuetioll ofDlaOOtes MillUtus 13$ 
Diabetes. mellitus was induced in the diabetic 8muP of 
TaL~ by intraperitoneal injections pf STZ (60 mg.kg-' ) in 
citr.tte buffer. pH 6.3. Vehicle (citrute buffer)-treau:d lIlli· 
mals acted as contro'!!l . Animals !JIst exhibited glucosuria 
after 24 h. tested by urine lest strip (Rapidmed. DiagtlQS- 140 
tiCI), Sandtoll, SQuth Africa). were cOllSidl.'TGd diabetic. 
Plasma glucose cQnceotroticm of 25 mmoLL-1 measured 
after one week was con.<d.dered as a stable dial;letic SWte 
bc.1'Ore OU1' expenll1ellud plooodw:cs. 
Series '1: OCT!' 
The tars used were di vided into the following groups 
for OGTT: floo -diabeticoolltrol, treated non-diabetic. 
oontroJ STz.trealed diabetic, and treated STZ-diabctic rats 
145 
(n "" 6 in ench group). Rats lreated wltb deionil-Od w:)te,f 
lICJ:ved (3 UlL.kg-l, p.o.) served as oofUt()l animals. All of 150 
Ihe animals were starved for IS h before being ornlly 
trented with gJlICOl'C (O.86g.kg-l. body weight. p.o.). fol~ 
lowed by FrS at vilriOu.<; doses (60, 120. tilld 240 l\lg.ktC'. 
p .D.) . To establisb whether PTE posse ses pbanl.lacoJogi-
cal acti\'i,des cOlllpa.rable lQ synlhetic hypoglycemic drugs ISS 
hlrMdy ill lise, stUdies were (-~ndueted in separate groups 
of non-diabetic lind S17.R"di:l1)etic r.IL~ (lrally treat.ed w,ilb 
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Pbylomedlcine 3 
l1letfonnln (500 mg.kg-', p.o.). Blooo . unp!es were col-
lected froiJl. the tail veins ur ibe anumlls at IS-ruin intervals 
160 foc the first hour. and hourly thereaf~ fOJ the subsequent 
3 h fur glucosc nlClISu.remculS llSing; 13a)'tt'", glUCO.rlllltcr 
F.Jjte~ (Elite (Ply) Ud.l:fealth Care Div ision, South Africu). 
Acute Studies 
J 65 Mole W 'istar rats were divided Into groups of 
I.ltltrc(lted ooutrol and INa ted ra,ts ttl = 6 in each group). 
Rats were anaestheti7.ed by an inlrdperilOniat injection of 
Ttnp ana! (sodium 5- ethyl-(1 -uletbylbulyl)- 2·llliobarbittl--
nlte, By" Gulden, KOl'luanz, Gertn.any) at d(lSe of 
17{l 0 . 11 g.kg-J and t racheotomized to mailuilin cie<u airway 
cutf)'. 'TIle :right jugular vein W~ cann ulated w ith p<>lyclh-
ylene Ulbi~g (i.d.. 0 .86 Inm~ o .d 1.27 mIn, Portex. Hytbo, 
K ent. UK) to allow )lltTaveoous 11 .• fusioJ\ of 0.077 M Na.CL. 
Til.::. ur inary bladdel: of each tal. was also canuulmed wi'!ll 
175 si.rn iJar CIilibre polythcnc tubing via an in c.i£i<al in tile 
abdominal wull . The Ixldy temperature of ench atlimal 'NilS 
maintnined at 37:t l oe with n heated tahle. 
TI\e c()lfcool group of nina ;.ail (u = 6) as. placed o n a. 
cQntiuuow; infu:rlvn of 0.077 M Nael a~ 9 mL·b-' (H;lrVw 
180 syringe i.nfusion Pump 22). r'OlIowing an initi .. l c:quil ibm -
noll period of 3.5 h. eight oonsecuti "tine oollectiorL~ 
were Ilmde into 'pre-wcigbcd plastic vials:at 30-ruin inJ'cl'-
vals over tlle subsequenl. 4 b for m.easuremCJIIS of urine 
110\v and Nn+ and K+ excretio:n nltes. T h e control group of 
185 ,nus was de.,igncd tQ check Ihe stability of reM I fUJlction. 
'treated Group 
RNlaL t."Jrects of the crude plant' s e;';'Il:nct (FI"E.) were 
studied in a grollj) oJ t atS following (l 3.5 .h equilibration 
period.F'I'B soluti.on was prepal'('d by llSin~ a modified 
190 melU.od thn~ has ~n previously tlescribed. m.ll ) The extr.~ct 
" '1)$ fxesltly dis.!ofved jn d.imelhyl suifo~ide (DMSO. :2 ml) 
and nomtal saliru:: (19 1m) before usc in i::>cll dls,c. Urine 
~'lmplcs were collected fur I h (cQotrol peric:xl.J for measure-
me.llets tt l' urine On"" :trIU Nti" and K· excretion r ,Ue.", foUow-
195 til&- which the cxtrnCl sollltio.n was infused at 0.06 Jj.g·mill· 1 
[()T 1_5 h (treatmellt period}, te,<;ulong in Il tot:\1 dose or 
18 g.k.g- t ([OJ n 3OO-g ;rat), The ani mals wetc then ~witcbt-'d 
back to the infusate ~Iolle for the last 1.5 h (r&:Overy period). 
_00 Tesl grDUp~ of rats we:re lturgically 'Prepared a'S 
dcsctibed, fue lbe relUll studies, e)(.cept \.h::ll it heplttini7..ed 
canllu la (porte. Ld. 0.86 nun ; o.d . 1.27 mm) w.M al 0 
inserted wt() the Jeft oouunon (~tld artet to 'P'-'"'tJlut the 
O"..cording or IDetln ll£lerial blood pressure al 30·min i nleT-
vats (St.allmffl MLT 0380, Ad fnstrumcllts, C01l1p~\tlhle 205 
with the PoweiLab System MIA10lW. A u Iralia). 
Chrollic:. Studies 
Wistnr ratS (250-300 g body weight) \ ere hQused 
i.ndividuuUy at the Biomedical Resource Unit, UniverSity 
.of KwltZul n- Nautl. in Makrolon polycarl)l)nale m e lIlbolic 210 
cages (Techniplats., South Africa) that were e lenl1Cd 
duily. All animal, were maintained on a fl b darkllight 
cycle a.wl aU wed free :)c¢c.s$ to wateI and lQod (BW1-
diet 4700. 8p<J. S IItll. AI:i:~). In tllO e Mlimals ill which 
the effects of FrG were ulVcstlsated, the nits were 215 
tre3.ted with PTE (120 mg.kg- I , p .o.) d;tily fur five weeks 
at 091"100. C()nt;to l ttit.<; were imilarly tr~ted wi lh (U -
tilted wnter ( tllL .kg-J ) . IJr,ilte volume and total urinary 
outpu ts of Na-t an d K + weTe determi n.ed f ro m 24 b sam-
ples for aU groupli . 220 
l\1can IlrICXilil bl(J(}d lJre~UTe (I\f A P) "I'll'" monirored 
every third con eclllive day fur five week." a t 091100 u.siJ)g 
nou·invasive tail cu(f 13¢thQd with photoelectric £CllSO,I~ 
(Iff'C Model 3 1 Computerized Blood Pressure Monitor. 225 
I.iie Sciences. Woodlan.d Hills, Califom:ia, USA). 'The unit 
\~ )rks with Lrrc hal'dll.te ystem to mcaure blood prc;'1-
sure and. b~u;t rate ill conscious rulli. The animllls.bad been 
w:lcnned in an eo.closed chamber (JfrC J\<lodcl 303liC Ani-
mal To:~t Chamber, UTC Life Scicuces, Woodland Hills, 230 
Cnlifontin. USA) for 3(> llitil1 at · :lO·e before taking BP 
to!udil'\gs. 
Terminal Studies 
At the end of the fivc-week plants' e."tl".tcts treat-
m ent per.iod. blood gluooi\c was m.e~lSu.red ITom the tail 2'35 
velns of a1l groups of non-fasted animals u sing Bayer' s 
gillcometer 'Eli te® (Elite (pty) Ltd, HeilJ!b Cure -Djvj -
sion, Somb Afdca). BlOOd amples w.::re a1110 collected 
from :>11 groups of animals by eardiac: puncture into ind i-
vidual ~ne-eooled lle l>arinized, containers. SeplI:ralctl 240 
plasma W~lS un.a1yz,ed for Na"', K', cl'catilline, aad ute.'l 
conccntrati(J1lS. B1000 for insulin \ 'US collected inio 
plain tubes. and Ihe separated serum was stored ill a Bio 





MeIl5ur':A1lent ofFJccl.rolytcs, lt4~I)JjIl, and G1Qmerular 
Filtratioll Rate 
Urine volume WIIS detcmlined gravimellicalLy. 1'13-
250 llnd K ' c()lleelltnltiol\~ were determined by ion activity 
Dusing Lbe Beckman Coulter ~~ynchron LX20 CI ini~1 Sy . 
terlls . USA}. lIre.a Dud cl'C<lhmne umd,yses were performed 
uSing the Beckman COulter iU$l(UJnenL Creatinine esti ln;l-
1100 emp.loyed \he reaction of crea.uuine and sodium 
2SS picrate to foml creatiniue picraIC. Urea estimation 
employed the hydrolytic degradation of urea jl1 the pres· 
ence of lU'e1\se. The methods used Tdlgent kit, tr(l.(l'1 BeclunllU 
Coultxlr, lrelatld . Inc,. and lneaSllred using. Beck.nlal\ 
[=:J Coulter (SYllcbron LX20 Clinical SySt4;J1lS. USA). G lom· 
26if cruw fll lrnlion rdte (GPR). as assessed by creatinine 
c leanlncc, W'.iS calculated from measuremenL,> of urinary 
m'l.d fl]IJSlllll cmtccntroti()ll$ of ct'e8tilline an4urillc no~ 
rotc in the !1Jtll. week. 
Plasma insulin c()tloentr:ntioos were m¢lIcSllred b.y Coat-
Z(,-i' A-Coun.t procedure using II kit from. Diugno tic Products 
Corpor3tk1n, Los Angeles:, USA. This is a solid·phaseradio-
immunoassay procedure hused on insulin-specific antibOO~ 
immo'bilired 10 tlte wl'lll or a. polypropylene tube. 'file lower 
limit of dctt:·.cdon wa." 5S pg.mI;l . Inter- WJd intm-assny 
270 coeffieicJlts of vad:ltion were 8.1 % (n = 20) 3 .11d 8.3% 
(0 ",,'20).respccttveiy. 
SI!t1es ~: Cell Culture Studies 
LLC·J>Kl and MDHK ceJh were grown .and main-
l."lined at 37"C in. B.'lgle·s. MiJliruum Essential MediuIII 
215 (EMBM) (contnining (l. I ml\'f Heres bufl'et) supplemented 
with·% heal: inacuvated footal caU' S.:;r'Ulll, 1% L-
glutaminc. and t% pettSIXep·fungizonc {C«I.,p!ete culture 
medium (CeM)} (Delta Bioprod\JZt.~ South Africa). Once 
,:be cells r"->"IC'..heo conflue.nce. they were detached from !'he 
2&0 culture flask (75 l:"U\l) with 0.025% (wlv) tr 1'sio ;104 
resllSpended ill. CCM. Cell viability was determined in tbe 
presence -of Q.2% (w/v) try-pan b lue in a uaernooywmetet. 
A 200·~t1 aliqUOt of the cell suspension (1.5 x lOt> cells) 
was tran.''iferred into sepat""dle 96-we U microtilcr p lates 
21't$ (Greiner T3io-one GmbH, Gennany). Thereafter, the via-
bility of cells :incubated at 37"C for '24, 36, <"lI\d 7"2 hours, 
conl3ilUIlg various conccmralions ot' fiE iu sepat'atc 
weD.. was l)S$e~ed (0. HID, :lOt), 400, 600, 800, and 
lOOO}JJ mL- ', n "" 6 for eacb dilution). Th(.\ wells were 
290 aspirated after each .illcuhation and wa.<;hed with Hank's 
balanced salt solution ( HBSS). All supel'rtlIla.ms wen'! 
discarded. TIle cells were resusperulC(.\ in 100 J.(j CeM 
containi ng 10 p.l of MTI (3-(4.5-dimetllylthiazol ·2-yl). 
2.,:5--tJiphenyll.etrnzo1ium bromideJ (i.~. 5mg.ml-1 MIT 
salt .in HBSS. Calbiochem. Darmst.'1dt, O~IJ\any) and 29$ 
incUbated for fOUT hours at S7°C. A {ter 4 h. the I»otcs wC-l."C 
ceutrifuged (20 m in, 2000 rptn at room teJlll>eruture). TIle 
$ull'etnatant was rel llOved. and any resulting fOl1:nU7.UO 
~Slals WeT then solubilized with l()O (.d ditnethylsul · 
phoxide {DMSO). After Gue hout, the optical density was 300 
determined p¢ClrophQtometticul1,y using an E.LtSA plate 
reader (Bio·T<!:k 111l>ttIl.lIICIUS) ,H 595 mll and a :rcfemnoo 
wavelengtb of 655 nm. Absorbance was e.x.presred as per-
centage cle.. .wngc activity. Pc.cccnlage ceil "jabllil)' was 
culculttted aq th¢ mean ab~orbance of wnirol ceU!'fll\c:m 3QS 
absorbance of treatt~ oeUs. 
Ser1es 4: J olated Atrbll Muscle Strips 
In order to (hrow some l ight on Ihe pfuusible mcch.a-
nisn;l(S) by which FT'E may tntlueJlce blood pres.~ure. we 
studied the effects of the extract 0 11 mt isolated airial muscle 31Q 
strip. l1le Wistar rut;; used W~':'e sacrificed by slunning and 
c...sanguination. The left lind right atrial mu.~cles of the Mi-
mills were bolated find mounted as descdbed "hy OjewolcP41 
'l'l'lo i ol.ated left atrium of each rat was impaled Olt a thin 
plntinum wiTe electl'ooe ~lJld suspended undeI' aI applied 31 
tc,~ti(Jg tension of 1.0 g :ill a 30·ml Ugo Dnsile orgarl·b;l!.h 
containing Krebs-H e.nseleil physj()logical solution (hy 
composition.. in mO'IQVL N{tC1, 118; KCI, 4 .7; NaH1P04 , 
1.2S; NlIHCO:\, 25.0; Mg~, 1.2; CaCl~, 2.52; and 
glucMe. 5.55 pH adju. ted to 7.4) mainUlined at 34 ± l "C 320 
and eantil\u'()\ls]y aemted ~\titJ\ ~l\rbogCfl, (959'0 O'! + S% 
CO2 gas mixlJ.U'\:). Each left atria l Inustle pn:parution ~Vll$ 
electri.cally dri.ven with $quare wove pol ell of 5 1'Ill eo 
durnti(m m" It frc<\uency of :3 Hz. lind 8upraulwmlll voit-
ag~, <,If 5-.0 \'olrs, delivered by ~\t\ SRl Hi.mulalOr. The 325 
spou\.atlcously beating right atrium of the animal was a lso 
set up uuder (be s .unc pbys.iologjcal, cAperinumtal c<Uldi-
Lions. 'Two i! olated cleotri.caUy driven ,left lltrial n11ll<C\e 
stdps and two lsohned s\XlUlaneou...<J -l>cati llg right :\tl'inl 
muscle preparmiolls. were always set up ata time (ouc 330 
u.sed us Ute test and. the oilier as the concrol) [(l allow for 
changes in tbe ntrinl. p\usele seusiU,· jty. T he !\tml ll'lilsde 
prcparnuQo.s were left to equilibrate for 45-60 ruin (during 
which tillUl the ba thing physiological sulution was 
cb~lJ\ged every '5 min) before they were cballenged with 335 
FTE or any of the reference drugs used. The te,~t a trial 
rnll~cle preparali.Oll11 wen: created witb SC{luclltia]/y 
app,lied. graded conce.l.ttr.ilions of Ihe ~lru.ct tmdlor rofer-
ence drug.'i used, wllile the ooll.t:.rol atrial JJI.uscie strip~ were 
trented with voltJmes of dL~lU\ed water cquiVll.lent to the yolo 34{) 
UU\£;S of bath-applied, PTE (5-80 g.fnL - I) .. 1'he electrically 
provoked and S1)(lnUin.oolJ~ conh-ncliollS of the au;l;.'ll mus-
des, as well ll."1 the PTE- (aud rofeI'cncc drug)·imluccd 
_____ • ___ ._ •••••••••••• _ •• _ •••••••••••••••••• 0 •• __ • ___ ,._ •••••••••••••••• _ •••••••• 
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respcl1Ises of Lhe atricl Illuscle prepurutions, were recorded 
345 isor:n~trically by means of Ugo Basile f()rce'(\i~placement 
transducer. and peu-writjng 'Gemini' rcccrders (model 
7070). 
DATA PRESENTAT10N 
AU data are ex,l)tesscdas means ±Slandard error of 
350 means (SUM). eel[ viability was c:l.pressed as II percclll-
4ge relati ve to conrrol <:eHs not exposed to any of the teSt 
compounds. pam oblnined from te.~l r.at isolated atria 
trea'!ed wilh PrE alone. as well as those obtained from 
deioo:i:r.ed W3f.(-I· trenlt~d control iltrial strip". were pooled 
355 and compared with those of rcfcreoce drugs. A S;ti.tistic..11 
compari (In oflhe difference!'; betweenFfE atld respCClh"e 
controls was performoo WiUl GnrpllPad (uSLolt Software 
(version 3.00. GraphPad SoftWtlre. Sun Diego. California. 
nSA) using one-way naly. is of variance (ANOVA ; 95% 
360 oollfideucc inteJ:'V1l1), foUowed by Tuke}·-K.rilluel' multiple 




365 Figure tA com.pates tire OGT'f responses in aculely 
trcaled mm-diabclic r.tt.<; with. respective ootllrol altUllal , 
Or'..tJ administration of yariou.<; dose..<; ofFTE (60, 1:20, and 
1;4() rog.kg- I) decrensed Ihe blood glucose cotlcentftttiotl.$ 
m ;) dosc-<lepeIl.oollt manlle.t, with all doses ex.enhlg maxi-
370 mum effects after 60 mill. The hYJXlglycemic effec:tof 
FI'E wa still . iguill nl by tll.¢ eud of the 4 h ex:perimen-
tal period A similar pattent oC hypoglycemic effects was 
observed with metfOlwin. Ulltrcatedoo!ltrol,tQn-diabetic 
mi. -e;o.hibitcdsigniliCl"tIlUy high plasma gLucose con centra-
315 ti(>ns I»' eomparison , ith U'oo.ted animals. Tbeplasma glu-
cose ooncen.uatiOI). of the controL Ilnlt-dIabetic rats 
increased. to 6.S ± 0 .3 mmol.L -I by 30 min from a baseline 
value of 4.2. ±O.l mrnol.L- ' be.fore s lowly declining to 4.3 ± 
0.1 mmol.L -I (n ;:: 6) after 4b. a value that was Sigllifi-
380 cantly clew,Hed whe't oompared to nnirn:tl M.fI1inistcred. 
the highest d.uiie of .PTE allhecorrespondint period. 
Silnilarly, I.beor..tJ adnuwstratiOil of vaOOllS doses of 
FTE (60, tW, and 240 I1\g.kg-') decreased !:be blood glu-
cose ooncCIltrotioll .. 'l of STZ·treated dillbelj tllts in II dosc-
385 de~">CndeJ\L Ill;)U1:le(" by 45 min until the end of the 4 h 
~riruental periOO (see Figure I B). Tht glucose COltCCIl-
tr<ltions of STZ- tr=ted diabetic contm.1 llTlimals omlly 
loaded ",ith glucose did 'lI(lt signirlCanUy d.eclille by the 
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Figur-e I. COl(lpaJisuu of OmT .resp<msC!; in SCI)lltale ;roups 
<If (A) non-diaberic and (:6) Slrept<nalacin (STZ)-t.realeil di~betic 
crus tcealed wlrh graded dosl>s of F'I1! wilb l..'Otttfol IlIIunals 
ucnll,,1 wilh deloni~d >VlIlcr or 1)Q$ilivc OO(l!roll' l.tl:~1 with 
mar!'ormin. V:uucs are pres.mted ;is In~l.l.~ . "ad vC:tticiIJ bar!' 
indiClHC. SB of menn.~ (.n = " in eooh gcou~ ). "'/) <: 0.0 I t> 
OOllljlnril1011 ",jIlt OOhfl()1 animals . 
marked reductions in blood glucose concentrations Py 390 
45 min until the elld ,of the 4 ·11 experimental perind. 
10 tlwse Itnim:d in whiell PTE wa~ chroniCtlUy 
rulmirustered OW Illg.kJ;Cl,p.o.) daily for th'o we,~\:s at 
09hOO. tbe ~an -pJasmu coocentnltion of gluco$c wa~ . ig-
l1ificftud)l decrt'"",5ed lnnon-d.iab·etic and STZ- induccd dia- 395 
betic TIlts by the end of the ex pt..-ri mental period in 
compmiS()1l \vil.b respecdveeontrol animals at the corre-
spondiug time (see 'fable 1). 
Urine flow and Na· eJl:.crclion l:aies rauged [:tOm 9 to 400 
to mt.h-1and ,619 to 660 pmoLh:- l • respectively. in vehicle-
~nfused COlHrol animals duJing Ihe 4 b post-equilibralion 
pe;rIOd. vaJues that compared \Vi tb Lhe infuSloil mle 
(9 mL.ll-1 and 693 I1fJlol.h-'. [" spectively). K+ excrClio 
nUe \V"dS rul>O stable tllluughoUl the past-equ'ilibr.nion 405 
period, ranging Cwol.226 to 256 fJ.lnoU.- 1• No si.gnificant 
cbl'ltlgcs i ll renal fluid now and elccll'o lyte excretion nICe!> 
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Tubkl 
Pla~m" lltu!:~e, Nn". K", Ul'ea and areatlnine conccnLcl\liOil.~ and (jf'R in non-diaberic a.r.d STZ·dinberic eontl'ot and 
,'&Jli l\dl'Qini l'lctOO Fl' B C"<:toy third (!t;lMCC'Hivc thy fnr five week- (It '" 6 01 aHtt'rOUI>t<) 
... ..,.----.-~---
NOI.-(ji" bffA'ic Nun-d iabelic S1'Z",lim:>eI.i<:: SYL;-di;lb<:lic 
r-.1ea$Ute control f-TB-trtilted conuo! .PTE-- (tCllUW. 
N;(" (mluol) ,·12 :t -:! 14.3± 2: l<tl ± 1 143±2 
K"(u1moJ) 3.& ± 0 .34 3.2 L.* 0 .13 3 .76 '± 0 .2 1 3 . 1O;t1),0 ! 
UI~I (IJlmol) 15 ± 1 14±'2 :>3 :t; 4 58±S 
C.J'l!mintne (~tmol 97 ± 4 85±2" 102:t 4 94±7'* 
GluooS(;'. (mInot) 7.7 ± 0 .2 5.5± 0.1'" 36 .(d;: O,3 21!.O ± 0-'>"-
GFR (ml.mln- I , 2.<14 ± 0 .02 2.98 ±O.(l) 0 .7 ± 0.2 1.4:t: 0.3+-
-¥--~-.--
"p <: 0.0 ' by comparison wllb. respective control. animals . 
were observed in an'it:nals tbal were ~tculely teNted with 
PTE. Cmn:pared with the control rats. the PTE-treated 
410 anlm:lls81Wo.ed stllble Na+ excretion and urine flow rule, 
Wllich .lpproxhuat d the lnfubioJl rates throllgbout the 
()'Jro.pcrimcllta l perio d . Similarly, the IlLCan weekly uriu.e 
,'olume and t1Hl udnnry Na+ and K + outputs were not sig· 
nificantly d ifferc.nt between arumals chronically treated 
4J5 witIl FTE ( 120 mg.kg- I• p ,o.) . IIltd u;nt.r~at-ed mts, Uri-
nary creatinine and urea outputs were not signiJiC4lUlly 
dIfferent betweeu the contrQl a nd. u-ented t<lts tllooughout. 
the Jive-week e!l.perimenlAl period. However, FTE treat-
ment significantl reduced (fJ < 0 .01) p ill. 111u etc-a tilt i ne 
420 c<mcentralion. unlik~ plasm.1 Ure;! concentr'.:lti()n thal 
was not aJLer~ (lice Table 1) . By the e nd of the five-
week period, FTE admil'llstration significantly e levated 
(p < 0 .01) me GJ?R value i n S1'7 .. tl:eutcd diabetic mis, 
but tbe increase iu llon-dinbetic rots did not achieve sm · 
425 tistical sigtlifieiillce. 
ITeJD()dymuni'C Studies 
The lIcute bliusiQ.n of bypownic $,nl.i ne t.o contl:!)1 an.i# 
mals did no.t now any siguifica nt ru-ja:t ions in the me4Ulc 
arterial bloOd. pressure Lhroug,houtrhe 4-h po t-equilibmtiO,n 
430 1X'..riod. H owever, acute itltr"I"lInOU,~ infusion of FTE at 
120 pg.bi':1 for (,5 h reduced the mean arterial blood pres-
Sure from a mean -Pfc- tre:abnent value ()f 1 19 ± 1 mmH to 
9 ;l;: 4 mmRg (n =6) by the end treatment. The hYPol:¢ll' 
si ve effect of FTE persisted during th e post - lre;ltlllcilt 
4-35 period to :l ulC;m Vlllu\} o f :UO ~\; 4 millRy at the cnd of th e 
experiment (see Figur' 2A). TIll! mean arterial Wood pres-
ure (MAP) «mnge!l due long·terlll (chronic) P T E trcat-
111'::11\$ are s !lown in .Fi&Ul'e 2B. Chronie ll:e;)Ul.lcnt of' the 
rats with PT E (12Q .mg.kg- 1 daily lot five ' .. eek..;;, p.o.), 
440 cau.o;cd s~gnmcant decreases .In '!Io'fAP in non-diabetic and 
STZ-treated dhlbcl1c rats t.hroughout the stoldy period i n 
A 
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Figure 2. Effects of chronic FTfi tJ'(:,.lJ'tlen( all nl' .... Jll:lcri:l;( 
bhx:>d pressures in (A) nOIl-dii\b.etic or (8 ST"kiod~ di:4)(:t;(: 
raiS. Yal'I!Cs a.re presel.ued as meaDS and vert.i~l bal'l< i.mlicalc S8 
of nlt::tms (Il .. 6 in each g:roup) . * p <: (1.01 by cQml':Ui"<lll wirl) 
r .. ontrol an imal. .. 
comparjson wim control ·to ts at the corresponding p e riud 
(Figure '2). 
CIt-Lt, CULT ' ru;;Sl'umHS 
The MIT ::ISS:'Y is aqunntitat.ive <:oloti.metric method 445 
based on the reduced c-leavas: of the. Wl\fcr soluhle 
- --------------- - _ .. _ ..._---_ ... _--------_ ... _-_._ ...... __ .--_._--
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I'hytOluctl ieiro .. 7 
:IYoOll.OtitlrazoliWI1 salt ~ll'T to II purple fOtIll3.zau in mct-
abolically active cells. Tlw MTf salt is actively lram'l-
poTted into 1l1t',tabolic."llly viable cells. Bolli Fjgures 3A 
450 a Ud 38 s lmw tllc viability of LLC-PKt and 1l.1DBK cclls 
treated with various concentrations of FTE arler 24, 48. 
and n . hout~ . l'b~ was no 10 icily noted in both cell 
Hues after treatment with PTE. In Pi.gu.1X 3A, LLC-PKl 
ceU lI1ct,,'bolism was increased witll increased doses of 
455 PTE (600-1000 ~g.1'l1L-l) for all incubation lime peri -
.)ds. In conttaSI. the MDDK cclh (Hgtlre 38) "how 
tucre" ed meulbolislll f()r nil concen.tratlon$ of PTE. 
TItere was a signilic(tnt iI.l.cl'ease iLt o\cl.'lbolism all~ celt 
viability after 72·11 i Jl cubaJjou. willi signifit.:.tuce being 
460 more pronounc.ed at the highestconoe:ntratioll~ (800 a nd 
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Figund. Vl:Ibilily o1(A) Ll.C-l'KI Imd ( 1:» MDSK cell ljne::; 
[reated wi th. PTE. Th.e CIl;J.I.$ were treated ",hil l on. 2(1), 400. 6t){l, 
800, or l()O() J.lg PTE. Cell. \'i"bililY was detumined by the 
T;ryph.ao blue exclusion ;\Sl<3Y. V.3lue~ for u/lrrcafed OlllroJ were 
• .liken as HIO%. Bach. dose mp~ts too lllC<lI' \if six rrt:am)cmlt. 
whit Iht!' "",'li(;<.l b",~ denote 1't.alid4td errors of lhe meallS. 
nat .Iso.luted A tt'iut Muscle Strips 
The cardi,a.c effects of FTE are ~hown in Figure. 4. 
l'bis figure shows that FTE (5-0 n\g~ntL - I) produced 
ool1centr'.l.tinn-.r;clate<i. negative chronotropic (Figure 4A) 465 
an(l inotropic (Pigure 4l3) effect.~ 011 rat lsolar.ed spontatle-
ou..·dy beatiug ri~ht· and electrically dci,,·cu fen- ao:hll tll.Uscl.c 
strip~. respectively. The carillo-depressant effects 01' FIE 
were not modified by batll-,\pplioo atropine (10-8.- 10-0 M), 
IIggesting that the cnrdio-iallibilOry effects of the plant's 470 
extract lire unlikely to be mediated through cbo.linergic 
InecbanisJll . 
DISCUSSION 
In the present st\ldy, we have evalliuted the effects of 
short-te:rfll (acute) and long-tetm (chronic) oxal U'C.'lt/neot..~ 475 
or [licus chomlingii ste.rn .. bnrk ethan.olio OMtract (FTE) on 
cardiovll .... cular sy-!ltems. aud ki<fuey fllnc.tions or rnL~ . The 
major findings of Ihis study, apart from coltflnning our 
previous observatioru of the hypog:l)'caemiceffccts of or.:d, 
administrations of Ihe plant's e.'llr'.l.c1,!t! 8.how Utat F1E 480 
de=ses blood pre..~sure without sigllificant inl1ucnces on 
~. :ac. ==1 ~ .... ~~_uuu. 
c;.1") ~  ___ ... 
i. t -= ~ 5 -00 
t5 '0 () 
.,p. - 100 
- . .. ,. VetlM,..'1e-tta~ted c:::o.o1ro. 
-FlEat""" 
- .- FTE + amr,;in" 
'1!' iguN!' 4. .Bffecl~ tlf I''''luenlilllly aPlllied g.mded ootlCCIi-
trnlion~ o.f f-'TS (5 0 mg.mL"'I) 011 the (A) nile and (.8 ) fOtC¢ of 
conn'llcnons of flU l.s.wu:d ~pontnneoll-"Iy bealing right- <lnil 
eleco:iC'lJly Qriven h, I't-:1tri,,1 ~,ele strip" • . re."l)C'Cfively. e(lc.l'l 
pOint tepteSeru:I; \he Itlealt of 8-10 obse.rvmions. whil" Ih .. 
vertical bars d .. nole , I:m<t:lld erf(tnJ. uf Ii\e. me.an"'. "p < 0 . .05, 
".'>oJ' <: O.OJ • ""*/1 < 0.00\ ~'e.rlrol\ contml. 
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ron.1! function in n<:tr:nlOteo.si ve 1"".11$, "Jll¢ rnauagement of 
diabetes mellitus without s ide clTects is a g.lobal challenge. 
Lhus increasing the dell1ilnd for naluml product!; with 
485 atllidia\>etic aCtivity,ll j, Qlrdiovuscul:'tr and renal compU-
caf.iOll1i ,i[O the major eauses of"m.O'Ctality in diabetes melli, 
tus.fl f•1 V,1e s uggesl that tbe lUie ,of FrE in tlw control of 
diabetes meUitus may be ben.eficial when. hype(lcllsioo 
and. compromised xcillU f unctioll <:o-e",ist. This is signifi-
490 eant. (;{)usiderin.g the face that diabetes mcUilu:s is associ-
ated withc rdiovlIsculrtr complications Iluti ueter.iorntion 
of Iddney dYj;;nun::llo!\. n di)lbetic pati.emsl m and CX-pe(J-
IlIerl.tal aoimli'lsPI-"llll The.refoTe, the Illllnagement. of dia-
beteS with Flu b;!s tile JXltenti~1l to adc1rcs bQto rcna1 aud 
495 cardin asculm: protection. Conventionally, renoproto<:uou 
i ll achieved Ihrough a reduction jll blOQd -pressure with 
antihypertcllSive regimells.!J'· 21-2-11 Of note in the pre.~eIU 
S1udy is the bypotensive effect of PTE witllQtlt altering 
kidney function. in {)(lnl.nl.Sl to 'Previ,ow; reports Qf 
500 imp<liredrenal fun lion following the administl'lltion of 
rome hypoglycacnuc "ll1nt eX.WlCts.{"~·1 A siguific.'InJ 
in~asc i n GFR as <lsse.",~cd by creatinine clearance and a 
conec:nnitalll de(>J'e~l.Se ill plasma crentinillc concentration 
wait obscrvcd for the ST&jndll(,.t~ diabetic group treated 
505 with Fl':B "vcr tlw. the-week period, This findiug i gnif-
iellnl.. given the fac t thaI. some anl.lllyperteusive. lIgents 
e .g .• tllia<cide diurelics) and B-bl<x:kccs inOuence g l.rclI.e-
mic conll:oJ in II deleterious mauner.{Z.~1 Evidence fron~ 
1:>iolJ).edi<:lli liternture sugge I» that SOOIe bero:11 extract: 
510 tUlVe prowcuvc effecls agau l carcllov~scular disease in 
dia\)ele.l;.tUI We and. e\'cral olb¢l' awJII:n:s have previously 
used ctentinine clearance jn TaL~ to monitor GFR. j9-j(), l~1 1 
It is lU;,ely tbat c.bronic PTE treatment increased creatinin 
secretion »1> evide(l~d by i~sed MD13K<:ell metabolic 
515 activity. Howeve,., f~~rtller studies are tequirt'.<1 to est"l;>lish 
the I'neclun.ism(s) tnrQugh which F'T'E reduces plasll:i.a cce-
otinine levels. The cell culture studies provide an c,,-perl . 
mental mooel to IIsseM cytotoxicity and. metabolic activity 
of FTE and the two rena l cell lines. Initially, Ule MIT 
520 ASsay WIlS used as u meas.ure of cell yjabiHty and :pr()IitCr''II-
liou, with. the mitochondrial reduction by sued illite reduc-
tase system beiug the major CQIIr.ri~utor to .MIT 
reduction.f291 However, recent evidence shows that most 
MTT. reduction oecurs extra-mjlOchondrially with MIT 
525 salt eros:s~l\g the ju,taCt plasmn Ol.cfubrancs to he reduced 
iUll;acellularly.f301 Other iuvc tig;ltors bave 110' 1\ that 
most oj" the cellular .re<im;u-ou!l of MTl' are depe.nden.t on 
microsomal cll7.ymes and not only QIl Succin<lle debydto-
g¢.lHlse.nl~lJ I 11li~ rnioroHmwl reduction requit:e.<; NAnn 
530 and NADPi:I and i o.ot a.ffected by n::,<;pi.r.UOT}I inJlibt . 
lO(s.{lll Tliis cleurI indicalC',s ilinl cellula! redt! lioo or 
MlT is l'Cll'd.cd Itlor.c to the g l.ycolytic rate, and rhus 
NADH prOOucl'ion . th~H\ to respi:(»..tjon. nnd i~ th.erefote 
'primilrily a mc..:tsure ()f lhc rail::'; of g lycolytic NADH 
......... ..... ..................... _ ....... _-------
277 
produl.--tiun,u' 1 'Our cell c~lture data clcadysuppoTt thi.." 535 
finding. lIS MIT reduction is in\.Tensed in the pres.ence of 
PTE, especially a t the higher concentr.Jtion.q. Our data also 
c<')lulrm Ihe lack of to".;icity of PTE on renal f;;eJl$ derived 
from 1.\\10 species, viz .• pig. and bo\·ine. The filldings of the 
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A picture of the experimental apparatus used for in vitro studies. The picture shows the 
water bath containing organ baths, a network of tubings for perfusing isolated tissues and 
the force displacement transducer indicated by the arrow on the picture. 
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Ugo-Basile 'Gemini' Recorder 
Figure 36 
Picture showing other components of the experimental apparatus used for in vitro studies. 
It shows stimulator and the Ugo-Basile ' Gemini ' recorder. 
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